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ABSTRACT OF THE DISSERTATION
GLYCEMIC CONTROL: RISK FACTORS, QUALITY OF LIFE, WORKFORCE
PARTICIPATION, AND MORTALITY AMONG US ADULTS WITH TYPE 2
DIABETES
by
Evelyn Patricia Davila
Florida International University, 2010
Miami, Florida
Professor Theophile Niyonsenga, Major Professor
Despite research showing the benefits of glycemic control, it remains suboptimal
among adults with diabetes in the United States. Possible reasons include unaddressed
risk factors as well as lack of awareness of its immediate and long term consequences.
The objectives of this study were to, using cross-sectional data, 1) ascertain the
association between suboptimal (Hemoglobin A1c (HbA1c) ≥7%), borderline (HbA1c 78.9%), and poor (HbA1c ≥9%) glycemic control and potentially new risk factors (e.g.
work characteristics), and 2) assess whether aspects of poor health and well-being such as
poor health related quality of life (HRQOL), unemployment, and missed-work are
associated with glycemic control; and 3) using prospective data, assess the relationship
between mortality risk and glycemic control in US adults with type 2 diabetes. Data from
the 1988-1994 and 1999-2004 National Health and Nutrition Examination Surveys were
used. HbA1c values were used to create dichotomous glycemic control indicators. Binary
logistic regression models were used to assess relationships between risk factors,
employment status and glycemic control. Multinomial logistic regression analyses were
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conducted to assess relationships between glycemic control and HRQOL variables. Zeroinflated Poisson regression models were used to assess relationships between missed
work days and glycemic control. Cox-proportional hazard models were used to assess
effects of glycemic control on mortality risk. Using STATA software, analyses were
weighted to account for complex survey design and non-response. Multivariable models
adjusted for socio-demographics, body mass index, among other variables. Results
revealed that being a farm worker and working over 40 hours/week were risk factors for
suboptimal glycemic control. Having greater days of poor mental was associated with
suboptimal, borderline, and poor glycemic control. Having greater days of inactivity was
associated with poor glycemic control while having greater days of poor physical health
was associated with borderline glycemic control. There were no statistically significant
relationships between glycemic control, self-reported general health, employment, and
missed work. Finally, having an HbA1c value less than 6.5% was protective against
mortality. The findings suggest that work-related factors are important in a person’s
ability to reach optimal diabetes management levels. Poor glycemic control appears to
have significant detrimental effects on HRQOL.
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CHAPTER I.
INTRODUCTION
Overview
Diabetes mellitus is one of the most serious chronic diseases in the United States
(US) and in the world. In the US alone, diabetes affects an estimated 7.0% (20.8 million)
of the total population, and another 54 million are at risk.1 The prevalence of diabetes in
the US is expected to rise in the future given the continued increase in the prevalence of
associated risk factors such as older age, obesity, and minority race and ethnicity (e.g.
Blacks and Hispanics).2 Projections have indicated that the prevalence of diabetes will
increase to 366 million worldwide by the year 2030,3 with 39 million in the US by the
year 2050.4 In the US, the death rate for diabetes increased by 45% from 1970 to 2002,5
and in 2006, diabetes was the sixth leading cause of death in the US.6 In addition to the
high risk of mortality associated with diabetes, diabetes is also associated with great
morbidity and disability. For example, among adults over 20 years of age, diabetes is the
leading cause of blindness, leg amputations, and kidney disease.1, 7 Consequently, both
indirect (e.g. due to disability, unemployment, premature death) and direct (e.g. medical
costs including hospitalizations and treatment) costs associated with diabetes are high,
with the total costs estimated at about $174 billion, of which $116 billion are medical.7 In
fact, the medical expenditures among those individuals with diabetes are estimated to be
more than twice of those without.7 Therefore, the public health and economic burden
associated with diabetes is large and is likely to increase.
Diabetes is generally diagnosed using a fasting plasma glucose test with a glucose
result of 126 mg/dl after an eight-hour fast or by a two hour oral glucose tolerance test
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with a glucose result of 200 mg/dl or more.8 Diabetes is primarily categorized as type 1
or type 2. Type 1 diabetes is the least common, accounting for less than 10% of all cases;
it is caused by almost complete lack of insulin secretion, usually due to the autoimmune
destruction of pancreatic beta cells.9 Type 2 diabetes is much more common accounting
for 90-95% of cases. Type 2 diabetes is characterized by impaired insulin secretion that
could arise due to insulin resistance and it is highly associated with obesity.9 Although
diabetes can be diagnosed at any age, individuals diagnosed at an older age are usually
diagnosed with type 2 diabetes. Regardless of the classification of diabetes, the outcome
is the same, namely high levels of blood glucose or hyperglycemia due to a combination
of an increase in insulin resistance, a decrease in beta cell function, and a decrease in
insulin secretion by the pancreas.1
People can live with diabetes without major complications as long as it is well
controlled and managed. The aim of diabetes management is to adequately maintain
normal blood glucose levels (i.e. 70-130 mg/dl) in order to prevent microvascular (e.g.,
retinopathy, neuropathy, nephropathy) and macrovascular (e.g., peripheral vascular or
cardiovascular disease [CVD]) complications.10 A key element in diabetes management
is glycemic control, which may be indicated by a person’s HbA1c. The hemoglobin A1C
test measures the percent of glucose in the bloodstream attached to hemoglobin
molecules in the previous two to three months, which is the lifespan of red blood cells.
Thus, the more excess glucose in the bloodstream, the higher the percentage of
hemoglobin molecules attached, the higher the HbA1c level. This test has been
considered the gold standard for assessing glycemic control in diabetes care for the last
25 years.10, 11 Although there are other methods of assessing glycemic control, the HbA1c
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test has been shown to be better than serum fructosamine tests because the latter only
measures glycemic control in the last 2 weeks.12 Although continuous (daily) blood
glucose monitoring would provide the most accurate evaluation of a person’s average
blood glucose levels, the HbA1c test is more practical, less costly, and more convenient
than continuous blood glucose monitoring.
Several guidelines for glycemic control currently exist. The American Diabetes
Association (ADA) treatment goals for glycemic control recommend HbA1c values of <
7.0%.9 The International Diabetes Federation and the American Association of Clinical
Endocrinologists (AACE) recommend an HbA1c value of <6.5 %.13 However, an HbA1c
value of <7.0% is not always realistic for individuals who are older and with several coexisting conditions and/or those facing terminal illness.14 Thus, two commonly used
thresholds for glycemic control are a HbA1c value of > 7%, which is generally
considered suboptimal glycemic control, and a HbA1c value of > 9%, which is an
indicator of poor glycemic control and more often used as a target value for patients in
worse health (e.g., greater comorbidity and/or terminally ill).15-18
Research has shown clear evidence of the benefits of good glycemic control in
terms of diabetes-related complications. For example, it has been noted that a 1%
decrease in the HbA1c value can lead to a 10% reduction in risk of coronary artery
disease.19, 20 Moreover, good glycemic control has been associated with fewer diabetic
complications and better metabolic control.11 Studies have also shown that
macrovascular and microvascular complications are related to poor glycemic control. For
example, poor glycemic control has been associated with severe periodontitis,21 incidence
of proteinuria and symptoms consistent with diabetic neuropathy,22 and elevated C-
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reactive protein, a marker of systemic inflammation and risk factor for cardiovascular
disease.23
Given the medical benefits of good glycemic control, strong efforts by public
health advocates and the medical community have been made to improve glycemic
control among adults with diabetes. For example, national diabetes programs, targeted at
the general public, such as the National Diabetes Education Program have launched
campaigns like the “Control the ABC’s” campaign, which stresses the importance of the
HbA1c test, in addition to frequent blood pressure and cholesterol check-ups.24 The
Diabetes Quality Improvement Project is another diabetes program that has been
developed in order to improve diabetes management.25 This program’s mission is to
develop a set of standardized performance and outcome measures in order to make equal
comparisons of diabetes management health care plans across the US.25
Despite research showing the importance of lower HbA1c levels for preventing
diabetic complications and despite public health efforts towards diabetes management,
glycemic control remains a serious public health problem in the US. For example, in the
1980s and 1990s, only about 37% of US adults diagnosed with diabetes had HbA1c
levels < 7% (i.e. optimal glycemic control).25 Others have noted that 18% of the US
population with diabetes in the 1980s and 1990s had HbA1c values of >9.5%.26 More
recent data have shown slight improvements, yet still about 44% of the population with
diabetes has an HbA1c value of suboptimal glycemic control.27
There are several possible reasons why adults with diabetes are not reaching
optimal (i.e. HbA1c of <7%) or good (HbA1c of < 9%) glycemic control. One of the
reasons could be the presence of unknown risk factors for suboptimal or poor glycemic
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control that may be acting as barriers to proper diabetes management. Another reason
could be the fact that information about the known morbidity outcomes does not promote
a sense of urgency to the individuals with diabetes that would otherwise motivate them to
adhere to their diabetes treatment regimen. Thus, it is important to assess potentially new
risk factors for suboptimal, borderline, and poor glycemic control, as well as to learn
about the consequences of suboptimal, borderline, and poor glycemic control other than
those that are traditionally studied and reported (e.g., macrovascular and microvascuar
complications).
The objectives of this study were to: 1) ascertain whether suboptimal, borderline,
or poor glycemic control are associated with factors such as numbers of hours worked,
type of occupation, secondhand smoke (SHS) exposure, and desire to lose weight in US
adults with type 2 diabetes; 2) assess whether aspects of poor health and well-being such
as poor quality of life, unemployment and missed work days are associated with
suboptimal, borderline, and poor glycemic control in US adults with type 2 diabetes; and
3) assess the relationship between the risk of mortality and suboptimal, borderline, and
poor glycemic control in US adults with type 2 diabetes.

Research questions and hypotheses
This research used secondary, cross-sectional data from a nationally
representative sample survey (1999-2004 NHANES) and a prospective study design
(1988-1994 NHANES and its linked mortality file) to assess the relationship between
suboptimal, borderline, and poor glycemic control and potentially four new risk factors i)
number of hours worked per week, (ii) type of occupation, (iii) SHS exposure, and (iv)
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desire to lose weight. In addition, this study assessed the relationship between
suboptimal, borderline, and poor glycemic control and employment status, absenteeism
and mortality. NHANES is a series of population based surveys conducted by the Centers
for Disease Control and Prevention (CDC) and designed to monitor several aspects of
health, thereby providing a nationally representative picture of the health and nutritional
status of the US population.28 A summary of the research questions and hypotheses for
this study is shown in figure 1.

Figure 1. A diagrammatic view of study hypotheses
Research Question 1:

Research Questions 2 and 3:

Employed in
service or bluecollar industry

Greater hours
worked
Secondhand smoke
exposure

Greater days of
inactivity, poor
mental, and
physical health

Suboptimal/
borderline/poor
glycemic control

Greater missed
work days

Unemployment

Desire to lose
weight

All-cause and
CVD mortality

Research Question 1: Are suboptimal (HbA1c > 7%), borderline (HbA1c 78.9%), and poor (HbA1c > 9%) glycemic control associated with potentially new risk
factors such as i) number of hours worked per week, (ii) type of occupation, (iii) SHS
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exposure, and (iv) desire to lose weight among US adults with type 2 diabetes? This
question leads to the following hypotheses.
Hypothesis 1a: Suboptimal, borderline, and poor glycemic control are associated
with greater number of hours worked per week after controlling for potential confounders
such as (i) duration of diagnosis, (ii) body mass index (BMI), (iii) alcohol use, (iv)
greater number of non-CVD chronic conditions, (v) family history of diabetes, (vi)
insurance status, (vii) sex, (viii) physical activity, (ix) diabetes treatment, and (x)
race/ethnicity.
Hypothesis 1b: Suboptimal, borderline, and poor glycemic control are associated
with occupational groups with greater time constraints or demands such as blue collar
and service workers versus white collar workers after controlling for potential
confounders such as (i) duration of diagnosis, (ii) BMI, (iii) alcohol use, (iv) greater
number of non-CVD chronic conditions, (v) family history of diabetes, (vi) insurance
status, (vii) sex, (viii) physical activity, (ix) diabetes treatment, and (x) race/ethnicity.
Hypothesis 1c: Among self-reported non-smokers, suboptimal, borderline, and
poor glycemic control are associated with being exposed to secondhand smoke after
controlling for potential confounders such as (i) duration of diagnosis, (ii) BMI, (iii)
alcohol use, (iv) greater number of non-CVD chronic conditions, (v) family history of
diabetes, (vi) insurance status, (vii) sex, (viii) physical activity, (ix) diabetes treatment,
and (x) race/ethnicity.
Hypothesis 1d: Suboptimal, borderline, and poor glycemic control are associated
with desire to lose weight after controlling for potential confounders such as (i) duration
of diagnosis, (ii) BMI, (iii) alcohol use, (iv) greater number of non-CVD chronic
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conditions, (v) family history of diabetes, (vi) insurance status, (vii) sex, (viii) physical
activity, (ix) diabetes treatment, and (x) race/ethnicity.
Research Question 2: Are a) health-related quality of life (HRQOL) measures
indicative of poor health [i.e. (i) poor self-reported general health and greater number of
days (ii) poor physical health, (iii) poor mental health and (iv) limited activity in the past
30 days]; b) greater days of missed work in the past 12 months (i.e. absenteeism), and c)
unemployment, associated with suboptimal (HbA1c > 7%), borderline (HbA1c 7-8.9%),
and poor (HbA1c > 9%) glycemic control among US adults with type 2 diabetes, after
controlling for potential confounders (mentioned in hypothesis 1)? This research question
leads to the following hypotheses:
Hypothesis 2a: All four HRQOL measures are associated with suboptimal,
borderline, and poor glycemic control, after controlling for potential confounders.
Hypothesis 2b: Greater number of missed work days in the past 12 months is
associated with suboptimal, borderline, and poor glycemic control, after controlling for
potential confounders.
Hypothesis 2c: Unemployment is associated with suboptimal, borderline, and
poor glycemic controls, after controlling for potential confounders.
Research Question 3: Greater mortality risk among are associated with suboptimal
(HbA1c > 7%), borderline (HbA1c 7-8.9%), and poor (HbA1c > 9%) glycemic control
among US adults with type 2 diabetes after controlling for potential confounders as noted
in hypothesis 1? Two hypotheses are derived from this research question.
Hypothesis 3a: All-cause mortality risk is associated with suboptimal, borderline,
and poor glycemic control, after controlling for potential confounders.
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Hypothesis 3b: CVD mortality risk is associated with suboptimal, borderline, and
poor glycemic control, after controlling for potential confounders.

Significance of the present study
Results from this study will provide information of public health significance for
several reasons. First, by using a nationally representative sample of adults, this proposed
study will allow generalization of the findings related to glycemic control among US
adults with a self-reported diagnosis of diabetes. Second, by using a large nationally
representative database, a comprehensive and thorough statistical assessment of the
relationship between potentially new risk factors (e. g. type of occupation, hours worked,
secondhand smoke exposure, and desire to lose weight) with suboptimal, borderline, and
poor glycemic control, while adjusting for potential confounders, will be possible. Third,
by studying the relationship between glycemic control and HRQOL, as well as
employment and absenteeism, a better understanding of the overall well-being and the
disability/dysfunction associated with poorly managed diabetes will be gained; thus,
providing an estimate of the impact of disease that is not obtained in traditional morbidity
and mortality outcome measures.29 Fourth, by studying the association between glycemic
control and mortality risk using prospective data, the long-term benefits due to good
diabetes management will be elucidated.

9

CHAPTER II.
LITERATURE REVIEW
Overview
The literature search for this study included a comprehensive review of scientific articles
in English available in databases such as MEDLINE using MeSH and keywords such as
glycemic control, A1C, diabetes management, diabetes control, hemoglobin, diabetes
treatment, among others from all years, as early as from 1950. In addition, articles that
were found to be relevant from these searchers were used to capture additional articles by
examining their reference lists as well as by looking at others who cited them. The
literature review is presented separately for each research question and hypothesis.

Risk factors of suboptimal and poor glycemic control
There have been several national and international studies assessing factors
associated with poor glycemic control such as (i) minority race-ethnicity (e.g. Blacks and
Hispanics), (ii) older age, (iii) male sex, (iv) drinking alcohol, (v) longer duration of
diabetes, (vi) diabetes treatment (e.g., insulin or oral antidiabetic drugs), (vii) lack of
insurance, (viii) having a CVD-related comorbidity (e.g. hypercholesterolemia,
hypertension, microalbuminuria, kidney disease), (ix) positive family history of diabetes,
BMI, smoking, (x) greater physical activity, (xi) lack of adherence to diabetes
management, and (xii) certain non-CVD chronic conditions (such as depression).30-39
Though these traditionally studied factors are important in glycemic control, research has
suggested that other factors such as work characteristics (e.g. an individual’s occupation40
and the number of hours worked per week),41, 42 secondhand smoke exposure,43 and the
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desire to lose weight may also influence glycemic control; yet the nature of the
relationship between these factors and glycemic control has not been well studied.

Potentially new risk factors for suboptimal and poor glycemic control
Work constitutes an important part of most adult lives, and under several
conditions can be the cause of the ill health. Thus, it is possible that glycemic control is
also affected by work factors. However, few studies exist relating work characteristics
with glycemic control among adults with diabetes.
The number of hours a person works is one factor that may be associated with
poor glycemic control. Indeed, it is plausible that individuals working long hours are less
likely to be able to properly manage their diabetes due to the lack of time to check their
blood glucose levels, inject insulin, take oral agents when necessary, or eat well-balanced
meals at regular time intervals, all factors that may affect glucose levels. Furthermore,
research has shown that individuals with diabetes do consider their disease as an issue of
concern affecting the type of jobs they seek, as well as the breaks and the work schedule
they need.44, 45 Although work-hours alone have not been linked to glycemic control, a
related variable, job stress, has been associated with greater HbA1c levels even among
employed individuals without diabetes in non-US studies.42, 46, 47 Job stress, a term used
to describe the psychological and physiological effects resulting from being employed in
a high pressure and pace job coupled with lack of workplace decision or control, has even
been associated with other cardiovascular risk factors.48-51
Work characteristics including the length of and control over work schedules may
also affect glycemic control. In fact, commercial truck drivers reported problems
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regulating their glucose levels and have blamed their unhealthy dietary patterns due to
being on the road.52 In relation to diabetes, certain occupations that are characterized as
having high work demands (e.g. long work hours with limited breaks) have been shown
to have a higher prevalence of diabetes.53 For example, in a study of industrial factory
workers in Japan, Japanese transport workers (e.g. those picking up and delivering
factory materials) were shown to have greater risk of developing type 2 diabetes,
compared to Japanese managers, clerical workers, and technical workers, even after
adjusting for obesity and other potential confounders.54 Industrial male workers and
female nurses have also been shown to have greater risk of type 2 diabetes.41, 55
Nonetheless, office workers have also been shown to be at lower risk for incidence of
diabetes.56 In the only known study relating occupation to glycemic control, which was
based on data of adults with diabetes in New Zealand, the authors showed that glycemic
control, as measured by fructosamine levels, did not vary by type of occupation (i.e. no
difference found among administrative, clerical/sales/service, skilled trades, and
unskilled manual workers).57 Given the few studies relating occupation to glycemic
control diabetes,41, 54-57 more research is needed to determine the association between
glycemic control and occupational factors.
Another factor that has not been fully investigated but is gaining recognition as a
major determinant of several chronic conditions is passive smoking, also known as SHS
exposure or environmental tobacco smoke. Aside from its effects on lung and respiratory
functions, SHS exposure has been associated with greater acute coronary syndromes and
an increase in inflammatory markers.58 Research has shown that there is an association
between diabetes and smoking.59 Specifically, studies have shown that smoking
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contributes to worse metabolic control among individuals with diabetes,60 greater
likelihood of both microvascular61 and macrovascular complications,62 and worse
glycemic control.63, 64 There have been fewer studies on the relationship between SHS
and diabetes.43, 65 Nevertheless, these studies have shown a relationship between SHS and
glucose intolerance among young adults43 as well as incidence of diabetes.65 To date,
there are very few if any studies, to the author’s knowledge based on a robust MEDLINE
search of published articles since 1950, investigating the effects of SHS and glycemic
control.
Another potential risk factor for suboptimal and poor glycemic control is an
individual’s desire to lose weight or control their weight. For example, it is possible that
some adults with diabetes who want to lose or control their weight avoid taking insulin as
recommended by their physician knowing that weight gain is one of the potential side
effects of insulin use.66-69 Thus, not taking insulin when needed may result in poor
glycemic control, particularly if the individual has other unhealthy dietary and eating
behaviors. In fact, poor glycemic control has been found among adolescents and young
adult females with eating disorders70-72 and among adolescents that perceived themselves
as being overweight.73 Furthermore, not taking insulin in order to avoid weight gain is
actually considered one of the DSM-IV diagnostic criteria for bulimia.72 However, there
are very few if any studies specifically assessing the relationship between the desire to
lose weight and glycemic control among US adults with diabetes.
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Consequences of suboptimal and poor glycemic control
Increasing the years of healthy life and improving the quality of life (QOL) are
some of the overarching goals of Healthy People 2010.74 Although the term QOL is
mostly used by the social sciences, in public health and the medical professions, the focus
has been placed on the concept of Health Related Quality of life (HRQOL). The CDC
defines HRQOL as an individual’s “perceived physical and mental health over time”, a
measure which provides a better insight into how an illness or condition can affect
everyday life.75 In general, HRQOL indicators can be thought of as a way to assess
overall disability and poor function resulting from a disease or condition, aspects that
may not be determined when looking at traditional measures of morbidity and
mortality.76 In addition, HRQOL measures can be especially useful when assessing the
long term consequences of chronic conditions since poor disease management can take
years to develop as a clinical or medical outcome,77 impairing a person’s overall health
status and well-being, particularly one’s mental health.
Since the 1990s, there has been growing interest in HRQOL, partly due to the
growth of the US aging and chronically-ill population.76 Consequently, the CDC
developed four “core” HRQOL questions, also referred to as “Core Healthy Day”
measures, which were first included in the Behavioral Risk Factor Surveillance System
(BRFSS) in 1993, and were then included in the National Health and Nutrition
Examination Surveys (NHANES) beginning with the 2001-2002 cycle. These four
questions measure: 1) overall self-rated general health [fair/poor versus excellent/very
good/good]; 2) physical health based on the number of days with poor physical health in
the past 30 days; 3) mental health based on the number of days with poor mental and
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emotional health in the past 30 days; and 4) disability and loss in productivity based on
the number of days with activity limitation in the past 30 days. These core HRQOL
questions have been found to have an acceptable validity and reliability when compared
to the Medical Outcomes Short-Form 36 (SF-36).78 The SF-36 is a validated instrument
with 36 questions about perceived health status and number of disability days, and is
considered the gold standard for evaluating overall health including physical and mental
health.78

Diabetes, glycemic control and health related quality of life
Individuals with diabetes have been shown to have poor quality of life.79 One of
the reasons for such poor quality of life could be the increased number of daily medical
(or health) responsibilities adults diagnosed with diabetes have. The constant reminder of
the importance and necessity of responsibilities and activities such as taking insulin or
oral diabetic medication at regular time intervals (e.g. after consuming certain meals or
performing various physical activities) can take its toll in a person’s life.79 In fact,
because of the potential effects on HRQOL, it is believed that some physicians delay the
initiation of insulin treatment, although a study showed that initiation of insulin treatment
does not necessarily alter quality of life in a negative way.80 Nevertheless, it is possible
that adults with diabetes have poor quality of life because of the health complications
related to poorly managed diabetes, such as retinopathy, neuropathy, and cardiovascular
conditions.77, 81, 82 Furthermore, given that fewer diabetic complications are found among
those with better glycemic control, HRQOL is likely to be associated with glycemic
control. However, the effect of glycemic control on HRQOL among diabetics is not clear.
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Indeed, while some studies have found poor glycemic control to be associated with poor
quality of life,83-85 other studies have not found any association.86-89 For example,
functional disability, which is a component of HRQOL, has shown an inconsistent
relationship with glycemic control among adults with diabetes.90, 91
None of the studies relating QOL and glycemic control were based on a nationally
representative data of adults with diabetes. In addition, the discrepancies in the results of
these studies could be a function of the different QOL measurement instruments
employed. For example, while some studies have used what are known as “generic” QOL
measures such as those developed and used by the CDC, others have used more “illness
oriented” measures that are developed specifically for health conditions such as diabetes
and include the Diabetes Qualify of Life Measure, the Diabetes Treatment Satisfaction
Questionnaire, and the Problem Areas in Diabetes.77, 79 Thus, there is a need of nationally
representative studies aimed at understanding the association between poor glycemic
control and HRQOL among US adults with diabetes using validated measures.

Workforce participation: unemployment and absenteeism
As the US population continues to change, so does the US workforce.
Specifically, the workforce is expected to become increasingly diverse with growing
number of elderly and minority workers. In fact, Hispanics are projected to represent
17% of the workforce by 2020, an increase of 11% from the1980s.40 Moreover, by the
year 2012, there will be over 40 million American workers aged 65 and older.92 Since the
elderly, racial and ethnic subgroups such as Hispanics and Blacks are known to have a
higher prevalence of many chronic health conditions such as diabetes,93 the number of
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workers with these chronic conditions is expected to steadily increase. The consequences
of these increases are likely to adversely impact workplace productivity, resulting in
economic losses not only to the individual or the employer, but also to the nation as a
whole.94 Furthermore, a person’s employment status, and consequently economic status,
may directly influence their access to health care and their ability to pay for medications
or treatment requirements, which in turn affect proper management of the disease, and
therefore may worsen patient prognosis. In addition to employment status, the number of
missed work days is another individual-level measure for monitoring the impact of
chronic disease on worker productivity. Missed work or “absenteeism” may provide a
reflection of the disability that is experienced by diabetics with poor health and wellbeing that may perhaps not be obtainable by employment statistics.95, 96 The disability
and consequently diminished productivity at work may be of particular concern for
employers given the financial implications such as decreased productivity.

Workforce participation and glycemic control
There are various studies assessing the relationship between diabetes status and
workforce participation. For example, studies have shown that diabetics are both less
likely to be represented in the workforce and more likely to miss work,57, 97-99 particularly
among those individuals with more severe diabetic complications.94, 100, 101
What makes some adults with diabetes more likely to miss work or be unemployed
versus other adults with diabetes is not entirely clear. However, one of the reasons could
be a person’s level of glycemic control.
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There are few studies assessing the relationship between glycemic control and
workforce participation. In a double-blind randomized controlled trial of adults with type
2 diabetes, the treatment group with more strict diabetes treatment regimens (e.g. lower
HbA1c target) had a more favorable outcome in terms of retained employment and less
absenteeism.102 In a cross-sectional study of diabetic patients from Michigan, having
more hours of missed work in the past month was associated with poor glycemic
control.103 However, in a study of adults with diabetes referred to a multi-center diabetes
program in the US, there appeared to be no significant relationship between glycemic
control and the risk of days lost from school or work even after controlling for
confounders.104 Thus, the association between glycemic control and missed work days
requires further study.

Glycemic control and mortality risk
Along with improved quality of life and reduction in health disparity, increased
life expectancy is a major goal of Healthy People 2010. Most studies that have assessed
the relationship between glycemic control and mortality have been based on international
studies, adults without diabetes, and/or chronically-ill populations. These studies have
found that greater mortality risk is associated with poor glycemic control. For example,
greater mortality risk among advanced chronic kidney disease and dialysis patients with
poor glycemic control has been observed.105-107 In a prospective study of individuals in
the United Kingdom to assess the relationship between HbA1c levels and all-cause and
CVD mortality (after a 6 year follow-up), it was shown that the all-cause and CVD
mortality risk increased with greater HbA1c levels.108
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Furthermore, most of the studies investigating the relationship between diabetes
management measures (e.g., fasting blood glucose, HbA1c) and CVD events, including
mortality risk, have been primarily of men.108 The few studies that do exist among
women have suggested differences in risk for CVD events and/or mortality, with most of
them noting a lower mortality risk among women.108-110 Some studies have even found a
counterintuitive relationship between HbA1c and mortality, suggesting that strict diabetic
treatment regimes may eventually be more harmful than beneficial in certain populations
such as those with greater comorbidity.111, 112 Thus, more research is needed to determine
the association between glycemic control and mortality risk among US adults with
diabetes.
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CHAPTER III.
METHODOLOGY
Overview
This study used cross-sectional secondary data from a nationally representative
survey sample (1988-1994 NHANES [also known as NHANES III] and 1999-2004
NHANES) to assess the relationship between four potentially new risk factors (type of
occupation, number of hours worked per week, SHS exposure, and desire to lose weight)
and suboptimal, borderline, and poor glycemic control. In addition, this study estimated
the association between suboptimal, borderline, and poor glycemic control and
employment status, missed work, and mortality.

Sample and description of data sets
The National Health and Nutrition Examination Survey (NHANES) is a health
survey developed by the National Center for Health Statistics (NCHS) to gather
information about the health status of the US population. NHANES uses a stratified,
multi-stage complex probability design that allows for a nationally representative
estimation of the non-institutionalized US population.28
Briefly, the sampling scheme in NHANES consists of four stages. The first stage
involves selecting primary sampling units (PSU) from the entire nation. These are
approximately the size of a large county or several small ones. The second stage involves
the PSU units being divided in to small sections, usually about the size of city blocks.
The third stage consists of selecting households at random within each of the sectors.
Finally, stage four is where individuals are chosen from selected households, and
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selection is based on age-sex-race screening strata. Weights are based on the probability
of a person being selected at each of these stages. Sampling weights are created to
provide unbiased national estimates, and are adjusted for non-response and then poststratified to match with the US population census counts of subpopulations.28
NHANES data are collected by a trained team of professionals through a series of
in-person interviews and medical examinations conducted at mobile examination clinics
or at home. All NHANES data are de-identified, with only sequential numbers
identifying each participant in order to protect participant confidentiality. Most NHANES
data files are public-use files and the NHANES files used in this study were all publicuse files that were downloaded from the NCHS website. The NHANES III linked
Mortality File used in this study was the public-use file that contains data of the major
causes of death (i.e. not specific cause of death) from the National Death Index, with
follow-up through December 31, 2000.113 Depending on the hypotheses being tested in
this study, different NHANES survey years were used. The reason for this is because not
all variables were available in all survey years. In addition, depending on the sampling
methodology, NCHS does not recommend merging of the older NHANES (i.e. 19881994) with the more recent NHANES survey years. NHANES 1999-2004 was used for
hypotheses 1, 2b, and 2c for utilized. NHANES 2001-2004 was used for hypothesis 2a,
while NHANES 1988-1994 and its Mortality file for hypothesis 3a and 3b was used.
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Inclusion and exclusion criteria
Individuals with a self-report of diabetes, aged 20 years or older, and not pregnant
were included in the study. Individuals defined as having type 1 diabetes were excluded;
the remaining sample was considered to have type 2 diabetes, as defined in previous
studies.31, 36, 40

Variables used for inclusion/exclusion criteria:
Self-report of diabetes: This was a categorical variable defined as: 1) yes and 2)
no, based to the question “Other than during pregnancy, have you been ever been told by
a physician that you have diabetes or sugar diabetes?” Participants who were diagnosed
with diabetes before the age of 30 (see variable question below), and were treated with
insulin only were further classified as having type 1 diabetes. This definition is consistent
with that used in previous studies utilizing NHANES data and is due to the agreement
within clinicians that an individual diagnosed with diabetes before the age of 30 is more
likely to have type 1 diabetes, but since type 2 diabetes is becoming more prevalent
among youth, taking insulin only is likely a result of having type 1 diabetes.31, 36, 40 Those
individuals considered not to have type 1 diabetes, were classified as having type 2
diabetes, a definition consistent with previous NHANES analyses.31, 36, 40
Age at diabetes diagnosis: This was a continuous variable expressed in years
based on the question “How old were you when a doctor or health care professional told
you that you had diabetes or sugar diabetes?” and asked among all individuals that selfreported being diagnosed with diabetes.
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Outcome and predictor variables:
Glycemic control: the HbA1c value was a continuous variable expressed as a
percentage of glucose in the bloodstream that is attached to hemoglobin molecules.
Suboptimal and poor glycemic control: An individual with a HbA1c value equal
to or greater than 7% was said to have suboptimal glycemic control. On the other hand,
an individual with a HbA1c value equal to or greater than 9% was said to have poor
glycemic control. To be consistent with many of the studies using glycemic control
variables, suboptimal glycemic control was defined as: 1) yes, if HbA1c > 7%, and 2) no,
if HbA1c < 7% (reference group); while poor glycemic control was defined as: 1) yes, if
HbA1c > 9%, and 2) no, if HbA1c < 9% (reference group).
Since a response of “yes” to the suboptimal glycemic control variable actually
includes individuals with poor glycemic control and there are clinical differences or
manifestations between suboptimal and poor glycemic control, a third glycemic control
variable was also created, labeled “borderline” glycemic control, for the purposes of this
study. This variable was defined as: 1) yes if HbA1c >7% but HbA1c <9%, and 2) no, if
HbA1c < 7% (reference group); thus, for this variable all individuals with HbA1c >9%
were excluded from the analyses. All analyses were repeated for this new glycemic
control variable.
In the 1999-2004 NHANES, glycosylated hemoglobin in whole blood was
measured by the Diabetes Diagnostic Laboratory at the University of Missouri-Columbia
using Primus CLC330 and Primus CLC 385 (Primus Corporation, Kansas City, MO)
with a high performance liquid chromatography system among all participants age 12
years of age or older.114 Several quality control procedures were taken to ensure accuracy
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of measures. These measures included verifying and repeating plasma (or blood)
specimens of HbA1c that were above 14% or below 4% (the accepted range for HbA1c
measures were from 2% to 20%).114 From the measurements that were repeated, a few
were selected at random and the coefficient of variation (CV) calculated. The CV
provides an estimate of the amount of dispersion in the measure, in other words, how
much one measure differs from the second measure taken, with a lower CV indicating
lower dispersion and less measurement error. The CV for these specimens ranged from
1.53 to 1.29, which indicates adequate similarity in the specimens when repeated.114
Health related quality of life: HRQOL was based on four different variables: selfrated general health, number of days of poor mental health, days of poor physical health,
and days of activity limitation. Each HRQOL measure, except for the general health
variable, was categorized into three levels in order to be consistent with previous studies
while the general health variable was dichotomized.115, 116
General health: General health was a categorical variable based on the question
“Would you say your health in general is fair, poor, good, very good, and excellent?” It
was recoded to include only two categories: 1) fair/poor and 2) good/very good/excellent
(reference group).
Days with poor mental health: This was a discrete variable expressed in days and
based on the question “Now thinking about your mental health, which includes stress,
depression, and problems with emotions, for how many days during the past 30 days was
your mental health not good?.” This variable was recoded into a categorical variable as
follows: 1) > 14 days, 2) 1-13 days, and 3) none (reference group).
Days with poor physical health: This was a discrete variable expressed as days,
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and based on the question “Now thinking about your physical health, which includes
physical illness and injury, for how many days during the past 30 days was your physical
health not good?.” For purpose of the analyses, this variable was redefined into a
categorical variable as follows: 1) ≥ 14 days, 2) 1-13 days, 3) none (reference group).
Days with limited activity: This was a discrete variable expressed as days, and
based on the question “During the past 30 days, for about how many days did poor
physical or mental health keep you from doing your usual activities, such as self-care,
work, school or recreation?.” For the analyses, this variable was redefined into a
categorical variable as follows: 1) ≥14 days, 2) 1-13 days, and 3) none (reference group).
All-causes and CVD mortality: The all-cause mortality variable was defined
consistent with NCHS standards. Among participants in the NHANES III file, those that
were found in the NHANES III Linked Mortality public-use file were considered dead,
but if the person was not found in the file than the person was assumed alive.113, 117
Briefly, this linkage was conducted by the NCHS and was done by a probabilistic match
of information from participants aged 17 years or older in NHANES III with information
from the National Death Index through December 31, 2000 to determine mortality status.
More detail about the matching on mortality conducted by NCHS can be found
elsewhere.113, 117 Verification of correct matches was also conducted by NCHS staff. The
underlying causes of death were based on the International Classification of Diseases
(ICD), 9th and 10th Revision Clinical Modification and were grouped by the NCHS staff
into a standard list of 113 death categories. The CVD mortality variable was defined
based on the ICD-10 variable for CVD mortality, and coded as: 1) yes, and 2) no. The yes
category corresponds to ICD-10 deaths codes: I10-I13, I20-I25, I44-I49, I50, I60-I69, and
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I70-I78.113, 117 The no category corresponds to anyone who died from another cause.
Person-years of follow-up is included as a variable in the NHANES III linked mortality
data file and were calculated by NCHS staff by subtracting the NHANES III examination
date (as listed in the NHANES III data file) from the date of follow-up (when the death
status was ascertained).
Desire to lose weight: This was a categorical variable based on the question
“Would you like to weigh less, about the same, or more.” For the purposes of the present
analyses, this variable was defined as: 1) less, and 2) about the same or more (reference
group).
Employment status: This was a categorical variable based on the question “Did
you work last week (at a job or business)?” This variable was defined as: 1) yes, and 2)
no (reference group).
Numbers of hours worked: This was a numeric variable expressed in hours, based
on the question “How many hours did you work last week at all jobs or businesses?”
Along with using this variable as a numeric variable, it was also categorized into three
categories: 1) 1-20 hours (to include those with part-time or less), 2) 21-40 (to include
those with more than a part-time and inclusive of full-time, and 3) 41+ (to include those
considered generally to be working overtime). These categories were partially based on
the definitions of part-time, full-time, and over-time employment based on federal labor
laws, particularly over-time work which is defined as more than 40 hours by the Bureau
of Labor Statistics.118, 119
Number of missed work days (absenteeism): This was a variable expressed in days
based on the question “During the past 12 months, about how many days did you miss
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work at a job or business because of an illness or injury (do not include maternity leave)?
Type of occupation: This was a categorical variable based on the NCHS industry
codes.120 This variable was collapsed into four NCHS occupational groups: 1) white
collar, 2) blue collar, 3) service, and 4) farm worker, as done in previous studies.121
Smoking status: This was a categorical variable created from several variables to
have the following categories: 1) non-smoker with undetectable cotinine (reference
group), 2) non-smoker with detectable cotinine, and 3) smoker. For this study, smoking
status was defined as a combination of self-report and serum cotinine levels. Current
smokers were participants who answered yes to the question “Do you smoke cigarettes
now?”, and/or with serum cotinine levels >15 ng/mL.122 Participants who answered yes
to the question “Does anyone who lives [with you] smoke cigarettes, cigars, or pipes
anywhere inside this home?” and/or had had a serum cotinine level at or above the level
of detection but below < 15 ng/ml, and reported not being current smokers were
categorized as being exposed to secondhand smoke. Non-exposed non-smokers were
participants who reported being former smokers or never smoking, no reported home
secondhand smoke, and had cotinine levels below the detection limit. The detection limit
for NHANES III and NHANES 1999-2000 surveys was 0.035 ng/ml, while for NHANES
2001-2004 it was 0.015 ng/ml.123, 124

Potential confounding variables
Confounding variables that were tested included the following:
Sex was a categorical variable defined as: 1) female (reference group), 2) male.
Age group in years was a continuous variable that was also categorized as
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follows: 1) 20-44 (reference group), 2) 45-64, and 3) 65 or more. Most analyses used the
categorized variable in order to be consistent with the other continuous variables that
were categorized, such as body mass index.
Race/ethnicity was a categorical variable defined as: 1) non-Hispanic White
(reference group), 2) non-Hispanic Black, 3) Hispanic, and 4) other.
Educational level was a categorical variable defined as: 1) less than high school
(reference group), 2) high school graduate or equivalent, and 3) > high school.
Marital status was a categorical variable defined as: 1) not married (reference
group), and 2) married/with partner. The not married category included responses of
single, divorced, and widowed, while the married category included living with partner.
Alcohol consumer was a categorical variable created based on the question “In
your entire life did you drink at least 12 drinks of any type of alcoholic beverage?”. It
was defined as: 1) no, and 2) yes. This question was the only question related to alcohol
that was used because of the large number of missing data for the other alcohol-related
questions that exist in the NHANES data files.
Insurance status was a categorical variable defined as: 1) uninsured (reference
group), and 2) insured.
Physical activity (PA) level was a categorical variable defined as 1) vigorous, 2)
moderate, and 3) none (reference group). “Vigorous” was a response of yes to the
question: “Over the past 30 days did you do any vigorous PA for at least 10 minutes that
caused heavy sweating, or large increases in breathing or heart rate?. “Moderate” was a
response of yes to the question “Over the past 30 days did you do any moderate PA for at
least 10 minutes that caused heavy sweating, or large increases in breathing or heart
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rate?” but no to the question of vigorous physical activity. A response of “no” to both the
vigorous or moderate physical activity questions was defined as none. [Note: Although
NHANES has other questions related to PA, these were the ones that where consistently
asked from 1999-2004 and contained the least missing data.
Measured BMI group (kg/m2) was continuous variable that was redefined into a
categorical variable as: 1) BMI < 25 (reference group), 2) BMI 25-29.9, and 3) BMI >30.
Take insulin was a dichotomous variable based on the self report of currently
taking insulin defined as: 1) yes take insulin, and 2) do not take insulin (reference group).
Take anti-diabetic pills was a dichotomous variable based on self-report of taking
diabetic pills defined as: 1) yes take diabetic pills, and 2) do not take diabetic pills
(reference group).
Duration of diabetes was a numeric variable expressed in number of years based
on the variable for age of diabetes diagnosis and the variable for age.
Hypertension diagnosis was a categorical variable defined as: 1) no (reference),
and 2) yes.
Total cholesterol (milligrams (mg)/deciliter(dl) was a continuous variable
expressed in mg/dl.
Albumin/creatinine ratio was a continuous variable based on a formula using two
other variables: urinary albumin divided by urinary creatinine.
Percent (%) carbs in diet was a continuous variable representing the percent of
calories in the diet that came from carbohydrates and was based on a formula using two
separate questions in the nutrition file of NHANES: the number of total calories in the
diet and the number of calories from carbohydrates consumed (derived based on grams of
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carbohydrates consumed in the previous day; a 24 hour diet recall).
Cancer history was a created as a dichotomous variable based on the following
two questions: “Has a doctor ever told you had skin cancer?” and “Has a doctor ever told
you had other cancer?” A response of yes to either of the questions was defined as: 1)
yes, while a response of no to both question was defined as 2) no (reference group).
History of stroke or heart failure was a dichotomous variable based on the
following two questions: “Has a doctor ever told you had a stroke” and “Has a doctor
ever told you had congestive heart failure.” A response of yes to either question was
defined as 1) yes, while a response of no to both questions was defined as 2) no
(reference group).
Presence of asthma was a dichotomous variable based on the questions: “has a
doctor ever told you had asthma” and “do you still have asthma?” A response of yes to
both was defined as 1) yes, while a response of no to these two questions was defined as
2) no (reference group).

Sample weight variables
Each sampled person has a sampling weight providing unbiased national
estimates. NHANES surveys use an unequal selection probability design. It is
particularly important to know the weights when analyzing NHANES data because the
NHANES oversamples some subgroups that may be of greater public health interest (e.g.
African Americans). Weights are created by calculating a base weight (the reciprocal of
the final probability of selection at each stage), then adjusting for non-response, and
finally adjusting for post-stratification.28
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Sample weight variables are calculated by the NCHS in two-year increments. For
the continuous NHANES 1999-2002, a sample weight variable was created by NCHS
(based on population estimates by the Bureau of the Census before the 2000 Decennial
Census counts prior to public release), and can be obtained from the demographic data
files for both cycles.28 The variable name for the weight variable depends on the type of
data that are being investigated in the analysis and what data exists for the individuals in
the study. Only one weight variable is typed in the command line in the STATA software
for the analyses, and this weight variable is the one for the data file with a smaller sample
size. For example, the questionnaire data files are those that have data on questions asked
to participants while the laboratory files are those files that have data on blood or urine
samples drawn from participants. Since it is more feasible and inexpensive to ask only
questions in person rather than collect urine and blood samples, not all individuals have
laboratory data. If one is interested in data from the laboratory file and an individual exist
in both the questionnaire and laboratory files, then the weight variable for the laboratory
file would be used.
As detailed in the NCHS documentation,28 each survey participant has several
weights given differences in overall response rates to different survey components (e.g.
home interview versus physical examination or laboratory specimen collection) as well as
differences in population estimates provided from the Bureau of the Census for each
given year. When using the NHANES III data file, we used the NCHS weight variable
labeled wtpfhx6, which is the weight variable to be used for survey participants who had
not only in-person interview data but also examination and laboratory data.125
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Because we analyzed pooled NHANES data across years 1999 to 2004, we
created a 6-year sample weight variable for these analyses. In addition, we also created a
4-year sample weight for analyses involving data from survey years 2001-2004. These
variables had to be created since NHANES data files only contain 2-year sample weights
and a 4 year sample weight for NHANES 1999-2004. The 6-year (1999-2004) sample
weight variable was created as follows: 1) the 4-year sample weight variable created by
NCHS staff for participants sampled from 1999-2002 (labeled by NCHS as MEC4YR)
was downloaded, 2) the 2-year sample weight created by NCHS staff for participants
sampled from 2003-2004 (labeled by NCHS as MEC2YR) was downloaded, 3) a new
variable was created based on the multiplication of the MEC4YR variable by 2/3 if the
participant was sampled from the 1999-2000 or the 2001-2002 survey years data file and
multiplication by 1/3 if the participant was sampled from the 2003-2004 survey years
data file. The multiplication by 2/3 was done for participants sampled from 1999-2002
because they are contributing 2/3 of the total 6 years of weights while the multiplication
by 1/3 was done for participants sampled from 2003-2004 because they are contributing
only 1/3 of the total 6 years of weights. The 2001-2004 weight variable was created by
dividing the weight from the 2001-2002 or the 2003-2004 by half, depending on which of
the two 2-year survey cycles the person was sampled in.

Primary sampling units (PSU) and strata variables:
The NHANES uses various methods and survey software to calculate sampling
errors, which is used to determine the reliability of the statistics performed. These
variables, however, are not disclosed to the public. Variances thus need to be calculated
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based on masked variance units (MVUs). Variance units are based on strata and PSU
variables. The NCHS created these PSU and strata variables and has them available in all
NHANES data files. These variables are labeled sdmvpsu and sdmvstra for the NHANES
1999 to 2004 cycles, and sdppsu6 and sdpstra6 for NHANES III. Both PSU and strata
variables are used to provide appropriate adjustment in all statistical models for the
complex sample design of the NHANES.

Data management and preparation
The public-use NHANES data files were downloaded from the NCHS website
(http://www.cdc.gov/nchs/nhanes.htm). The consistency of variable labels across all
cycle years was checked; variable labels were changed if needed. Data files were then
appended. Certain variables were redefined in order to allow for appendage. In order to
determine the extent of missing data, the presence of outliers (by looking at extreme
values outside the upper or lower quartiles in boxplots) , and any non-normality issues,
frequency distributions were performed for discrete variables, and mean, standard
deviation, and range for continuous variables were checked. Normality plots were also
done. Transformations were not performed. Extreme outliers were not found.

Missing data
In addition to variables that are naturally defined as missing because they were
left blank, values that were defined as “don’t know” were redefined as missing and
excluded from the analyses. Following the NCHS rule for missing data, if a variable had
less than <10% missing data, that variable was used. However, if there was more missing
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data for a variable, sample characteristics were compared in terms of demographic
variables (e.g. age, sex, race/ethnicity) to determine if there were any nonrandom missing
data pattern that may indicate selection bias. If there were no differences in demographic
characteristics, then an imputation method was proposed to be used to replace missing
values. In the present analyses however, none of the variables used had more than 10%
missing data (responses of “don’t know” or left blank) and therefore imputation method
not used. Variables that were omitted in the analyses were those that were asked of only a
small portion of survey participants. The variables omitted from the analyses included
variables related to the frequency and duration of physical activity and variables related
to the frequency and the number of alcohol beverages consumed.

Model criteria and strategy
The purpose or goal of the present study was to test the proposed hypotheses
derived from the research questions. Because for the first research question there was a
relatively small sample and in order to avoid an over-parameterized model,126, 127
parsimonious models (i.e. models with less variables) that would best explain the
relationship between the main independent (predictor) variables and the outcome variable
while controlling for potential confounders were sought. In general, the more variables
added to a model, the more significant the model is or the better fit of the model; at the
same time, this may lead to confusion in the interpretation of the findings and to complex
interactions.126, 127 128 In this study, model evaluation was not based on the overall fit or
model significance, but rather the inclusion of the most important variables that if were
otherwise omitted could lead to a type I error (false positive).126, 127 128
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This method of model evaluation allowed for a parsimonious model with mainly
important and clinically relevant variables and ease of interpretation of findings.
Variables were added in a step-wise fashion (i.e. one at a time) with the main
independent variable added first. At each time a variable was added, any changes in the
coefficients and the p-value of the main independent variables as well as other covariates
of interest in the model were noted; changes of 20-25% of the coefficients were
considered meaningful.126 Thus, the assessment of the interactions and/or confounding
was possible using this approach. The approach used in the present analyses is not the
same as stepwise modeling. This stepwise modeling approach is mainly concerned with
the inclusion of variables that are statistically significant.126, 127
Variables that were candidates for inclusion in the models were those that were
pre-determined based on the literature to have clinical significance and/or that were
significant at the 0.20 alpha level in univariable analyses. The 0.20 alpha level was
chosen in order to allow for inclusion of variables that were perhaps clinically significant
but not statistically significant at a stricter 0.05 alpha level; the age group, race/ethnicity,
and sex variables were automatically included in all models regardless of statistical
significance.126, 127
However, since a parsimonious model was sought and because by definition a
confounder has to be associated with both the main predictor variable and the outcome
variable, only variables associated with both were used in the multivariable regression
analyses (either logistic, multinomial, or Poisson models). For example, since
occupational group was one of the potentially new factors of interest which was
associated with glycemic control at the univariable level, variables associated with both
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occupational group and with glycemic control at the univariable level were included in
the multivariable logistic regression model as well as were age group, sex, and
race/ethnicity.

Interaction terms
Several potential interactions were tested based on other studies that found them
to be important.36, 41, 55, 129, 130 The following interactions were tested for each hypothesis:
Hypotheses 1a-1d:
o ‘age group’*sex
o ‘age group’*race/ethnicity
o race/ethnicity*education
o race/ethnicity*sex
o physical activity*sex
o

occupation*marital status

o desire to lose weight*sex.
Hypotheses 2a-2c:
o ‘age group’*sex
o ‘age group’*race/ethnicity
o race/ethnicity*education
o race/ethnicity*sex,
o ‘suboptimal glycemic control’*sex‘
o ‘borderline glycemic control’*sex
o

‘poor glycemic control’*sex.
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Hypotheses 3a-3b:
o ‘age group’*sex
o age group*race/ethnicity
o race/ethnicity*sex
o sex*education,
o ‘suboptimal glycemic control’*sex‘
o ‘borderline glycemic control’*sex
o

‘poor glycemic control’*sex, and sex*’BMI category’

Only statistically significant interactions at the 0.05 alpha level were included in
the adjusted models or discussed in the results sections for each hypothesis.

Statistical analyses
All analyses were conducted using STATA 10.0 statistical software (College
Station, TX, USA) because of its ability to adjust for the complex sample survey design
of the NHANES. The type I error was set at 0.05, and an observed statistic was deemed
statistically significant if the association was at or below the alpha 0.05 level. Several
statistical analyses were performed after the preliminary analyses. Preliminary analyses
included assessing if the assumptions to perform the regression analyses were met. For
example, before performing multivariable logistic regression analyses, the linearity in the
residuals was assessed using residual versus predicted plots and scatter plots, for each
predictor variable. The assumption of independence and randomness was checked by
looking at any patterns in the residuals. Nevertheless, independence and randomness are
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more likely because this was a cross-sectional study (except for the mortality analyses)
with a multi-stage complex sampling frame that includes a random selection of
participants at the first stage of sampling. The proportionality assumption for Cox
proportional hazard analyses was also assessed. The SVYSET and SVY commands in
STATA, for indicating survey analyses, take into account the complex survey sample,
and were used for all univariable and multivariable regression analyses.
In general, first descriptive statistics and other preliminary analyses such as chisquare tests were performed.131 Chi-square tests were done in order to evaluate if there
were statistically significant differences in the percentage of the outcome variables based
on the independent variable. In addition, cross-tabulations allowed for the assessment of
any cell sizes of less than 5 that could possibly lead to unstable regression estimates or
prevent regression models to run properly. Second, univariable regression analyses were
performed in order to evaluate the un-adjusted relationship (e.g. odds ratio or hazards
rate) between the outcome variable and each independent variable. Third, multivariable
regression analyses were performed with only clinically and/or statistically significant
covariates included in the final models while controlling for potential confounders.127
Dummy variables were automatically created by STATA for categorical variables when
performing regression analyses. However, when testing interactions, dummy variables
were created manually (e.g. a variable with 4 categories would have 3 dummy variables,
each dummy variable as 0 vs. 1).
Where the literature suggested the need for stratified analyses (e.g. sex-specific
analyses) or the use of variables in a different fashion (e.g. numerical versus categorical)
or using different categorization, analyses in addition to the ones proposed were also
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conducted. Moreover, mediation tests, such as the Sobel test,132 were also performed to
help explain the association (or indirect effect) between the main independent variable
being tested and the outcome variable. The indirect effect of the mediator is the product
of path “a” (the estimate of the independent variable predicting the mediator) and “b” (the
estimate of the mediator predicting the dependent variable). This test is conducted by first
determining the standard error of the indirect effect, dividing the estimate of the path
“ab” with the standard error of the indirect effect; a Z test is then used comparing this
ratio with a critical value for a given alpha level.132 Statistical analyses for each
hypothesis derived from the different research questions are described below.

Hypothesis 1a
It was hypothesized that individuals with type 2 diabetes who worked more hours
were more likely to have suboptimal, borderline, and/or poor glycemic control, after
controlling for potential confounders.
Hypothesis 1b
It was hypothesized that individuals with type 2 diabetes who had occupations
which are known for having stricter or demanding time schedules (i.e. service workers
and blue collar workers relative to white collar workers) were more likely to have
suboptimal, borderline, and/or poor glycemic control, after controlling for potential
confounders.

39

Hypothesis 1c:
It was hypothesized that individuals with type 2 diabetes who were exposed to
secondhand smoke that were self-reported non-smokers were more likely to have
suboptimal, borderline, and/or poor glycemic control compared to non-smokers not
exposed to secondhand smoke, after controlling for potential confounders.
Hypothesis 1d:
It was hypothesized that individuals with type 2 diabetes who desired to lose
weight were more likely to have suboptimal, borderline, and/or poor glycemic control,
after controlling for potential confounders.
The NHANES 1999-2004 merged data file was used to test hypotheses 1a-1d
using the sample of adults classified with type 2 diabetes. Only the employed sample,
based on self-report of being employed, was used when testing the association between
glycemic control and occupation and work hours. However, when using the desire to lose
weight and the secondhand smoke exposure as independent variables, the full sample (i.e.
regardless of employment) was used.
Chi-square tests were first conducted cross-tabulating the independent variables
separately with each of the three measures of glycemic control status (i.e. suboptimal,
borderline, and poor glycemic control). For the independent variables that were
continuous, t tests were conducted instead of chi-square tests; these variables had normal
distributions. After these preliminary analyses, univariable and multivariable logistic
regression analyses were performed since the dependent variables were each
dichotomous variables. The LOGISTIC command in STATA was used. The dependent
variables were suboptimal, borderline, and poor glycemic control (0 if no, 1 if yes).
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Hypothesis 2a
It was hypothesized that individuals with type 2 diabetes who had suboptimal,
borderline, and poor glycemic control would be more likely to have poor health-related
quality of life (HRQOL) (i.e. poor self reported general health, more days with poor
mental and physical health, and more days of inactivity in the past 30 days), after
controlling for potential confounders.
The NHANES 2001-2004 data were used to test hypothesis 2a, using the sample
of adults classified with type 2 diabetes. Chi-square tests were first conducted crosstabulating separately the four HRQOL measures with the three variables for glycemic
control status. Univariable analyses for the general health variable were performed since
it was a dichotomous variable. Univariable and multivariable multinomial
(polychotomous) logistic regressions were then performed for dependent variables for
number of days of poor mental health, poor physical health, and limited activity since
these dependent variables are each categorical with three levels. The MLOGIT command
in STATA was used, which does not assume ordering of the dependent variable
categories. The dependent variables are the four HRQOL measures [1) general health, 2)
days of poor mental health, 3) days of poor physical health, and 4) days of limited
activity due to poor health in the past 30 days]). For the general health variable,
‘excellent health, very good, and good’ was the reference group, and it was compared to a
response of ‘fair or poor health’. For the ‘days or poor mental health’ and ‘days of poor
physical health’ variables, ‘0 days with poor health’ was the reference group, and it was
compared to ‘1-13 days of poor health’ and ‘>14 days of poor health’. Similarly, for the
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‘days with limited activity’ variable, ‘0 days with inactivity’ was the reference group, and
it was compared to ‘1-13 days of inactivity’ and ‘>14 days of inactivity’.

Hypothesis 2b
It was hypothesized that individuals with type 2 diabetes who had suboptimal,
borderline, and poor glycemic control would have a greater number of missed work days
in the past 12 months, after controlling for potential confounders.
The NHANES 1999-2004 data were analyzed using the sample of adults
classified with type 2 diabetes. Univariable and multivariable Zero Inflated Poisson (ZIP)
regression analyses were performed since the dependent variable, missed work days, was
a count variable associated with rare events. The variable missed work days also showed
over-dispersion (i.e., the mean was larger than the variance, with dispersion index or
variance-to-mean ratio [VMR]) of 126) and excess zeros (over 50% were zero). Zeroinflated Poisson (ZIP) regression models were used because, unlike traditional Poisson
regression, this analytic approach is robust even in the presence excess zeros and overdispersions.133, 134 The ZIP regression protocol was used for these analyses because
STATA is capable of incorporating adjustments for the NHANES complex sample
survey design.133, 134

Hypothesis 2c
It was hypothesized that individuals with type 2 diabetes who had suboptimal,
borderline, and poor glycemic control would be less likely to be employed, after
controlling for confounders.
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The NHANES 1999-2004 merged data file was used to test hypothesis 2c, using
all adults classified with type 2 diabetes. Chi-square tests were first conducted, crosstabulating employment status and the three glycemic control variables separately.
Univariable and multivariable logistic regression analyses were then performed since the
dependent variable was a dichotomous variable, employed [1) yes, 2) no (reference
group)]. The LOGISTIC command in STATA was used.

Hypotheses 3a
It was hypothesized that individuals with type 2 diabetes who had suboptimal,
borderline, and poor glycemic control would have a greater risk of all-cause mortality,
after controlling for potential confounders.
The NHANES III (1988-1994) data file was used to test hypothesis 3a, using all
adults classified with type 2 diabetes. Cox proportional hazards regression analyses were
performed since the dependent variable was time to death (the event of interest) and the
death indicator was defined as 1 if the person died, and 0 if otherwise (event-free or
censored). The STCOX command in STATA was used.

Hypotheses 3b
It was hypothesized that individuals with type 2 diabetes who had suboptimal,
borderline, and poor glycemic control would have a greater CVD mortality risk, after
controlling for potential confounders.
The NHANES III (1988-1994) data file was used to test hypothesis 3a, using all
adults classified with type 2 diabetes. Cox proportional hazards regression analyses were
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performed since the dependent variable was time to death (the event of interest) and the
death indicator was defined as 1 if the person died, and 0 if otherwise (event-free or
censored). The STCOX command in STATA was used.
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CHAPTER IV.
RESULTS
Overview
All statistical analyses for the present study are described for adults with type 2
diabetes and were conducted using weighted statistics and using STATA software 10.0.
Table 1 provides a summary of the STATA commands used in this study. Descriptive
statistics for all NHANES datasets used are shown first. For ease of presentation (e.g. to
avoid very long tables) descriptive tables and tables of preliminary analyses (e.g. crosstabulations) are generally divided into the following sections: 1) demographics, 2)
potentially new risk factors, and 3) health indicators and behaviors. Following these
tables, the main results (i.e., multivariable regression models) are presented based on the
research question and hypothesis tested. Results are divided into sections based on the
outcome variable. For example, for hypotheses 1a-1d, 2a, and 3a-3b, the results are
shown based on the glycemic control variable used (i.e. suboptimal, borderline, or poor
glycemic control). For research question 2a, the results are shown based on the variable
for HRQOL used (i.e. self-reported general health, poor mental or physical health, and
days of inactivity). The results for each hypothesis are embedded in the section for that
hypothesis. A summary of results for each research question is also included at the end of
the results for that research question.
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Table 1. List of key STATA commands used in the present study
STATA Command
Purpose
svy
Indicates analyses of surveys, weighted analyses
svyset
Sets all future STATA commands to be using weighted
analyses of survey data
svy: tab
For cross-tabulations of weighted analyses of survey data
stset
Sets all future STATA commands to be using weighted
mortality analyses of survey data. For example the following
commands were written in STATA:
svy: mean
svy: reg
svy: logistic
st cox
svy: mlogit

svy: zip
pweight
sdmvpsu
strata
xi:

i.

subpop

svyset sdmvpsu [pweight=mec6yr], strata (sdmvstra)
For means of weighted analyses of survey data
For univariable and multivariable regression analyses of
weighted analyses of survey data
For univariable and multivariable logistic regression analyses
of weighted analyses of survey data
For Cox-proportional analyses of weighted analyses of
survey data
For multinomial logistic regression analyses of weighted
analyses of survey data
For Zero Inflated Poisson (ZIP) regression analyses of
weighted analyses of survey data
Indicates that a weight will be used in the analyses, precedes
the weight variable used
Indicates that a psu variable is being used in the analyses
Indicates that a strata variable will be used in the analyses,
precedes the strata variable used
Indicates that categorical variables will be used in the
analyses and tells STATA to automatically create dummy
variables for the categorical variables. For example the
following commands were written in STATA:
xi: svy, subpop (if adultdiabetic): logistic suboptimala1c
i.workhours
Must precede the categorical independent variable being
used and indicates that the variable should be made into
dummy variables automatically (i.e. not manually) by
STATA software
Indicates that the analyses will only be using a subsample of
the entire date set file and usually follows the “svy”
command
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General characteristics of study sample
The general characteristics of the study sample for all NHANES data files are
described in Tables 2a-2d. A total of 1273 individuals classified as type 2 diabetics aged
20 years or older who participated in the NHANES surveys anytime from 1999-2004
were included in the study. Of these, 384 (28.5%) were employed (at a job or business in
the prior week). In the 2001-2004 NHANES survey period, there were a total of 827
individuals classified as type 2 diabetes, aged 20 years or older, while there were a total
of 1381 individuals with type 2 diabetes, aged 20 years and older, who participated in
NHANES III (1988-1994) and who had mortality data available. There was a fairly equal
representation of males and females across all NHANES.
The mean age across all NHANES data files ranged from 53 (in the employed
NHANES 1999-2004 sample) to 65 (in the NHANES III sample). The mean duration of
diabetes ranged from 8.7 years (employed NHANES 1999-2004 sample) to 13.2 years
(NHANES 2001-2004 sample). Furthermore, over half of the study sample had at least a
high school education irrespective of survey period. The sample had a slightly greater
percentage of individuals who were married or living with a partner versus single,
divorced or widowed across all survey periods. The majority of the sample across all
NHANES survey periods was overweight or obese (79.3 to 85.2%). In the NHANES
1999-2004, among all adults with type 2 diabetes, there were 671 (52.7%) with
suboptimal glycemic control (HbA1c ≥7), 449 (42.7%) with borderline glycemic control
(i.e. 7≥ HbA1c < 9), and 222 (17.4%) with poor glycemic control (HbA1c ≥9). In the
employed NHANES 1999-2004 sample, there were 216 (58.5%) adults with suboptimal
glycemic control, 134 (46.7%) with borderline glycemic control, and 82 (22.2%) with
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poor glycemic control. In the NHANES 2001-2004, there were 423 (48.0%) adults with
suboptimal glycemic control, 289 (38.7%) with borderline glycemic control, and 134
(15.2%) had poor glycemic control. In the NHANES III data file, there were 507 (43.2%)
adults with suboptimal glycemic control, 204 (23.4%) with borderline glycemic control,
and 303 (25.8%) with poor glycemic control. There were a total of 600 (43.5%) deaths
from 1986 to 2000 among adults with type 2 diabetes sampled in NHANES from 19862000. Of these deaths, 315 (52.5%) were due to cardiovascular disease.

Table 2a. Demographic characteristics among individuals classified with type 2 diabetes, 20+ years
of age, NHANES III (1988-1994) and NHANES 1999-2004
NHANESa
All Adults
Employed
Adults
1988-1994
2001-2004
1999-2004
1999-2004
(n=1381)
(n=921)
(n=1348)
(n=384)
Characteristic
Frequency
Frequency
Frequency
Frequency
(Percent)
(Percent)
(Percent)
(Percent)
Sex
Female
755 (54.7)
459 (49.8)
678 (50.3)
157 (40.9)
Male
626 (45.3)
462 (50.2)
670 (49.7)
227 (59.1)
Age group
20-44
124 (9.0)
91 (9.9)
128 (9.5)
86 (22.4)
45-64
483 (35.0)
356 (38.7)
522 (38.7)
241 (62.8)
65+
774 (56.1)
474 (51.5)
698 (51.8)
57 (14.8)
Race/ethnicity
Non-Hispanic White
563 (40.8)
387 (42.0)
513 (38.1)
132 (34.4)
Non-Hispanic Black
365 (26.4)
208 (22.6)
326 (24.2)
101 (26.3)
Hispanic
402 (29.1)
287 (31.2)
454 (33.7)
134 (34.9)
Other
51 (3.7)
39 (4.2)
55 (4.1)
17 (4.4)
Education^
< HS
861 (63.1)
397 (43.2)
657 (48.8)
128 (33.3)
HS
287 (21.0)
201 (21.9)
277 (20.6)
85 (22.1)
> HS
216 (15.8)
322 (35.0)
412 (30.6)
171 (44.5)
Marital status
Not married/divorced/widowed
547 (39.8)
335 (36.4)
477 (36.6)
99 (26.9)
Married/living with partner
829 (60.3)
586 (63.6)
826 (63.4)
269 (73.1)
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Table 2a (continue)
All Adults
1988-1994
(n=1381)
Frequency
(Percent)

2001-2004
(n=921)
Frequency
(Percent)

Employment status
Unemployed
-656 (71.3)
Employed
-264 (28.7)
Insurance status
Uninsured
-91 (10.0)
Insured
-823 (90.0)
a
Sample sizes do not always equal column totals due to missing data.
^ HS=High School

1999-2004
(n=1348)
Frequency
(Percent)

Employed
Adults
1999-2004
(n=384)
Frequency
(Percent)

963 (71.5)
384 (28.5)

-----

150 ( 11.3)
1,182 (88.7)

73 (19.3)
306 (80.7)

Table 2b. Presence of potentially new risk factors among individuals classified with type 2
diabetes, 20+ years of age, NHANES III (1988-1994) and NHANES 1999-2004
NHANESa
All Adults
Employed
Adults
1988-1994
2001-2004
1999-2004
1999-2004
(n=1381)
(n=921)
(n=1348)
(n=384)
Characteristic
Frequency
Frequency
Frequency
Frequency
(Percent)
(Percent)
(Percent)
(Percent)
Smoking and secondhand smoke
(SHS) exposure
Non-Smoker & no SHS exposure
185 (15.8)
187 (21.4)
357 (28.5)
77 (21.0)
Non-Smoker with SHS exposure
685 (58.3)
485 (55.5)
629 (50.2)
195 (53.3)
Smoker
306 (26.0)
202 (23.1)
267 (21.3)
94 (25.7)
Weight desirability
Stay the same or gain weight
--326 (35.4)
498 (37.0)
113 (29.4)
Lose weight
--595 (64.6)
849 (63.0)
271 (70.6)
Hours worked
0-20 hours
------54 (14.8)
21-40 hours
------188 (51.5)
41+ hours
------123 (33.7)
Occupational group
White collar worker
------177 (46.2)
Service worker
------78 (20.3)
Farm worker
------10 (2.6)
Blue collar worker
------118 (30.8)
a
Sample sizes do not always equal column totals due to missing data.
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Table 2c. Presence of glycemic control group characteristics among individuals classified with
type 2 diabetes, 20+ years of age, NHANES III (1988-1994) and NHANES 1999-2004
NHANESa
All Adults
Employed
Adults
1988-1994
2001-2004
1999-2004
1999-2004
(n=1381)
(n=921)
(n=1348)
(n=384)
Characteristic
Frequency
Frequency
Frequency
Frequency
(Percent)
(Percent)
(Percent)
(Percent)
Suboptimal glycemic
controlb
No
666 (56.8)
458 (52.0)
602 (47.3)
153 (41.5)
Yes
507 (43.2)
423 (48.0)
671 (52.7)
216 (58.5)
Borderline glycemic controlc
No
666 (76.6)
458 (61.3)
602 (57.3)
153 (53.3)
Yes
204 (23.4)
289 (38.7)
449 (42.7)
134 (46.7)
Poor glycemic controld
No
870 (74.2)
747 (84.8)
1051 (82.6)
287 (77.8)
Yes
303 (25.8)
134 (15.2)
222 (17.4)
82 (22.2)
a
Sample sizes do not always equal column totals due to missing data.
b
An individual is said to have suboptimal glycemic control if she or he has an HbA1c of > 7.0%.
c
An individual is said to have suboptimal glycemic control if she or he has an HbA1c 7-8.9%. In these
analyses, individuals with an HbA1c >9.0% are excluded from the analyses.
d
An individual is said to have suboptimal glycemic control if she or he has an HbA1c >9.0%.

Table 2d. Categorical health indicators and behavioral characteristics among individuals
classified with type 2 diabetes, 20+ years of age, NHANES III (1988-1994) and NHANES 19992004
NHANESa
All Adults
Employed
Adults
1988-1994
2001-2004
1999-2004
1999-2004
(n=1381)
(n=921)
(n=1348)
(n=384)
Characteristic
Frequency
Frequency
Frequency
Frequency
(Percent)
(Percent)
(Percent)
(Percent)
History of cardiovascular
disease
No
--662 (71.9)
937 (69.5)
338 (88.0)
Yes
--259 (28.1)
411 (30.5)
46 (12.0)
Cancer diagnosis
No
1225 (88.7)
------Yes
156 (11.3)
----Alcohol Use
No
-370 (42.8)
136 (36.7)
555 (44.0)
Yes
-494 (57.2)
235 (63.3)
707 (56.0)
Physical activity
None
--418 (51.8)
634 (54.3)
170 (45.2)
Moderate
--270 (33.5)
355 (30.4)
115 (30.6)
Vigorous
--119 (14.8)
178 (15.3)
91 (24.2)
Take anti-diabetic Pills
No
690 (50.2)
254 (27.7)
375 (27.9)
114 (29.7)
Yes
685 (49.8)
664 (72.3)
969 (72.1)
270 (70.3)
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Table 2d (continue)
All Adults
1988-1994
(n=1381)
Frequency
(Percent)

2001-2004
(n=921)
Frequency
(Percent)

Take insulin
No
972 (70.4)
727 (78.9)
Yes
408 (29.6)
194 (21.1)
Table 2d (continue)
Family history of diabetes
No
--218 (24.5)
Yes
--672 (75.5)
Hypertension diagnosis
No
596 (43.3)
297 (32.3)
Yes
782 (56.8)
624 (67.8)
BMI category
Normal/under weight
253 (20.7)
143 (16.5)
Overweight
475 (38.9)
299 (34.6)
Obese
494 (40.4)
423 (48.9)
a
Sample sizes do not always equal column totals due to missing data.

1999-2004
(n=1348)
Frequency
(Percent)

Employed
Adults
1999-2004
(n=384)
Frequency
(Percent)

1052 (78.1)
295 (21.9)

323 (84.1)
61 (15.9)

331 (25.3)
976 (74.7)

60 (15.9)
316 (84.0)

419 (31.2)
929 (68.9)

169 (44.0)
215 (55.0)

210 (16.6)
442 (34.9)
616 (48.6)

55 (14.8)
128 (34.3)
190 (50.9)

Table 2e. Numerical health indicators and behavioral characteristics among individuals
classified with type 2 diabetes, 20+ years of age, NHANES III (1988-1994) and NHANES 19992004
NHANESa
All Adults
Employed
Adults
1988-1994
2001-2004
1999-2004
1999-2004
(n=1381)
(n=921)
(n=1348)
(n=384)
Characteristic
Mean (SE)
Mean (SE)
Mean (SE)
Mean (SE)
10.61 (9.6)
13.19 (15.0) 12.79 (14.3)
8.57 (10.4)
Diabetes duration (years)
--199.77
200.27
201.64 (44.6)
Total cholesterol (mg/dl)
(47.8)
(47.1)
--20.34 (95.9)
25.17
21.23 (136.9)
Albumin/Creatinine Ratio
(110.2)
--49.44 (12.1)
49.51
47.73 (12.2)
Percent calories from
(12. 2)
carbohydrates
a
Sample sizes do not always equal column totals due to missing data.
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Potentially new risk factors and glycemic control
The first research question was whether the work hours, the type of occupation,
secondhand smoke exposure, and the desire to lose weight were associated with
suboptimal, borderline, and poor glycemic control among individuals with type 2
diabetes who were 20 years of age or older. It was hypothesized that individuals who
worked greater number of hours (i.e. 20-40 hours or more than 40 hours relative to less
than 20 hours), had occupations which are known for having stringent or demanding time
schedules (i.e. service worker and blue collar workers relative to white collar workers),
were exposed to secondhand smoke, and desired to lose weight were more likely to have
suboptimal and/or poor glycemic control, after for potential confounders.
The associations between categorical independent variables involved in
hypothesis 1a-1d and suboptimal, borderline poor, and poor glycemic control among the
employed sample of adults with type 2 diabetes are tabulated and the significance of the
chi-square statistics are presented in Tables 3a-3c. In addition, the means of numerical
independent variables involved in hypothesis 1a-1d and significance of the t-test statistics
are presented in Table 3d. Furthermore, univariable logistic regression analyses for
suboptimal, borderline, and poor glycemic control among the employed sample of adults
with type 2 diabetes are presented in Table 4a-4c. Odds ratios are presented along with
95% confidence intervals and the corresponding p values. P values are shown only for
tables 4a-4d since p values at the 0.20 alpha level in the univariable analyses were used to
determine which variables were to be included in subsequent multivariable analyses.
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Table 3a. Cross-tabulations† of demographic variables with suboptimal (HbA1c > 7.0%),
borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control, employed adults
classified with type 2 diabetes, NHANES 1999-2004
Glycemic Control*
Suboptimal**
Borderline**
Poor**
N (%)
N (%)
N (%)
No
Yes
No
Yes
No
Yes
Sex
Male
93 (46.2) 131(53.8)
93(58.1)
77 (41.9) 170(77.0)
54 (23.0)
Female
60 (49.5)
85 (50.5)
60 (60.0)
57 (40.0) 117(85.3)
28 (14.7)
Age group
20-44
29 (42.6)
51 (57.4)
29 (58.8)
27 (41.2)
56 (72.4)
24 (27.6)
45-64
93 (47.7) 140(52.3)
93 (59.0)
85 (41.0) 178(80.7)
55 (19.3)
65+
31 (58.5)
25 (41.5)
31 (60.7)
22 (39.3)
53 (96.4)
3 (3.6)
Race/ethnicity
Non-Hispanic
72 (65.3)
39 (34.7) 111(85.3)
72 (55.7)
56 (44.3)
17 (14.7)
White
Non-Hispanic
29 (44.2)
36 (55.9)
29 (30.7)
63 ( 69.3)
65 (69.5)
27 (30.5)
Black
Hispanic
46 (57.6)
52 (42.4)
46 (40.1)
87 (59.9)
98 (69.6)
35 (30.4)
Other
6 (36.6)
7 (63.6)
6 (30.0)
10 (70.0)
13 (82.2)
3 (17.8)
Education^
< HS
39 (46.6)
49 (53.4)
88 (72.0)
37 (28.0)
39 (33.5)
86 (66.5)
HS
40 (65.0)
26 (35.0 )
66 (79.3)
14 (20.7)
40 (51.5)
40 (48.5)
> HS
74 (60.8)
59 (39.2) 133(83.7)
31 (16.3)
74 (50.9)
90 (49.1)
Marital status
Not married
109(47.7) 152(52.3) 109(57.8)
94 (42.2) 203(82.5)
58 (17.5)
Married/living
38 (45.8)
54 (54.2)
38 (61.7)
34 (38.3)
72 (74.3)
20 (25.7)
with partner
Insurance Status
Uninsured
32 (46.1)
40 (53.9)
32 (76.6) 120(57.8)
48 (60.1)
24 (39.9)
Insured
120(48.2) 172(51.8)
16 (23.4)
115(42.2) 235(83.3)
57 (16.7)
*row percentages=100, percentages do not reflect sample size in each cell due to weighted analyses.
** Statistically significant differences at the 0.05 level appear in bold.
†
Designed based Pearson statistics performed to account for complex survey design.
^ HS=High School

Table 3b. Cross-tabulations† of potentially new risk factors variables with suboptimal (HbA1c >
7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control, Employed
adults classified with type 2 diabetes, NHANES 1999-2004
Glycemic Control*
Suboptimal**
Borderline**
Poor**
N (%)
N (%)
N (%)
No
Yes
No
Yes
No
Yes
Smoking and
Secondhand
smoke (SHS)
exposure
None smoker/&
30 (48.4)
47 (51.6)
30 (57.0)
31 (43.0)
61 (88.0)
16 (15.0)
no SHS
Non-smoker
81 (47.3) 111(52.7)
81 (60.0)
67 (40.0)
148 (78.9)
44 (21.1)
with SHS
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Table 3b (continue)
Suboptimal**
N (%)
No
Yes
38 (45.1)
53 (54.9)

Glycemic Control*
Suboptimal**
N (%)
No
Yes
38 (57.1)
34 (43.0)

Suboptimal**
N (%)
No
Yes
72 (79.0)
19 (21.0)

Smoker
Weight
Desirability
Stay the same or
48 (57.6)
36 (42.4)
48 (57.6)
36 (42.4)
84 (76.3)
27 (23.7)
gain weight
Lose weight
105 (59.8) 98 (40.2) 105(59.8)
98 (40.3)
203 (81.5)
55 (18.5)
Hours of worked
group
0-20 hours
26 (61.50
26 (38.5)
26 (68.3)
19 (31.7)
45 (90.0)
7 (10.0)
21-40 hours
74 (49.8) 106(50.2)
74 (62.4)
62 (37.6)
136 (79.7)
44 (20.3)
41+ hours
44 (38.6)
75 (61.4)
44 (50.8)
47 (49.2)
91 (76.0)
28 (24.0)
Occupational
group
White collar
75 (53.1)
91 (46.9)
75 (62.2)
61 (37.8)
136 (85.5)
30 (14.6)
worker
Service worker
28 (42.5)
46 (57.5)
28 (52.1)
31 (47.9)
59 (81.7)
15 (18.3)
Farm worker
1 (4.9)
9 (95.1)
1 (12.5)
6 (87.5)
7 (38.9)
3 (61.1)
Blue collar
48 (41.5)
70 (58.6)
48 (58.0)
36 (42.0)
84 (71.5)
34 (28.5)
worker
*row percentages=100, percentages do not reflect sample size in each cell due to weighted analyses.
** Statistically significant differences at the 0.05 level appear in bold.
†
Designed based Pearson statistics performed to account for complex survey design.

Table 3c. Cross-tabulations† of health indicators and behaviors variables with suboptimal
(HbA1c > 7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control,
employed adults classified with type 2 diabetes, NHANES 1999-2004
Glycemic Control*
Suboptimal**
Borderline**
Poor**
N (%)
N (%)
N (%)
No
Yes
No
Yes
No
Yes
History of CVD
No
132(47.2) 192(52.8) 132(60.1)
117(39.9)
249(78.5)
75 (21.5)
Yes
21 (49.0)
24 (51.0)
21 (53.9)
17 (46.1)
38 (91.0)
7 (9.0)
Alcohol Use
No
49 (42.8)
78 (57.3)
49 (50.7)
51 (49.3)
100(84.4)
27 (15.6)
Yes
101(49.7) 131(50.3) 101(63.3)
81 (36.7)
182(78.5)
50 (21.5)
Physical activity
None
63 (44.8) 101(55.2)
63 (59.6)
61 (40.4)
124(75.2)
40 (24.8)
Moderate
46 (47.4)
64 (52.6)
46 (54.6)
44 (45.4)
90 (86.8)
20 (13.2)
Vigorous
39 (48.9)
48 (51.1)
39 (60.7)
29 (39.3)
68 (80.6)
19 (19.4)
Take antidiabetic pills
No
90 (78.3)
22 (21.7)
62 (57.9)
50 (42.1)
62 (74)
91 (52.6)
Yes
197(81.0)
60 (19.0)
91 (42.6) 166(57.4)
28 (26)
106(47.4)
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Table 3c (continue)
Suboptimal**
N (%)
No
Yes

Glycemic Control*
Suboptimal**
N (%)
No
Yes

Suboptimal**
N (%)
No
Yes

Take insulin
No
140(50.8) 171(49.2) 140(62.2)
107(37.8)
247(81.7)
64 (18.3)
Yes
13 (27.5)
45 (72.5)
13 (39.0)
27 (61.0)
40 (70.7)
18 (29.3)
Family history
of diabetes
No
33 (59.4)
26 (40.6)
33 (70.1)
19 (29.9)
52 (84.7)
7 (15.4)
Yes
116(45.4) 186(54.6)
116(56.4)
114(43.6)
230(80.4)
72 (19.6)
Hypertension
diagnosis
No
62 (45.0) 101(55.0)
62 (55.6)
62 (44.4)
124(80.9)
39 (19.1)
Yes
91 (49.6) 115(50.4)
91 (62.5)
72 (37.5)
163(79.4)
43 (20.6)
BMI category
Normal/under
22 (34.7)
33 (65.3)
39 (69.5)
16 (30.5)
22 (49.9)
17 (50.1)
weight
Overweight
53 (54.1)
71 (45.9)
95 (75.4)
29 (24.6)
53 (71.8)
42 (28.2)
Obese
75 (46.3) 108(53.7)
147(84.7)
36 (15.3)
75 (54.7)
72 (45.3)
*row percentages=100, percentages do not reflect sample size in each cell due to weighted analyses.
** Statistically significant differences at the 0.05 level appear in bold.
†
Designed based Pearson statistics performed to account for complex survey design.

Table 3d. Mean comparisons for numerical variables with suboptimal (HbA1c > 7.0%),
borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control, employed adults
classified with type 2 diabetes, NHANES 1999-2004
Glycemic Control*
Suboptimal
Borderline
Poor
Characteristic
Mean
Mean
Mean
(SE)
(SE)
(SE)
No
Yes
No
Yes
No
Yes
7.07
8.13
7.07
8.22
7.55
8.0
Diabetes duration
(1.07)
(0.78)
(1.07)
(1.14)
(0.90)
(0.86)
(years)
197.2
198.4
Total cholesterol (mg/dl)
197.0
211.0
197.69
232.01
(3.01)
(5.15)
(6.29)
(5.02)
(2.79)
(8.76)
Albumin/Creatinine
2.98
15.60
2.98
13.98
7.42
18.21
Ratio
(0.67)
(4.87)
(0.67)
(7.14)
(2.91)
(5.45)
0.47
0.45
0.47
0.46
0.47
0.44
Percent calories from
(0.01)
(0.01)
(0.01)
(0.012)
(0.01)
(0.02)
carbohydrates
* Statistically significant differences at the 0.05 level appear in bold.
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Table 4a. Univariable logistic regression. Relationships between demographic characteristics
with suboptimal (HbA1c > 7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%)
glycemic control, employed adults classified with type 2 diabetes, NHANES 1999-2004
Glycemic Control
Suboptimal
Borderline
Poor
Characteristic
Odds Ratio (95%
Odds Ratio (95%
Odds Ratio (95%
Confidence Interval),
Confidence Interval),
Confidence Interval),
p value
p value
p value
Sex
Female
1.00
1.00
1.00
Male
1.14 (0.60-2.17), 0.68
0.92 (0.49-1.74), 0.80
1.73 (0.87-3.44), 0.12
Age group
20-44
1.00
1.00
1.00
45-64
0.81 (0.38-1.76),0.60
0.99 (0.41-2.37), 0.98
0.63 (0.26-1.50), 0.29
65+
0.530 (0.21-1.30), 0.16
0.93 (0.37-2.33), 0.87
0.10 (0.02-0.66), 0.02
Race/ethnicity
Non-Hispanic
1.00
1.00
1.00
White
Non-Hispanic
2.84 (1.56-5.17), 0.00
2.37 (1.26-4.49), 0.01
2.55 (1.13-5.7), 0.03
Black
Hispanic
1.88 (1.11-3.12) 0.02
1.38 (0.87-2.20), 0.17
2.54 (1.08-5.97), 0.03
Other
2.94 (0.74-11.64) 0.12
3.28 (0.73-14.72), 0.12
1.26 (0.39-4.06), 0.69
Education^
< HS
1.00
1.00
1.00
HS
0.47 (0.22-1.04),0 .06
0.47 (0.20-1.11), 0.08
1.67 (0.30-1.52), 0.33
> HS
0.49 (0.28-0.84), 0.01
0.56 (0.30-1.01), 0.08
0.50 (0.28-0.89), 0.02
Marital status
Not married
1.00
1.00
1.00
Married/living with
1.08 (0.60-1.93), 0.79
0.85 (0.44-1.65), 0.62
1.64 (0.88-3.04), 0.12
partner
Insurance status
Uninsured
1.00
1.00
1.00
Insured
0.28 (0.15-0.53), 0.00
2.40 (1.19-4.79), 0.02
0.30 (0.14-0.64), 0.00
^
HS=high school

Table 4b. Univariable logistic regression. Relationship between potentially new risk factors
with suboptimal (HbA1c > 7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%)
glycemic control, employed adults classified with type 2 diabetes, NHANES 1999-2004
Glycemic Control
Suboptimal
Borderline
Poor
Characteristic
Odds Ratio (95%
Odds Ratio (95%
Odds Ratio (95%
Confidence Interval),
Confidence Interval),
Confidence Interval),
p value
p value
p value
Smoking and
secondhand smoke
(SHS) exposure
None smoker/& no
1.00
1.00
1.00
SHS
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Table 4b (continue)

Non-smoker with
SHS exposure
Smoker
Weight desirability
Stay the same or
gain weight
Lose weight
Hours of worked
group
0-20 hours
21-40 hours
41+ hours
Occupational group
White collar worker
Service worker
Farm worker
Blue collar worker

Suboptimal
Odds Ratio (95%
Confidence Interval),
p value
1.05 (0.45-2.38),
0.92
1.14 (0.45-2.93),
0.77

Glycemic Control
Borderline
Odds Ratio (95%
Confidence Interval),
p value
1.72 (0.27-11.01), 0.56
0.70 (0.288-1.68), 0.41

Poor
Odds Ratio (95%
Confidence Interval),
p value
1.51 (0.58-3.92),
0.39
1.50 (0.52-4.37),
0.45

1.00

1.00

1.00

0.83 (0.44-1.56),
0.55

0.91 (0.46-1.83),
0.80

0.73 (0.33-1.62),
0.43

1.00
1.61 (0.77-3.38),
0.20
2.54 (1.24-5.22),
0.01

1.00
1.30 (0.52-3.26),
0.57
2.10 (0.93-4.68),
0.07

1.00
2.28 (0.59-8.78),
0.22
2.84 (0.72-11.18), 0.13

1.00
1.52 (0.77-3.04),
0.89
22.07(2.47202.11),0.01
1.60 (0.85-3.01),
0.14

1.00
1.51 (0.67-3.38),
3.57
11.45 (1.17-112.09),
0.03
1.19 (0.57-2.47),
0.64

1.00
1.31 (0.49-3.51),
0.58
9.21 (1.66-51.09), 0.01
2.34 (1.05-5.21),
0.04

Table 4c. Univariable logistic regression. Health indicators and behaviors factors associated
suboptimal (HbA1c > 7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%)
glycemic control employed adults classified with type 2 diabetes, NHANES 1999-2004
Glycemic Control
Suboptimal
Borderline
Poor
Characteristic
Odds Ratio (95%
Odds Ratio (95%
Odds Ratio (95%
Confidence Interval),
Confidence Interval),
Confidence Interval),
p value
p value
p value
CVD history
No
1.00
1.00
1.00
Yes
0.93 (0.40-2.16), 0.86
1.29 (0.52-3.23), 0.58
0.36 (0.12-1.08), 0.07
Alcohol use
No
1.00
1.00
1.00
Yes
1.35 (0.96-1.90), 0.08
0.60 (0.32-1.17), 0.10
1.48 (0.82-2.66), 0.19
Physical activity
None
1.00
1.00
1.00
Moderate
0.90 (0.46-1.77),0.76
1.23(0.59-2.55), 0.58
0.46 (0.22-0.99), 0.05
Vigorous
0.85 (0.45-1.62), 0.61
0.96 (0.47-1.94), 0.90
0.73 (0.32-1.64), 0.44
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Table 4c (continue)

Take anti-diabetic
pills
No
Yes
Take insulin
No
Yes
Family history of
diabetes
Yes
Hypertension
diagnosis
No
Yes
BMI category
Normal/under
weight
Overweight
Obese
Diabetes duration
(years)
Total cholesterol
(mg/dl)
Albumin/Creatinine
Ratio
% calories from
carbohydrates

Suboptimal
Odds Ratio (95%
Confidence Interval),
p value

Glycemic Control
Borderline
Odds Ratio (95%
Confidence Interval),
p value

Poor
Odds Ratio (95%
Confidence Interval),
p value

1.00
1.17 (0.69-1.97), 0.55

1.00
2.57 (1.39-4.72), 0.00

1.00
0.85 (0.39-1.81), 0.66

1.00
2.07 (1.34-3.21), 0.00

1.00
2.57 (1.12-5.88), 0.03

1.00
1.85 (0.85-4.05), 0.12

1.30 (0.78-2.14),0.31

1.61 (1.13-2.27), 0.01

1.34 (0.47-3.83), 0.66

1.00
0.85 (0.55-1.30), 0.44

1.00
0.75 (0.41-1.38), 0.35

1.00
1.10 (0.54-2.23), 0.78

1.00

1.00

1.00

0.45 (0.17-1.22), 0.11
0.62 (0.27-1.40), 0.24
0.99 (0.98-1.00), 0.25

0.39 (0.15-1.01), 0.05
0.82 (0.34-1.98), 0.66
1.01 (0.98-1.04), 0.41

0.74 (0.26-2.11), 0.57
0.42 (0.16-1.04), 0.06
1.01 (0.98-1.03), 0.72

1.02 (1.00-1.02), 0.00

1.00 (0.99-1.00),0.83

1.02 (1.01-1.03), 0.00

1.00 (1.00-1.00), 0.05

1.00 (1.00-1.02), 0.11

1.00( 0.98-1.01), 0.35

0.36 (0.03-3.96), 0.40

0.64 (0.05-8.08), 0.73

0.15 (0.01-2.53), 0.18

Suboptimal glycemic control
Among the employed sample, individuals with type 2 diabetes who worked
greater than 40 hours relative to those who worked 20 hours or less had greater odds for
suboptimal (HbA1c >7) glycemic control (Odds Ratio, OR,= 2.54 [95% confidence
interval, CI, = 1.24-5.22]) (Tables 4a-c). In addition, farm workers were more likely than
white collar workers to have suboptimal glycemic control (OR=22.07 [CI=2.40-202.11]).
Other factors associated with suboptimal glycemic control at the 0.20 alpha level ( the
level for determining potential confounders) included: taking insulin (OR=2.70 [p
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<0.001]), being 65 years of age or older relative to 20-44 years of age (OR=0.53
[p=0.016), being insured (0.28 [p<0.001]), being non-Hispanic Black (OR=2.37
[p=0.01]), Hispanic (OR 1.38 [p=0.17]), being of ‘other’ race (OR=2.94 [p=0.12]), and
being overweight (OR=0.39 [p=0.05]). The other independent variables of interest for
research question 1 (i.e. secondhand smoke exposure and desire to lose weight) were not
statistically associated with suboptimal glycemic control at the 0.20 alpha level among all
adults of the sample (i.e., regardless of employment status).
Multivariable model development: For the model to assess the relationship
between work hours and suboptimal glycemic control, variables were entered in this
logistic regression model in the following order: 1) work hours, 2) sex, 3) age group, 4)
race/ethnicity, 5) occupation, 6) education, 7) insurance status, 8) taking insulin, and 9)
BMI category.
These variables were added because they have shown clinical significance in the
literature30-39 and were statistically associated with work characteristics and glycemic
control in the present study (see for example tables 4a-4d).
The order for the model was based on adding variables that had the greatest magnitude in
the association with glycemic control in the univariable model. Only the variables
statistically associated with both work hours and glycemic control and that had clinical
significance were entered in the model. There were no notable difference (i.e. change of
20% or greater in coefficients or p values) in the direction of the estimates (odds ratios)
and the p values for each category of the work hours variable and the other covariates in
the models at each step in the mode building procedure.
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The final multivariable logistic regression model assessing the relationship
between suboptimal glycemic control, work hours, and occupation among employed
adults with type 2 diabetes using NHANES 1999-2004 data are presented in Table 5.
Individuals aged 20 years or older with type 2 diabetes working greater than 40 hours
were more likely to have suboptimal glycemic control compared to those working 1-20
hours (OR= 5.03 [CI=1.37-18.42]), after controlling for sex, age group, race/ethnicity,
occupation, education, insurance, taking insulin, and BMI category. Although not
statistically significant at the 0.05 alpha level, individuals working 21-40 hours also had
greater odds for suboptimal glycemic control compared to those working 20 hours or less
(OR=1.91 [CI= 0.72-5.07]). In addition, farm workers were more likely to have
suboptimal glycemic control relative to white collar workers (OR=28.2 [CI=1.96-403.3]).

Table 5. Multivariable logistic regression. Relationship between suboptimal glycemic
control and work characteristics among employed adults with type 2 diabetes,
NHANES 1999-2004
Characteristic
Odds Ratio
95% Confidence Interval
Work hours
1-20 hours
1.00
21-40 hours
1.91
0.72- 5.07
41+ hours
5.03
1.37-18.42
Sex
Male
1.00
Female
0.92
0.35-2.44
Age group (yrs)
20-44
1.00
45-64
0.89
0.39- 2.02
65+
0.94
0.36-2.45
Race/Ethnicity
Non-Hispanic White
1.00
Non-Hispanic Black
3.36
1.49-7.58
Hispanic
2.10
0.91-4.81
Other
4.24
0.91-19.79
Occupation
White collar worker
1.00
Service worker
1.18
0.51- 2.72
Farm worker
28.2
1.96- 403.3
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Table 5 (continue)
Characteristic
Blue Collar worker
Education^
<HS
HS
>HS
Have insurance
No
Yes
Taking insulin
No
Yes
BMI category
Under/normal weight
Overweight
Obese
^ HS=High School

Odds Ratio
0.77

95% Confidence Interval
0.37-1.62

1.00
0.53
0.61

0.20-1.40
0.29-1.29

1.00
0.87

0.35- 2.12

1.00
3.97

1.45-10.89

1.00
0.48
0.79

0.16-1.48
0.34-1.82

Borderline glycemic control
Among the employed sample, univariable analyses indicated that individuals with
type 2 diabetes who worked greater than 40 hours relative to those who worked 20 hours
or less had greater odds for borderline glycemic control (OR=2.09 [CI=0.93-4.68])
(Table 4a-c). Although not statistically significant at the 0.20 alpha level (the level for
determining potential confounders), employed individuals with type 2 diabetes who
worked 21-40 hours were more likely than those who worked less than 20 hours
(OR=1.30 [CI=0.52-3.26]) to have borderline glycemic control. In addition, the type of
occupation was marginally associated with borderline glycemic control at the 0.20 alpha
level (the level for determining potential confounders). Specifically, farm workers were
also more likely than white collar workers to have borderline glycemic control
(OR=11.25 [p=0.03]). Other factors associated with greater odds of borderline glycemic
control at the 0.20 alpha level included: being a non-Hispanic Black (OR=2.37 [p=0.01]),
Hispanic (OR=1.38 [p=0.17]), or of other race/ethnic background (3.28 [p=0.12]) relative
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to non-Hispanic whites, taking diabetic pills (OR=2.57 [p=<0.001]), taking insulin
(OR=2.57 [p=0.03]), and having family history of diabetes (OR=1.61 [p=0.01]).
The other 2 main independent variables of interest for research question 1 (i.e.,
secondhand smoke exposure and desire to lose weight) were not statistically associated
with borderline glycemic control at the 0.20 alpha level among all adults or the employed
sample.
Multivariable model development: For the model to assess the relationship
between work hours, occupation, and borderline glycemic control, the order of how the
variables were entered in this logistic regression model was as follows: 1) work hours
category, 2) sex, 3) age group, 4), race/ethnicity, 5) occupation, 6) education, 7)
insurance status, 8) taking insulin, and 9) BMI category. These variables were added
because they have shown clinical significance in the literature30-39 and were statistically
associated with work characteristics and glycemic control in the present study (see for
example tables 4a-4d). The order for the model was based on adding variables that had
the greatest magnitude in the association with glycemic control in the univariable model.
Only the variables statistically associated with both work hours and glycemic control and
that had clinical significance were entered in the model.
When sex, age group, race/ethnicity, occupation, education, and insurance status
were added in the model, the direction of the estimates (odds ratios) for each category of
the work hours variable and the corresponding p values remained relatively unchanged
except that the work hours variable category of 41+ hours became statistically significant
when sex was added. When the variable ‘taking insulin’ was added, the odds ratio for the
category for ‘21-40 work hours’ and ‘41+ work hours’ doubled. When the BMI category
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and hypertension diagnosis were added, the direction of the estimates and the p values for
the work hours and the covariates (i.e., sex, age group, race/ethnicity, occupation,
education, and insurance status) remained relatively unchanged.
The final multivariable logistic regression model assessing the relationship
between borderline glycemic control, work hours, and occupation among employed
adults with type 2 diabetes using adjusting for confounders is presented in Table 6.
Individuals aged 20 years or older with type 2 diabetes working over 40 hours were more
likely to have borderline glycemic control compared to those working 1-20 hours
(OR=7.19 [CI= 1.88-27.45]), after controlling for sex, age group, race/ethnicity,
occupation, education, insurance, taking insulin, and BMI category.

Table 6. Multivariable logistic regression. Relationship between borderline (HbA1c
7-8.9%) glycemic control and work characteristics among employed adults with type
2 diabetes, NHANES 1999-2004
Characteristic
Odds Ratio
95% Confidence Interval
Work hours
1-20 hours
1.00
21-40 hours
2.39
0.82-6.90
41+ hours
7.19
1.88-27.45
Sex
Male
1.00
Female
1.03
0.37-2.83
Age group (yrs)
20-44
1.00
45-64
1.04
0.43-2.57
65+
1.90
0.59-6.12
Race/Ethnicity
Non-Hispanic White
1.00
Non-Hispanic Black
2.93
1.16-7.38
Hispanic
1.95
0.90-4.24
Other
4.99
0.83- 29.90
Occupation
White collar worker
1.00
Service worker
1.47
0.56-3.83
Farm worker
13.30
0.51-347.65
Blue Collar worker
0.71
0.28-1.83
Education
<HS
1.00
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Table 6 (continue)
Characteristic
HS
>HS
Have insurance
No
Yes
Taking insulin
No
Yes
BMI category
Under/normal weight
Overweight
Obese
^ HS=High School

Odds Ratio
0.36
0.56

95% Confidence Interval
0.10-1.29
0.22-1.43

2.67

0.98-7.27

1.00
3.35

1.13-9.88

1.00
0.35
1.04

0.12-1.07
0.38- 2.81

Of the interactions that were tested for the borderline glycemic control variable,
only ‘desire to lose weight’*race/ethnicity and ‘desire to lose weight’*sex were
significant. Individuals who wanted to lose weight and were of other race were
significantly less likely to have borderline glycemic control compared to individuals who
did not want to lose weight and were white (OR=0.23 [CI=0.06-0.95]). Females who
wanted to lose weight were more likely to have borderline glycemic control compared to
males who did not want to lose weight (OR=2.17 [CI=1.18-4.02]). The addition of these
interactions in the model did not appreciably alter the OR estimates for the ‘desire to lose
weight’ variable or the work hours or occupation variables in the logistic regression
model. Therefore the interaction variable was not included in the final model shown in
Table 6.

Poor glycemic control
At the 0.20 alpha level, among the employed sample, individuals with type 2
diabetes who were farm workers or blue collar workers were more likely to have poor
glycemic control relative to white collar workers (OR=9.21 [CI=1.66-51.09]) and
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(OR=2.35 [CI=1.06-5.21]), respectively (Table 2). Other factors associated with greater
odds of poor glycemic control included at the 0.20 alpha level included: being a nonHispanic Black (OR=2.55 [p=0.03]), and Hispanic (OR=2.54 [p=0.03]) relative to nonHispanic whites. Factors that were inversely related to poor glycemic control included
having more than a high school education compared to having less than a high school
education (OR=0.50 [p=0.03]), being 65 years of age or older relative to those aged 2044 years (OR=0.10 [p=0.02]), and having insurance (0.30 [p<0.01). The other 3 main
independent variables of interest for research question (i.e. work hours category,
secondhand smoke exposure and desire to lose weight) were not statistically associated
with poor glycemic control at the 0.20 alpha level among all adults or the employed
sample.
Multivariable model development: For the model to assess the relationship
between occupation and poor glycemic control, the order of how the variables were
entered in this logistic regression model was as follows: 1) occupation, 2) sex, 3) age
group, 4) race/ethnicity, 5) work hours category, 6) education, 7) insurance status, 8)
taking insulin, and 9) BMI category.
These variables were added because they have shown clinical significance in the
literature30-39 and because they were statistically associated with work characteristics and
glycemic control in the present study (see for example tables 4a-4d).
The order for the model was based on adding variables that had the greatest magnitude in
the association with glycemic control in the univariable model. Only the variables
statistically associated with both work hours and glycemic control and that had clinical
significance were entered in the model. When age group, race/ethnicity, and work hours,
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education, insurance, taking insulin, and BMI category were added, the direction of the
estimates and the p values for the occupation and the other covariates remained relatively
unchanged.
The final multivariable logistic regression model assessing the relationship
between poor glycemic control, occupation, and work hours among employed adults with
type 2 diabetes using NHANES 1999-2004 data are presented in Table 7. Among
individuals aged 20 years or older with type 2 diabetes and after adjusting for potential
confounders such as sex, age group, race/ethnicity, work hours category, education,
insurance, taking insulin, and BMI category, there was no statistically significant
relationship between poor glycemic control and being a farm worker (OR=9.93 [CI=0.94105.21]).

Table 7. Multivariable logistic regression. Relationship between poor glycemic
control (HbA1c > 9.0%) and work characteristics among employed adults with type
2 diabetes, NHANES 1999-2004
Characteristic
Odds Ratio
95% Confidence Interval
Work hours
1-20 hours
1.00
21-40 hours
1.32
0.30- 5.93
41+ hours
1.88
0.37-9.44
Sex
Male
1.00
Female
0.68
0.32-1.46
Age group (yrs)
20-44
1.00
45-64
0.58
0.24-1.38
65+
0.10
0.02- 0.73
Race/Ethnicity
NH White
1.00
NH Black
3.18
1.24-8.15
Hispanic
2.02
0.70-5.86
Other
1.51
0.42-5.35
Occupation
White collar
1.00
Service
0.89
0.29-2.72
Farm worker
9.93
0.94-105.21
Blue Collar
1.20
0.43-3.34
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Table 7 (continue)
Characteristic
Education^
<HS
HS
>HS
Have insurance
No
Yes
Taking insulin
No
Yes
BMI category
Under/normal weight
Overweight
Obese
^ HS=High School

Odds Ratio

95% Confidence Interval

1.00
1.21
0.78

0.41-3.63
0.34 -1.82

0.37

0.15-0.91

2.21

1.10-4.84

1.00
0.77
0.42

0.27-2.24
0.16-1.10

The Sobel test for mediation was used to test for the indirect effect of work hours
on suboptimal and borderline glycemic control through the number of visits to a
healthcare provider. This test was not statistically significant for suboptimal or borderline
glycemic control (test statistic 1.294, [p=0.195] and 0.744 [p=0.456]) or for the indirect
effect of farm worker occupation on suboptimal glycemic control (test statistic 1.817,
[p=0.069]).

Summary of results of research question 1
In summary, it was found that diabetics working greater than 40 hours per week,
relative to those working 1-20 hours per week, had greater odds of having suboptimal and
borderline glycemic control, after adjusting for potential confounders. Farm workers,
relative to white collar workers, were also at greater odds for suboptimal glycemic
control, after adjusting for potential confounders. In addition, being a non-Hispanic
Black, compared to non-Hispanic white, and taking insulin as opposed to not taking
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insulin, were risk factors for suboptimal, borderline, and poor glycemic control.
However, secondhand smoke exposure among non-smokers and desire to lose weight
were not found to be statistically significant with glycemic control.

The association between glycemic control and HRQOL
Part of the second research question in this study was whether suboptimal,
borderline, and poor glycemic control were associated with HRQOL measures indicative
of poor health (i.e., greater days of poor physical and mental health and inactivity and
poor self-reported general health). It was hypothesized that suboptimal, borderline, and
poor glycemic control would be inversely associated with all four HRQOL measures,
after controlling for potential confounders.
Cross-tabulations for each of the four HRQOL measures and each of the three
glycemic control variables and the corresponding chi-square test statistics are shown in
Table 8. The univariable multinomial regression analyses for number days of poor
mental health, physical health and activity limitation are presented in Table 9. The
univariable analyses for the self-reported general health variable are reported separately
(i.e., not in Table 9) because it is a dichotomous variable requiring logistic regression as
opposed to the other HRQOL variables that require multinomial logistic regression due to
the three categories for each variable.
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Table 8. Cross-tabulations† of health related quality of life variables and suboptimal (HbA1c >
7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control, adults classified
with type 2 diabetes, NHANES 1999-2004
Glycemic Control*
Suboptimal**
Borderline**
Poor**
N (%)
N (%)
N (%)
No
Yes
No
Yes
No
Yes
Self-rated health
Fair/poor
227(56.3)
200(43.7) 227(65.2)
139(34.8)
366 (84.3)
75 (15.7)
Good/very
213 (57.1
198(42.9) 213(65.4)
133(34.6)
346 (84.0)
77 (16.0)
good/excellent
Days of poor
mental health
0
188 63.1)
287(54.5)
273(45.5) 287(58.9)
475 (84.4)
98 (15.6)
1-13
44 (25.7)
102(67.0)
63 (33.0) 102(74.3)
146 (86.5)
24 (13.6)
14-30
69 (59.5)
57(40.5))
69 (49.0)
87 (51.0)
126 (72.6)
52 (27.4)
Days of poor
physical health
0
244(58.5)
213(41.9) 244(54.5)
137(45.8)
381 (82.5)
88 (17.5)
1-13
100(52.8)
104(47.2) 100(58.9)
77 (28.8)
177 (86.8)
34 (13.2)
14-30
114(62.5)
106(46.0) 114(23.1)
75 (37.5)
189 (77.6)
52 (22.4)
Days of inactivity
0
340(56.5)
313(43.5) 340(73.5)
21(34.3)
555 (83.6)
116(16.4)
1-13
56 (55.0)
51 (45.1)
56 (12.6)
36 (40.0)
92 (86.8)
21 (13.2)
14-30
62 (53.7)
59 (46.3)
62 (13.9)
38 (14.0)
100 (72.5)
37 (27.4)
*row percentages=100, percentages do not reflect sample size in each cell due to weighted analyses.
** Statistically significant differences at the 0.05 level appear in bold.
†
Designed based Pearson statistics performed to account for complex survey design.

Self-rated general health
As shown in the cross-tabulations distributions (table.8), self-rated health groups
did not differ significantly with respect to suboptimal, borderline, and poor glycemic
control. In addition, in the univariable logistic regression models, neither suboptimal
glycemic control (OR=0.97 [CI=0.67-1.40]), borderline (OR=0.99 [CI=0.67-1.47]), or
poor glycemic control (OR=1.02 [CI=0.62-1.67]), were associated with fair/poor selfrated general health (versus excellent, very good, or good health) among adults with type
2 diabetes sampled from 2001-2004.
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Days of poor mental health in the past 30 days
As shown in the cross-tabulations (table 8), the proportions of suboptimal,
borderline, and poor glycemic control were significantly different among poor mental
health groups. In the univariable models, suboptimal, and poor glycemic control were
each associated with greater number of days of poor mental health days among adults
with type 2 diabetes who were 20 years of age or older sample in NHANES 2001-2004
(table 9). Specifically, suboptimal glycemic control (OR=0.59 [CI=0.38-0.92]) was
associated with lower odds of having 1-13 days of poor mental health versus ‘0 days of
poor mental health in the past 30 days. However, poor glycemic control was associated
with greater odds of having 14 days or more versus 0 days of poor health in the past 30
days (OR=2.04 [CI=1.34-3.11]). In addition, borderline glycemic control was marginally
associated with 1-13 days of poor mental health (OR=0.59 [CI=0.36-1.00). Since there
was marginal significance for the relationship between borderline glycemic control and
poor mental health, further multinomial logistic regression analyses were conducted
adjusting for potential confounders.

Table 9. Multinomial logistic regression. Relationship between days of poor physical and mental
health and activity limitation among adults with type 2 diabetes with suboptimal (HbA1c > 7.0%),
borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control, NHANES 2001-2004
Days of
Poor Physical Health
Poor Mental Health
Limited Activity
1-13 days
>= 14
1-13 days
>= 14 days
1-13 days
>= 14 days
days
Characteristic
OR
OR
OR
OR
OR
OR
(95% CI) (95% CI)
(95% CI)
(95% CI)
(95% CI)
(95% CI)
Suboptimal
glycemic
control
No
1.00
1.00
1.00
1.00
1.00
1.00
Yes
1.18
1.23
1.25
1.06
1.12
0.59
(0.84(0.78(0.89-1.74)
(0.63-1.78)
(0.65-1.93)
(0.89-0.92)
1.66)
1.95)
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Table 9 (continue)
Poor Physical Health
1-13 days
>= 14
days
OR
OR
(95% CI) (95% CI)
Borderline
No
Yes

1.00
1.53
(1.002.34)

1.00
1.31
(0.891.92)

Days of
Poor Mental Health
1-13 days
>= 14
days
OR
OR
(95% CI) (95% CI)
1.00
0.59
(0.361.00)

1.00
1.17
(0.771.76)

Limited Activity
1-13 days
>= 14 days
OR
(95% CI)

OR
(95% CI)

1.00
1.28
(0.75-2.18)

1.00
1.05
(0.60-1.82)

Poor
No
Yes

1.00
1.00
1.00
1.00
1.00
1.00
0.72
1.36
0.85
0.78
2.04
1.93
(0.40(0.81(0.48(0.42-1.43)
(1.34(1.01-3.70)
1.32)
2.29)
1.52)
3.11)
Note: 0 days of poor physical, mental health or activity limitation is the reference category.

Multivariable model development: For the models built to assess the relationship
between number of days of poor physical health and all of the three glycemic control
variables, the variables were entered in this multinomial logistic regression model in the
following order: 1) sex, 2) age group, 3) race/ethnicity, 4) education, 5) employment
status, 6) insurance status, and 7) taking insulin. The order for the model was based on
adding variables that had the greatest magnitude in the association with glycemic control
in the univariable model. Only the variables statistically associated with both day of poor
physical health and glycemic control and that had clinical significance were entered in
the model. There were no meaningful changes in the direction, strength or significance of
the odds ratio of the glycemic control variables or the other covariates added at each
point that a covariate was entered.
Table 10 shows the final multivariable multinomial logistic regression model for
the relationship between suboptimal glycemic control and poor mental health. Adults
with type 2 diabetes who had suboptimal glycemic control were less likely to have > 1-13
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days versus 0 days of poor mental health compared to those with good glycemic control
(OR=0.50 [CI=0.30-0.83]), after controlling for sex, age group, race/ethnicity, education,
insurance, employment status and taking insulin.

Table 10. Multinomial logistic regression. Relationship between suboptimal glycemic control
(HbA1c >7.0%) and days with poor mental health among adults with type 2 diabetes, NHANES
2001-2004
Days of poor mental health
1-13 days
≥14 days
Characteristics
OR
95% CI
OR
95% CI
Suboptimal
glycemic control
No
1.00
1.00
Yes
1.03
0.67-1.60
0.50
0.30-0.83
Sex
Male
1.00
1.00
Female
1.07
0.69-1.67
1.53
0.86-2.72
Age group (yrs)
20-44
1.00
1.00
45-64
1.29
0.65-2.55
0.90
0.41-2.01
65+
0.49
0.20-1.19
0.20
0.08-0.47
Race/Ethnicity
NH White
1.00
1.00
NH Black
0.98
0.57-1.67
0.69
0.38-1.24
Hispanic
1.22
0.61-2.46
0.43
0.22-0.84
Other
0.36
0.18-1.11
0.65
0.21-2.03
Education^
<HS
1.00
1.00
HS
1.23
0.63-2.38
0.74
0.35-1.56
>HS
1.40
0.77-2.53
0.43
0.24-0.75
Employed
No
Yes
0.79
0.49-1.28
0.39
0.24-0.65
Have insurance
No
1.00
1.00
Taking Insulin
No
1.00
1.00
Yes
1.62
0.78-3.39
2.07
1.14-3.76
Note: 0 days of poor physical, mental health or activity limitation is the reference category.

^ HS=High School

Table 11 shows the final multivariable multinomial logistic regression model for
the relationship between borderline glycemic control and poor mental health. Adults with
type 2 diabetes who had borderline glycemic control were less likely to have > 1-13 days
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versus 0 days of poor mental health (OR=0.55 [CI=0.31-0.98]), after controlling for
potential confounders.

Table 11. Multinomial logistic regression. Relationship between borderline glycemic control
(HbA1c 7-8.9%) and days with poor mental health among adults with type 2 diabetes, NHANES
2001-2004
Days of poor mental health
1-13 days
≥14 days
Characteristic
OR
(95% CI)
OR
(95% CI)
Borderline glycemic
control
No
1.00
1.00
Yes
1.00
0.60-1.67
0.55
0.31-0.98
Sex
Male
1.00
1.00
Female
1.30
0.78-2.16
1.62
0.92-2.88
Age group (yrs)
20-44
1.00
1.00
45-64
1.13
0.55-2.32
0.74
0.32-1.73
65+
0.42
0.16-1.13
0.17
0.07-0.44
Race/Ethnicity
NH White
1.00
1.00
NH Black
0.89
0.52-1.52
0.75
0.38-1.48
Hispanic
1.70
0.84-3.43
0.52
0.24-1.14
Other
0.39
0.13-1.14
0.63
0.19-2.10
Education^
<HS
1.00
1.00
HS
1.27
0.61-2.61
0.84
0.43-1.64
>HS
1.54
0.82-2.92
0.51
0.29-0.92
Employed
No
1.00
1.00
Yes
0.73
0.43-1.26
0.41
0.21-0.80
Have insurance
No
1.00
1.00
Yes
0.94
0.36-2.48
2.18
0.89-5.36
Taking insulin
No
Yes
1.43
0.59-3.48
1.94
1.01-3.74
Note: 0 days of poor physical, mental health or activity limitation is the reference category.
^ HS=High School

Table 12 shows the final multivariable multinomial logistic regression model for
the relationship between poor glycemic control and number of days of poor mental
health. Adults with type 2 diabetes who had poor glycemic control were more likely to
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have > 14 days versus 0 days of poor mental health compared to those with good
glycemic control (OR=1.73 [CI=1.14-2.64]), after controlling for sex, age group,
race/ethnicity, education, insurance, employment status and taking insulin. Although not
statistically significant but similar to results using the other glycemic control variables,
adults with poor glycemic control were less likely to have 1-13 days (versus 0 days) of
poor mental health compared to those with good glycemic control.

Table 12. Multinomial logistic regression. Relationship between poor glycemic control (HbA1c >
9.0%) and days with poor mental health among adults with type 2 diabetes, NHANES 2001-2004
Days of poor mental health
1-13 days
>= 14 days
Characteristic
OR
(95% CI)
OR
(95% CI)
Poor glycemic
control
No
1.00
1.00
Yes
0.69
0.38-1.26
1.73
1.14-2.64
Sex
Male
1.00
1.00
Female
1.08
0.71-1.64
1.65
1.03-2.65
Age group (yrs)
20-44
1.00
1.00
45-64
1.25
0.62-2.53
0.72
0.38-1.37
65+
0.50
0.21-1.16
0.69
0.08-0.36
Race/Ethnicity
NH White
1.00
1.00
NH Black
0.90
0.55-1.46
0.69
0.40-1.19
Hispanic
1.24
0.64-2.42
0.46
0.24-0.90
Other
0.66
0.24-1.81
0.30
0.10-0.93
Education^
<HS
1.00
1.00
HS
1.22
0.61-2.45
0.66
0.33-1.32
>HS
1.64
0.90-3.00
0.44
0.25-0.76
Employed
No
Yes
0.77
0.48-1.25
0.41
0.25-0.69
Have insurance
No
1.00
1.00
Yes
0.91
0.39-2.10
1.54
0.70-3.39
Taking insulin
No
1.00
1.00
Yes
1.37
0.68-2.79
2.32
1.51-3.58
Note: 0 days of poor physical, mental health or activity limitation is the reference category.
^ HS=High School
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Days of poor physical health in the past 30 days
As shown in the cross-tabulations (table 8), the proportions of days of poor
physical health were not statistically significantly different among the various glycemic
control groups. In addition, in univariable models, neither suboptimal nor poor glycemic
control was associated with number of days with poor physical health (table 9). However,
borderline glycemic control was marginally associated with poor physical health at the
0.20 alpha level. Specifically, borderline glycemic control was associated with greater
odds of having 1-13 days of poor physical health versus 0 days of poor physical health in
the past 30 days (OR=1.53 [CI=1.00-2.34]), p= 0.05). Since there was marginal
significance for borderline glycemic control, further multinomial logistic regression
analyses were conducted adjusting for potential confounders.
Multivariable model development: For the model to assess the relationship
between the number of days of poor physical health and borderline glycemic control, the
variables were entered in this multinomial logistic regression model in the following
order: 1) sex, 2) age group, 3) race/ethnicity 4) education, 5) employment status, 6)
insurance status, and 7) taking insulin. The order for the model was based on adding
variables that had the greatest magnitude in the association with glycemic control in the
univariable model. Only the variables statistically associated with both number of days of
poor physical health and glycemic control and that had clinical significance were entered
in the model. There were no meaningful changes in the direction, strength or significance
of the odds ratio for the borderline glycemic control variable or the other covariates
added at each point a covariate was entered.
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Table 13 shows the final multivariable multinomial logistic regression model
assessing the relationship between borderline glycemic control and number of days of
poor physical health. Adults with type 2 diabetes who had borderline glycemic control
were statistically more likely to have 1-13 days versus 0 days of poor physical health
compared to those with good control (OR=1.59 [CI=1.03-2.45]); the relationship was
however not statistically significant for having at least 14 days of poor physical health
(OR=1.30 [CI=0.81-2.07]), after controlling for sex, age group, race/ethnicity, education,
insurance, employment status, and taking insulin. Being employed was protective against
having > 14 days versus 0 days of poor physical health (OR=0.30 [CI=0.16-0.57]).

Table 13. Multinomial logistic regression. Relationship between borderline glycemic control
(HbA1c 7-8.9%) and days with poor physical health among adults with type 2 diabetes, NHANES
2001-2004
Days of poor physical health
1-13 days
≥14 days
Characteristic
OR
(95% CI)
OR
(95% CI)
Borderline glycemic
control
No
1.00
1.00
Yes
1.30
0.81-2.07
1.59
1.03-2.45
Sex
Male
1.00
1.00
Female
1.46
0.98-2.16
1.58
1.09-2.29
Age group (yrs)
20-44
1.00
1.00
45-64
0.91
0.39-2.11
1.14
0.55-2.37
65+
0.30
0.14-0.63
0.44
0.21-0.94
Race/Ethnicity
NH White
1.00
1.00
NH Black
0.92
0.47-1.80
1.14
0.62-2.09
Hispanic
0.81
0.30-2.15
0.44
0.21-0.92
Other
1.05
0.43-2.55
0.74
0.26-2.11
Education^
<HS
1.00
1.00
HS
1.38
0.77-2.48
0.72
0.36-1.43
>HS
1.69
0.98-2.91
0.53
0.27-1.01
Employed
No
Yes
0.30
0.16-0.57
0.44
0.24-0.80
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Table 13 (continue)
Characteristic
Have insurance
No
Yes
Taking insulin
No
Yes

OR

1-13 days
(95% CI)

OR

≥14 days
(95% CI)

1.00
0.69

0.28-1.70

1.00
1.30

0.59-2.79

1.00
1.83

0.85-3.96

1.00
1.44

0.73-2.85

Note: 0 days of poor physical, mental health or activity limitation is the reference category.

^ HS=High School

Days of inactivity due to poor health in the past 30 days
As shown in the cross-tabulations (table 8) proportions of suboptimal, borderline,
or poor glycemic control were not significantly different among days of inactivity groups.
In univariable models, while suboptimal or borderline glycemic control was not
associated with number of inactivity days, poor glycemic control was. Specifically,
among adults with type 2 diabetes, those with poor glycemic control were more likely to
have > 14 days versus 0 days of inactivity (OR=1.93 [CI=1.01-3.70]) (table 9).
Multivariable model development: For the model to assess the relationship
between number of days of inactivity and poor glycemic control the order of how
variables were entered in this multinomial logistic regression model was as follows: 1)
sex, 2) age group, 3) race/ethnicity, 4) education, 5) employment status, 6) insurance
status, and 7) taking insulin. The order for the model was based on adding variables that
had the greatest magnitude in the association with glycemic control in the univariable
model. Only the variables statistically associated with both inactivity days and glycemic
control and that had clinical significance were entered in the model.
Table 14 shows the final multivariable multinomial logistic regression model
assessing the relationship between number of days of inactivity and poor glycemic
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control. Adults with type 2 diabetes who had poor glycemic control were more likely to
have > 14 days versus 0 days of inactivity compared to those with good control
(OR=2.00 [CI=1.07-3.76]), after controlling for sex, age group, race/ethnicity, education,
insurance, employment status, and taking insulin. Among the confounders, being
Hispanic was inversely associated with having > 14 days versus 0 days of poor physical
health (OR=0.32 [CI=0.14-0.71]).

Table 14. Multinomial logistic regression. Relationship between poor glycemic control (HbA1c >
9.0%) and inactivity days among adults with type 2 diabetes, NHANES 2001-2004
Days of inactivity
1-13 days
≥ 14 days
Characteristic
OR
(95% CI)
OR
(95% CI)
Poor glycemic
control
No
1.00
1.00
Yes
0.71
0.35-1.43
2.00
1.07-3.76
Sex
Male
1.00
1.00
Female
1.63
0.89-2.97
1.31
0.81-2.14
Age group (yrs)
20-44
1.00
1.00
45-64
0.58
0.26-1.29
0.77
0.32-1.85
65+
0.22
0.07-0.66
0.22
0.09-0.53
Race/Ethnicity
NH White
1.00
1.00
NH Black
1.03
0.56-1.92
0.72
0.33-1.61
Hispanic
0.35
0.17-0.74
0.32
0.14-0.71
Other
0.7
0.24-2.12
0.88
0.36-2.14
Education^
<HS
1.00
1.00
HS
0.81
0.43-1.50
0.35
0.15-0.86
>HS
0.73
0.31-1.69
0.38
0.17-0.85
Employed
No
Yes
0.52
0.22-1.21
0.22
0.10-0.45
Have insurance
No
1.00
1.00
Yes
1.61
0.58-4.50
4.01
1.56-10.28
Taking insulin
No
1.00
1.00
Yes
1.83
0.99-3.34
1.68
0.86-3.26
Note: 0 days of poor physical, mental health or activity limitation is the reference category.
^ HS=High School
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Missed work days and glycemic control
Part of the second research question in this study was to examine whether
suboptimal, borderline, and poor glycemic control were associated with greater number
of missed work days in the past 12 months among workers with type 2 diabetes. It was
hypothesized that suboptimal, borderline, and poor glycemic control was associated with
greater number of missed work days in the past 12 months, after controlling for potential
confounders. Neither suboptimal (beta coefficient -0.50 [-1.23, -0.23]), borderline
glycemic control, or poor glycemic control (beta coefficient -0.39 [-0.98, -0.21]), were
associated with number of missed work days.

Employment and glycemic control
Part of the second research question in this study was whether suboptimal,
borderline, and poor glycemic control was associated with employment among adults
with type 2 diabetes. It was hypothesized that suboptimal, borderline, and poor glycemic
control was inversely associated with employment, after controlling for potential
confounders.
Cross-tabulations of employment and glycemic control and the corresponding
Chi-square test statistics are shown in table 15. The proportions of employed versus
unemployed did not vary by glycemic control groups. In univariable logistic regression,
neither suboptimal glycemic control (OR=1.22 [CI=0.88-1.70]) nor borderline glycemic
control (OR=1.05 [CI=0.75-1.48]) were significantly associated with employment.
However, poor glycemic control was significantly associated with employment status
(OR=1.62 [CI=1.05-2.53]).
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Table 15. Cross-tabulations† of health related quality of life variables and suboptimal (HbA1c >
7.0%), borderline (HbA1c > 7.0-8.9%), and poor (HbA1c > 9.0%) glycemic control among adults
classified with type 2 diabetes, NHANES 1999-2004
Glycemic Control*
Suboptimal**
Borderline**
Poor**
N (%)
N (%)
N (%)
No
Yes
No
Yes
No
Yes
Employed
No
449 (52.5)
454 (47.6)
449 (60.4)
314 (39.6)
763(86.8)
140 (13.2)
Yes
153 (47.4)
216 (52.6)
153 (59.2)
134 (40.8)
287(80.1)
82 (19.9)
*row percentages=100, percentages do not reflect sample size in each cell due to weighted analyses.
** Statistically significant differences at the 0.05 level appear in bold.
†
Designed based Pearson statistics performed to account for complex survey design.

Multivariable model development: For the model assessing the relationship
between employment status and poor glycemic control the variables were added in the
model as follows: 1) poor glycemic control, 2) sex, 3) age group, 4) race/ethnicity, 5)
education, 6) insurance, 7) taking insulin, and 8) CVD status. The order for the model
was based on adding variables that had the greatest magnitude in the association with
glycemic control in the univariable model. Only the variables statistically associated with
both employment and glycemic control and that had clinical significance were entered in
the model. When age group was added in the model, the estimate for poor glycemic
control changed direction, but was no longer statistically significant (0.98 [0.61-1.57]);
there were no sex differences. When race/ethnicity was added, the direction of the
estimates and the p values for the variables in the model remained relatively unchanged
except that the direction for poor glycemic control changed (OR=1.02 [CI=0.65-1.63]).
Sequential addition of the other covariates (i.e. education, insurance status, taking insulin,
and CVD status) did not result in any meaningful changes in the direction or significance
of the estimates for poor glycemic control or the other covariates.
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Table 16 displays the final multivariable logistic regression model for the
relationship between employment status and poor glycemic control. In the final adjusted
model, although the results were not significant, adults with type 2 diabetes who had poor
glycemic control were slightly more likely to be employed (OR=1.10 [CI=0.70-1.73]).
Sex specific analyses were also conducted. Females with poor glycemic control
were less likely to be employed (OR=0.84 [CI=0.39-1.79], while males with poor
glycemic control were more likely to be employed (OR=1.55 [CI=0.76-3.18]).

Table 16. Multivariable logistic regression. Relationship between employment status
and poor glycemic control (HbA1c >9%) among adults with type 2 diabetes,
NHANES 1999-2004
Characteristic
Odds Ratio
95% Confidence Interval
Poor glycemic control
Employment
No
1.00
Yes
1.10
0.70-1.73
Sex
Male
1.00
Female
0.42
0.29-0.62
Age group (yrs)
20-44
1.00
45-64
0.44
0.22-0.87
65+
0.05
0.03-0.09
Race/Ethnicity
NH White
1.00
NH Black
0.88
0.52-1.48
Hispanic
1.08
0.54-2.17
Other
0.77
0.37-1.57
Education^
<HS
1.00
HS
2.10
1.20-3.68
>HS
2.46
1.50-4.02
CVD history
No
1.00
Yes
0.46
0.29-0.74
Taking insulin
No
1.00
Yes
0.63
0.38-1.03
Have insurance
No
1.00
Yes
1.12
0.68-1.85
^ HS=High School
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Summary of results of research question 2
In summary, it was found that the odds having 1-13 days of poor mental health
were greater among those having suboptimal and borderline glycemic control.
Individuals with poor glycemic control were more likely to report at least 14 days of poor
mental health as well as inactivity in the past 30 days. In addition, greater odds for having
1-13 days of poor physical health in the past 30 days were reported among those with
borderline glycemic control. However, the other measures of overall health and wellbeing, such as self-rated general health, missed work in the past 30 days and employment
status, were not statistically associated with having suboptimal, borderline, or poor
glycemic control, after controlling for potential confounders.

Glycemic control and all-cause mortality risk
Part of the third research question was whether suboptimal, borderline, and poor
glycemic control were associated with greater all-cause mortality risk among US adults
with type 2 diabetes, controlling for potential confounders. It was hypothesized that
individuals with suboptimal, borderline, and poor glycemic control would have greater
all-cause mortality risk.
Cross-tabulations of all-cause mortality and participant characteristics including
glycemic control along with the corresponding chi-square test statistics are shown in table
17. In un-adjusted Cox proportional hazards models, neither suboptimal (HR=1.22
[CI=0.95-1.58]), borderline (HR=1.28 [CI=0.98-1.68]), or poor glycemic control
(HR=1.03 [CI=0.98-1.57]) were associated with greater likelihood of all-cause mortality
among adults with type 2 diabetes (Table 18). Factors associated with all-cause mortality
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in un-adjusted analyses included being greater than 65 years of age (HR=6.01 [CI=2.3615.61]), being Hispanic (HR 0.59 [0.44-0.78]), being married or living with a partner
(HR=1.75 [CI=1.29-2.36]), cancer history (HR=1.58 [CI=1.05-2.38]), being obese (HR=
0.54 [CI=0.37-0.78]), taking insulin (HR=0.59 [CI=0.41-0.85]), and being a high school
graduate (HR=0.66 [CI=0.49-0.91]) or having more than a high school education
(HR=0.57 [CI=0.37-0.88]) (Table 18). Since age is an important predictor of death, and
because we wanted to assess the possibility of confounders, age and other variables were
included in the adjusted model.
The covariates included in the adjusted models for each of the glycemic control
variables were entered in the following order: 1) age group, 2) sex, 3) race/ethnicity, 4)
education, 5) BMI category, 6) duration of diabetes, 7) cancer history, and
8) hypertension diagnosis. However, there were no differences in the association
between the glycemic control variables and mortality risk after each covariate was
sequentially added to the model. There were also no changes in the hazard ratios of the
other covariates as each variable was added in the model.

Table 17. Cross-tabulations† of cause of death with participant characteristics,
adults classified with type 2 diabetes, NHANES 1986-1994 and NHANES III
mortality linked data file
Cause of Death
All-cause
Cardiovascular
N (%)
N (%)
No
Yes
No
Yes
Suboptimal glycemic
control
No
296 (67.6)
210 (32.4)
96 (42.2)
114 (57.8)
Yes
402 (63.5)
264 (36.5)
137(52.3)
127 (47.7)

83

Table 17 (continue)
All-cause
N (%)

Cause of Death
Cardiovascular
N (%)
Yes
No
Yes

No
Borderline glycemic
control
No
296 (67.60
210 (32.4)
96 (42.2)
114 (57.8)
Yes
214 (62.1)
149 (37.9)
77 (56.2)
72 (43.8)
Poor glycemic
control
No
510 (65.3)
359 (34.7)
173(48.5)
186 (51.5)
Yes
188 (65.4)
115 (34.6)
60 46.6)
55 (53.4)
Sex
Male
321 (66.4)
304 (33.6)
140(42.6)
164 (57.4)
Female
458 (64.2)
296 (35.8)
145(52.9)
151 (47.1)
Age group
20-44
8 (69.0)
2 (31.0)
114 (87.7)
10 (12.3)
45-64
72 (54.1)
55 (45.9)
355 (79.9)
127 (20.1)
65+
205(45.1)
258 (54.9)
310 (44.2)
463 (55.8)
Race/ethnicity
Non-Hispanic White
127(46.5)
174 (53.5)
261 (63.4)
301 (36.6)
Non-Hispanic Black
84 (58.6)
69 (41.4)
212 (63.5)
153 (36.5)
Hispanic
70 (58.5)
64 (41.5)
267 (76.9)
134 (23.1)
Other
4 (36.3)
8 (63.7)
39 (81.5)
12 (18.5)
Education^
< HS
183(48.6)
212 (51.4)
465 (57.8)
395 (42.2)
HS
56 (49.5)
53 (50.5)
178 (69.4)
109 (30.6)
>HS
39 (45.4)
46 (54.6)
130 (74.4)
85 (26.0)
Marital status
Not married
145(42.7)
177 (57.3)
506 (70.8)
322 (29.2)
139(55.2)
137 (44.8)
Married/living with
270 (55.0)
276 (45.0)
partner
Hypertension diagnosis
No
357 (66.6)
238 (33.4)
114(49.7)
124 (50.4)
Yes
422 (64.2)
359 (35.8)
170(47.1)
189 (52.9)
Cancer history
No
234(45.6)
271 (54.4)
718 (67.0)
505 (33.0)
Yes
51 (60.7)
44 (39.2)
61 (53.9)
95 (46.1)
Take insulin
No
132(46.5)
158 (53.5)
197 (55.2)
211 (44.8)
Yes
153(52.3)
153 (47.7)
581 (68.8)
389 (31.2)
BMI category
Normal/under weight
65 (49.3)
66 (50.7)
122 (53.4)
131 (46.6)
Overweight
94 (41.8)
114 (58.2)
266 (64.5)
208 (35.5)
Obese
86 (54.0)
73 (46.0)
334 (70.6)
159 (39.4)
*row percentages=100, percentages do not reflect sample size in each cell due to
weighted analyses.
** Statistically significant differences at the 0.05 level appear in bold.
†
Designed based Pearson statistics performed to account for complex survey design.
^ HS=High School
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Table 18. Un-adjusted Cox proportional hazards model. Factors associated with all-cause
and cardiovascular mortality risk among adults with type 2 diabetes, NHANES III
Cause of Death
All-cause
Cardiovascular
Hazards
95%
Hazards
95%
Ratio
Confidence
Ratio
Confidence
Interval
Interval
Suboptimal glycemic control
No
Yes
Borderline glycemic
control
No
Yes
Poor glycemic
control
No
Yes
Sex
Male
Female
Age group
20-44
45-64
65+
Race/ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic
Other
Education^
< HS
HS
> HS
Marital status
Not married
Married/living with partner
Hypertension diagnosis
No
Yes
Cancer history
No
Yes
Take insulin
No
Yes
Duration of diabetes
BMI category
Normal/under weight
Overweight
Obese
^ HS=High School

1.00
1.22

0.95-1.58

1.00
1.04

0.75-1.44

1.00
1.28

0.98-1.68

1.00
1.00

0.68-1.49

1.00
1.03

0.98-1.57

1.00
1.09

0.54-2.19

1.00
1.06

0.82-1.38

1.00
0.91

0.67-1.23

1.00
1.57
6.01

0.63-3.94
2.36-15.61

1.00
2.14
10.56

0.34-13.19
1.77-63.21

1.00
1.04
0.59
0.53

0.80-1.35
0.44-0.78
0.21-1.37

1.00
0.81
0.47
0.63

0.58-1.12
0.29-0.77
0.19-2.15

1.00
0.66
0.57

0.49-0.91
0.37-0.88

1.00
0.57
0.66

0.39-0.83
0.44-0.99

1.00
1.75

1.29-2.36

1.00
1.40

0.91-2.16

1.00
1.05

0.77-1.42

1.00
1.08

0.74-1.58

1.00
1.58

1.05-2.38

1.00
1.14

0.71-1.85

1.00
0.59
1.03

0.41-0.85
1.02-1.04

1.00
0.67
1.03

0.41-1.09
1.01-1.04

1.00
0.70
0.54

0.47-1.04
0.37-0.78

1.00
0.80
0.47

0.51-1.24
0.28-0.79

85

Suboptimal glycemic control
The adjusted Cox proportional hazards model for the relationship between
suboptimal glycemic control and all-cause mortality risk for a participants is presented in
Table 19. Suboptimal glycemic control was not statistically associated with all-cause
mortality risk among adults with type 2 diabetes (HR=1.24 [CI=0.99-1.56]).

Table 19. Adjusted Cox proportional hazards model. Relationship between
suboptimal glycemic control and all-cause mortality risk among adults with type 2
diabetes, NHANES III
Characteristic
Hazards Ratio
95% Confidence Interval
Suboptimal glycemic control
No
1.00
Yes
1.24
0.99-1.56
Age group (yrs)
20-44
1.00
45-64
1.75
0.61-4.99
65+
5.66
202-15.82
Sex
Male
1.00
Female
0.90
0.68-1.18
Race/Ethnicity
NH White
1.00
NH Black
1.05
0.77-1.43
Hispanic
0.62
0.48-0.80
Other
0.63
0.24-1.63
Education^
<HS
1.00
HS
0.69
0.49-0.97
>HS
0.63
0.45-0.88
BMI category
Under/normal weight
1.00
Overweight
0.67
0.45-0.99
Obese
0.65
0.45-0.94
1.01
0.99-1.02
Duration of diabetes (yrs)
Hypertension diagnosis
No
1.00
Yes
1.07
0.80-1.42
Cancer history
No
1.00
Yes
1.21
0.79-1.86
^ HS=High School
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Borderline glycemic control
The adjusted Cox proportional hazards model for the relationship between
borderline glycemic control and all-cause mortality risk is presented in Table 20.
Borderline glycemic control was not statistically associated with all-cause mortality risk
among adults with type 2 diabetes in un-stratified analyses (HR=1.20 [CI=0.94-1.53]) or
in the stratified analyses (HR=1.02 [CI=0.61-1.71] and HR=1.21 [CI=0.78-2.86]) for
males and females, respectively.

Table 20. Adjusted Cox proportional hazards model. Relationship between
borderline glycemic control and all-cause mortality risk among adults with type 2
diabetes, NHANES III
Characteristic
Hazards Ratio
95% Confidence Interval
Borderline Glycemic control
No
1.00
Yes
1.20
0.94-1.53
Age group (yrs)
20-44
1.00
45-64
1.11
0.37-3.35
65+
3.69
1.25-10.87
Sex
Male
1.00
Female
0.96
0.71-1.30
Race/Ethnicity
NH White
1.00
NH Black
1.02
0.71-1.48
Hispanic
0.59
0.39-0.88
Other
0.46
0.16-1.34
Education^
<HS
1.00
HS
0.77
0.54-1.09
>HS
0.60
0.39-0.93
BMI category
Under/normal weight
1.00
Overweight
0.70
0.45-1.08
Obese
0.70
0.44-0.98
1.01
1.00-1.02
Duration of diabetes (yrs)
Hypertension diagnosis
No
1.00
Yes
1.16
0.88-1.54
Cancer history
No
1.00
Yes
1.18
0.77-1.81
^ HS=High School
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Poor glycemic control
The adjusted Cox proportional hazards model for the relationship between poor
glycemic control and all-cause mortality risk is presented in Table 21. Poor glycemic
control was not statistically associated with all-cause mortality risk (HR=1.24 [CI=0.791.95]). Of note, addition of the interaction term of BMI category and sex did not change
the results in the in the adjusted model nor was it statistically significant when added in
the model.

Table 21. Adjusted Cox proportional hazards model. Relationship between poor
glycemic control and all-cause mortality risk among adults with type 2 diabetes,
NHANES III
Characteristic
Hazards Ratio
95% Confidence Interval
Poor glycemic control
No
1.00
Yes
1.24
0.79-1.96
Age group (yrs)
20-44
1.00
45-64
1.81
0.62-5.20
65+
5.89
2.10-16.54
Sex
Male
1.00
Female
0.89
0.68-1.17
Race/Ethnicity
NH White
1.00
NH Black
1.03
0.77-1.41
Hispanic
0.63
0.49-0.81
Other
0.62
0.24-1.58
Education^
< HS
1.00
HS
0.71
0.50-0.99
> HS
0.63
0.45-0.89
BMI category
Under/normal weight
1.00
Overweight
0.67
0.45-1.00
Obese
0.64
0.44-0.93
1.01
0.99-1.02
Duration of diabetes (yrs)
Hypertension diagnosis
No
1.00
Yes
1.06
0.79-1.42
Cancer history
No
1.00
Yes
1.19
0.76-1.85
^ HS=High School
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Sex-specific analyses were also conducted. In the sex-specific analyses,
suboptimal glycemic control was not associated with all-cause mortality among males
(HR=1.19 [CI=0.80-1.77.]) nor females (HR=1.19 [CI=0.77-1.83]). In addition, there
were no statistically significant relationship between all-cause mortality risk and
borderline glycemic control among males (HR=1.02 [CI=0.61-1.71]) nor females
(HR=1.21 [CI=0.78-2.86]). In addition, all-cause mortality risk was not associated with
poor glycemic control among males (HR=1.45 [CI=0.88-2.39] nor females (HR=1.09
[CI=0.59-2.00]). Furthermore, when using the continuous variable of HbA1c values as
the independent variables, levels of HbA1c were not found to be statistically significantly
associated with all-cause mortality (HR=1.06 [CI=0.98-1.15]). However, when stratifying
by sex, a statistically significant association with all-cause mortality risk was found for
males (HR=1.14 [CI=1.02-1.28]) but not for females (HR=1.05 [CI=0.94-1.16]) in
multivariable analyses. There was no statistically significant relationship between
HbA1c values and CVD mortality risk. Sex-specific analyses for CVD mortality were not
possible due to the few CVD deaths.
Further analyses were also conducted using different HbA1c cut-offs.
Specifically, the thresholds of 6.5% and 6.0% we used. Diabetic individuals with a
HbA1c of less than 6.0% or 6.5% had a statistically significant lower mortality risk (HR
0.69 [0.48-99] and 0.72 [0.57-0.92], respectively) compared to individuals with greater
values, even after adjusting for potential confounders. The HbA1c threshold of 6.5% was
used since it is a cut-off used by AACE for suboptimal glycemic control.13 Additional
hazard analyses were conducted among four diabetic groups. Specifically, these groups
were the following: 1) 65 years of age or older (n=620), 2) 65 years of age or older and
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taking insulin only (n=169), 3) 65 years of age or older, taking insulin only, 4) 65 years
of age or older and being diagnosed with hypertension (n-344), 5) taking insulin only (n=
332), and 6) being diagnosed with hypertension (n=644). Among these diabetic groups,
statistically significant relationships between strict glycemic control and all-cause
mortality risk were not found. Specifically, diabetics 65 years of age or older with an
HbA1c of less than 6.5% had a mortality risk of 0.73 [CI=0.48-1.12]; diabetics 65 years
of age or older and taking insulin only with a HbA1c of less than 6.5% had a mortality
risk of 1.05 [CI=0.37-3.00]; diabetics 65 years of age or older and taking insulin only and
diagnosed with hypertension with an HbA1c of less than 6.5% had a mortality risk of
1.41 [CI=0.51-3.88]; 4) diabetics 65 years of age or older and diagnosed with
hypertension with an HbA1c of less than 6.5% had a mortality risk of 0.87 [CI=0.641.22]); 5) diabetics taking insulin only with an HbA1c of less than 6.5% had a mortality
risk of 0.95 [CI=0.46-1.97]; and 6) diabetics diagnosed with hypertension and with an
HbA1c of less than 6.5% had mortality risk of 0.84 [CI=0.52-1.36].

Glycemic control and cardiovascular mortality risk
Part of the third research question of this study was whether suboptimal,
borderline, and poor glycemic control were associated with greater cardiovascular
mortality risk among US adults with type 2 diabetes, after controlling for potential
confounders. It was hypothesized that individuals with suboptimal, borderline, and poor
glycemic control would have greater cardiovascular mortality risk.
Cross-tabulations of cardiovascular mortality and participant characteristics
including glycemic control along with the corresponding chi-square test statistics are
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shown in the table 17. In un-adjusted Cox proportional hazards models, neither
suboptimal (HR=1.04 [CI=0.75-1.44]), borderline (HR=1.0 [CI=0.68-1.49]), or poor
glycemic control (HR=1.09 [CI=0.54-2.19]) were associated with greater likelihood of
cardiovascular mortality among adults with type 2 diabetes (Table 18). To be consistent
with the hazard models for all-cause mortality, adjusted hazards models were also
performed with the same variables added in the model except for cancer diagnosis.
However, there were no differences in the association between the glycemic control
variables and CVD mortality risk after a covariate was added in the model.

Suboptimal glycemic control
The adjusted Cox proportional hazards model for the relationship between
suboptimal glycemic control and CVD mortality risk is presented in Table 22.
Suboptimal glycemic control was not statistically associated with CVD mortality risk
among adults with type 2 diabetes (HR=1.06 [CI=0.75-1.51]).

Table 22. Adjusted Cox proportional hazards model. Relationship between
suboptimal glycemic control (HbA1c >7.0%) and CVD mortality risk among adults
with type 2 diabetes, NHANES III
Characteristic
Hazards Ratio
95% Confidence Interval
Suboptimal glycemic control
No
1.00
Yes
1.06
0.75-1.51
Age group (yrs)
20-44
1.00
45-64
1.69
0.26-10.84
65+
6.92
1.12-42.69
Sex
Male
1.00
Female
0.77
0.51-1.18
Race/Ethnicity
NH White
1.00
NH Black
0.78
0.53-1.16
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Table 22 (continue)
Characteristic
Hispanic
Other
Education
<HS
HS
>HS
BMI category
Under/normal weight
Overweight
Obese
Duration of diabetes (yrs)
Hypertension diagnosis
No
Yes

Hazards Ratio
0.49
0.86

95% Confidence Interval
0.29-0.83
0.29-2.57

1.00
0.64
0.63

0.40-1.05
0.40-1.00

0.74
0.57
1.01

0.40-1.13
0.36-0.89
0.99-1.02

1.00
1.14

0.76-1.72

Borderline glycemic control
The adjusted Cox proportional hazards model for the relationship between
borderline glycemic control and CVD mortality risk is presented in Table 23. Borderline
glycemic control was not statistically associated with CVD mortality risk among adults
with type 2 diabetes (HR=0.91 [CI=0.62-1.33]).

Table 23. Adjusted Cox proportional hazards model. Relationship between
borderline glycemic control and CVD mortality risk among adults with type 2
diabetes, NHANES III
Characteristic
Hazards Ratio
95% Confidence Interval
Borderline glycemic control
No
1.00
Yes
0.91
0.62-1.33
Age group (yrs)
20-44
1.00
45-64
1.10
0.17-7.33
65+
4.30
0.73-25.34
Sex
Male
1.00
Female
0.77
0.48-1.24
Race/Ethnicity
NH White
1.00
NH Black
0.72
0.45-1.17
Hispanic
0.50
0.25-1.01
Other
0.48
0.12-2.08
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Table 23 (continue)
Characteristic
Education^
<HS
HS
>HS
BMI category
Under/normal weight
Overweight
Obese
Duration of diabetes (yrs)
Hypertension diagnosis
No
Yes
^ HS=High School

Hazards Ratio

95% Confidence Interval

1.00
0.79
0.62

0.47-1.35
0.33-1.16

1.00
0.80
0.60
1.01

0.49-1.29
0.34-1.04
0.99-1.03

1.00
1.19

0.75-1.90

Poor glycemic control
The adjusted Cox proportional hazards model for the relationship between poor
glycemic control and CVD mortality risk is presented in Table 24. Poor glycemic control
was not statistically associated with CVD mortality risk in un-stratified analyses
(HR=1.38 [CI=0.67-2.82]).

Table 24. Adjusted Cox proportional hazards model. Relationship between poor
glycemic control and CVD mortality risk among adults with type 2 diabetes,
NHANES III
Characteristic
Hazards Ratio
95% Confidence Interval
Poor glycemic control
No
1.00
Yes
1.38
0.67-2.82
Age group (yrs)
20-44
1.00
45-64
1.76
0.27-11.22
65+
7.25
1.14-45.90
Sex
Male
1.00
Female
0.76
0.50-1.16
Race/Ethnicity
NH White
1.00
NH Black
0.77
0.52-1.15
Hispanic
0.49
0.30-0.81
Other
0.87
0.29-2.59
Education^
<HS
1.00
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Table 24 (continue)
Characteristic
HS
>HS
BMI category
Under/normal weight
Overweight
Obese
Duration of diabetes (yrs)
Hypertension diagnosis
No
Yes
^ HS=High School

Hazards Ratio
0.65
0.64

95% Confidence Interval
0.41-1.06
0.40-1.01

1.00
0.75
0.56
1.01

0.48-1.15
0.36-0.89
0.99-1.02

1.00
1.13

0.75-1.72

Summary of results of research question 3
In summary, it was found that neither all-cause nor CVD mortality risk was
statistically associated with having suboptimal, borderline, or poor glycemic control, after
controlling for potential confounders. However, when HbA1c was used as a continuous
variable, males with greater HbA1c values were found to have greater all-cause mortality
risk. In addition, lower all-cause mortality risk was found among individuals with an
HbA1c of less than 6.5%. Stratification by diabetic groups did not result in any statically
significant relationships although the hazard ratios were in some cases in opposite
directions.
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CHAPTER V.
DISCUSSION
Overview
In diabetes management, although glycemic control is one of the main outcomes
for determining treatment prognosis, it continues to be inadequate in the US diabetic
population, with about half not having good control.27 Not being able to reach glycemic
control, despite adherence to diabetes management recommendations, can lead to
frustration, indifference, and unwillingness to continue treatment.135 In the present study
we attempted to assess both risk factors for suboptimal, borderline, and poor glycemic
control as well as its outcomes with the expectation of gaining knowledge of why there
may continue to be a high prevalence of suboptimal and poor glycemic control among
adults with diabetes despite medical awareness of their importance.

Potentially new risk factors and glycemic control
There has been much research into the possible determinants of glycemic control.
Most studies have repeatedly focused on demographic risk factors such as raceethnicity37 as well as characteristics specific to diabetes such as duration of diabetes and
type of diabetes treatment.35, 136 From the review of the literature of suboptimal and poor
glycemic control, it appears that other potential risk factors for suboptimal and poor
glycemic control may exist. For example, although it is not surprising the lack of
adherence to diabetes treatment is shown to be associated with poor glycemic control,39
reasons for this incompliance are not entirely known. Possible reasons for the
incompliance and consequent poor glycemic control may include a diabetic’s fear of
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weight gain. It may also be that there are barriers in the diabetic’s environment
preventing them from being compliant to diabetic treatment advice, such as lack of time
to take medication or eat regularly because of inflexible work schedules. Furthermore,
although an association between diabetes complications and glycemic control and
smoking has been found, 60-64 a factor closely associated, secondhand smoke exposure,
has not been fully investigated.

Glycemic control and work hours
Work constitutes an important part of most adult lives and sometimes is even a
culprit of ill health. Long work hours has been implicated as a risk factor for poor health,
including increased risk of mortality,137, 138 increased accidents,139 cardiovascular
disease,140-142 greater unhealthy behaviors such as alcohol consumption,143 increased
smoking,144 and less participation in physical activity.145 Thus, it is possible that glycemic
control is also affected by having long hours of work.
Most research studies on the effects of long work hours on diabetes and glycemic
control have been based on non-US populations.146, 147 However, the consequences of
long work hours should be of particular concern for American workers given that they
report some of the highest number of work hours among industrialized countries.147 In
fact, the amount of overtime in the US has increased since the 1970’s. 148, 149 147 Among
15 industrialized nations in the world, in 2003 the US ranked as the fourth highest in
average annual work hours, preceded only by Thailand, Hong Kong, and South Korea.150
Meanwhile, the European Union does not allow more than 48 hours per work week, and
Japan does not permit more than 100 hours of overtime per month. Yet in the US, only
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certain occupations (e.g. transport workers and medical residents)151 have restricted work
hours by law, and there are regulations regarding the amount to be paid for overtime
work but not limiting the number of overtime hours.152
In the present study we sought to understand the relationship between work hours
and glycemic control. We found that among adults with type 2 diabetes who worked
greater than 40 hours (about 34% of the sample) relative to those that worked 1-20 hours
were at least 7 times as likely to have suboptimal or borderline glycemic control.
Although research has shown a relationship between work hours and
cardiovascular disease,140-142 there is limited research specifically looking at its
relationship with diabetes or glycemic control. Thus, the findings from the present study
cannot be adequately compared to other studies. However, our findings are in agreement
with studies in which individuals have reported irregular work hours and inflexible work
schedule as a barrier to proper diabetes management.44, 45
There are several reasons why working a greater number of hours may be
associated with worse glycemic control. First, the reason for suboptimal glycemic control
among those working long work hours may be simply related to the lack of time (i.e. time
scarcity) to properly manage diabetes. For example, workers may not have enough time
to check blood glucose levels or eat regularly or at scheduled time intervals.153, 154 In a
study in the Netherlands, a higher work load was perceived as a barrier to proper diabetes
management, particularly insulin injection, in both type 1 and type 2 diabetes patients.153
Time scarcity has been associated with an increased risk of obesity and of making poor
food choices.154 Weight gain and obesity, both risk factors for type 2 diabetes, have also
been found to be greater among individuals working long hours.144 In addition, time
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scarcity is one of the barriers noted to be associated with the lack of adherence to a
diabetic regimen or treatment.155 Furthermore, lack of time because of greater work hours
may also interfere with important diabetes management activities outside of work such as
getting medical care or visiting a diabetes healthcare provider or educator. For example,
it has been shown that individuals who work a full-time or even a part-time job (as
opposed to being unemployed or retired) are more likely to discontinue going to diabetes
self-management education programs.156-158 In addition, lack of time has been associated
with self-reported inability to visit dieticians.159, 160
Second, longer work hours may result in suboptimal glycemic control due to
greater job stress or strain as a result of working greater hours. Job strain has been linked
to higher HbA1c levels among employed individuals without diabetes in non-US
studies,42, 46, 47 while stress management programs have been associated with improved
glycemic control.161 Although the biological mechanism is not well understood, stress
may affect glycemic control via behaviors and neurohumoral pathways such as the
counter-regulatory hormones,162, 163 and glycemic control may be related to the allostatic
load or body’s way of adjusting to long-term stress.164 Poor glycemic control could also
be in part due to the release of catecholamine and stress hormones (such as cortisol),
which have been linked with increased cardiovascular risk factors.165, 166 The elevated
stress levels could also result in negative behavioral habits, such as increased eating, in
order to cope with such stress. In fact, weight gain and obesity have been found to be the
highest among individuals reporting high job strain.167
Third, it is possible that greater work hours may lead to worse glycemic control
due to a greater propensity of late night eating since the time of day that meals are
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consumed has been reported to affect insulin levels and to increase glucose intolerance.168
Nevertheless, greater research is needed to understand the mechanism behind the
relationship between long work hours and suboptimal glycemic control among adult with
diabetes.

Glycemic control and farm workers
With regards to our findings about farm workers being more likely to have
suboptimal glycemic control compared to white collar workers, there are very few if any
studies that have investigated the association between glycemic control and being a farm
worker to compare to. There are several possible explanations to our findings
nonetheless. For example, it may be possible that farm workers, compared to white collar
workers, may have less knowledge about diabetes self-management,169have inflexible
work schedules,170 and be more likely to have unhealthy eating behaviors;171 all factors
that may be responsible for poor glycemic control. For example, unhealthy diets are said
to be greater among workers with high workloads,172 low status jobs,173 low control at
work,174 and among workers with lower education and income 175, 176 all characteristics
that may be more predominant among farm workers. Moreover, other factors such as
social isolation, lack of social support, and depression,177 178, 179among farm workers may
explain their higher likelihood of poor glycemic control. For example, a study of farm
workers with diabetes found that over 66% reported themselves as being depressed and
were greatly concerned about the long-term consequences of diabetes.171 In addition,
stress may be higher in farm workers compared to white collar workers and may be
contributing to the worse glycemic control in this group. Farm workers may be stressed

99

due to not knowing for how long they will be employed (fear of being unemployed),
working strenuous hours, being away from the family, fear of being deported or
discriminated against and exploited.171 This fear of losing their job may make the worker
more hesitant to ask for time off and therefore be less able to access healthcare180 and
routinely get diabetes care including getting their HbA1c checked and getting physician
advice about diabetes.181
We could not assess the relationship between the above mentioned potential
mediators of the relationship between work hours or farm worker occupation and
glycemic control. This is because the data were not available in NHANES, except for the
number of visits to a healthcare professional in the last 12 months. Nevertheless, the
mediation test with that variable was not significant suggesting that the number of visits
to a healthcare professional in the last 12 months does not explain the relationship
between work hours or farm worker occupation and suboptimal/poor glycemic control.

Glycemic control and desire to lose weight
Research has shown that one of the barriers to adherence to diabetes treatment
regimen is the fear of weight gain commonly associated with treatment regimens such as
taking insulin.66-72 Furthermore, adolescents with diabetes perceiving themselves as
overweight have reported poor glycemic control.73 Thus, it may be that individuals that
want to lose weight are less likely to be adherent to treatment regimens and consequently
have suboptimal or poor glycemic control. However, the association between glycemic
control and weight desirability among adults with diabetes has been understudied.
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In the present study, a statistically significant association between glycemic
control and desire to lose weight was not found. This finding is in agreement with a study
among adolescents with both type 1 and type 2 diabetes that found that trying to lose
weight or worrying about one’s weight was not associated with poor glycemic control,
although perception of being overweight was.73 Nevertheless, the null finding could also
be a reflection of the two possible directions of the association between glycemic control
and weight desirability. As the literature review indicated and as hypothesized, it is
possible that individuals who wanted to lose weight and who knew of the possible
consequences of tighter glycemic control such as weight gain,182-186would be less likely
to have suboptimal or poor glycemic control because of the lack of adherence to
treatment. A typical recommendation in diabetes management is weight loss if the person
is overweight or obese.187 Thus, it is also possible that those individuals who wanted to
lose weight would adhere more to diabetes management advice and would therefore be
more likely to have good glycemic control. Thus, it is possible that the null finding in the
present study is a factor of having two types of individuals, those not adherent to diabetes
management treatment due to fear of weight gain, and those adherent to diabetes
management treatment due to wanting to lose weight and already understanding the
detrimental effects of being overweight on diabetes prognosis.
There may also be other factors into play in the relationship between desire to lose
weight and glycemic control. For example, among adolescents, research has shown that
unhealthy weight loss practices is associated with poor glycemic control among females
but not among males.73 Given the potential differences in the relationship between
glycemic control and dieting behavior by sex, we tested the interaction between desire to
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lose weight and sex. We also conducted sex-specific analyses but did not find any
statistically significant results. Therefore, more research is needed to understand the
association between desire to lose weight and glycemic control.

Glycemic control and secondhand smoke exposure
Studies have shown a relationship between smoking and glycemic control63, 64 as
well as diabetes complications that are often a result of poor glycemic control.61, 62
Research on the various effects of SHS exposure on health outcomes aside from
respiratory function is also mounting. Studies have recently documented the potential
effects of SHS on cardiovascular disease,188, 189 glucose intolerance and diabetes
incidence.43, 65, 190-192 Given the literature, it is plausible that SHS affects glycemic control
as well.
We assessed the association between glycemic control and SHS among adults
with type 2 diabetes but did not find a statistically significant relationship. Our results
cannot be adequately compared to other studies since there are very few if any studies
assessing the relationship between glycemic control and SHS exposure. Nevertheless, the
lack of statistical significance may also be a result of lack of power. It may also be that
our definition of SHS exposure did not properly capture individuals with SHS exposure
due to the short half-life of detectable serum cotinine levels,193 not knowing how long
individuals were exposed to secondhand smoke, the absence of self-reported exposure to
smoke in other settings (e.g., restaurants, bars, or motor vehicles), and potential
misclassification of smoking and SHS exposure status.124 Because of this potential
misclassification, analyses were also done using cotinine as a continuous variable among
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individuals who reported not being current smokers but no statistically significant
relationship was found with this measure of SHS either. Therefore, because of the
possibility of error in defining smoking and SHS exposure groups, the uncertainty of the
accuracy of the measure for SHS exposure (which may explain the lack of statistical
significance), and because other studies have suggested that SHS effects glycemic
control,42, 64 further research is needed to fully understand the relationship between SHS
exposure and glycemic control among US adults with type 2 diabetes.

Glycemic control and health related quality of life
Quality of life measures have been gaining interest in the medical and public
health professions over the past years. In the late 1960’s to early 1970’s, HRQOL was
mentioned approximately 40 times in the medical literature while in the late 1980’s to
early 1990’s it was mentioned approximately 10,000 times.194
The HRQOL measures may indicate how an individual views his or her health.
This self-reflection of health status has been suggested to be a better indicator or ill health
and good predictor of mortality.195 The determinants of how a person’s self-perceived
health may be based on an array of factors such as family history and other risk factors,
medical history, and psychological orientation (i.e., optimism or pessimism).195
Furthermore, based on the premise of the “self-regulation theory”, one’s perception about
the seriousness of one’s illness does affect how one’s disease is managed.196
How HbA1c affects everyday activities may be important given that individuals
may perform certain self-management tasks as a result of short-term benefits such as lack
of negative symptoms that may accompany poor glycemic control.77, 197 Social activities
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such as gatherings with friends are among the activities that may be affected by poor
glycemic control because of fear of embarrassment from having the manifestation of
hypoglycemia or hyperglycemia symptoms in public. An individual may be more likely
to adhere to diabetes treatment if she or he knows that by following their physician’s
advice about proper diet for glycemic control, their respective risk of hypoglycemia or
hyperglycemia may be lowered. In fact, among adults with diabetes, knowledge of
HbA1c levels has been noted as an important factor determining how a patient rates his
or her health, particularly physical functioning, mobility, and satisfaction with physical
health and family life.198 In addition, among adults with diabetes, barriers for lack of
compliance have been noted to include lack of symptoms155 and the belief that having
diabetes is not serious.199 Patients with diabetes have stated that managing their diabetes
is associated with an impaired ability to engage in activities with their family and
friends.200 Thus, bringing awareness of how poor glycemic control affects everyday life
may lead to better treatment compliance.
Diabetes is a disease that requires self-management behaviors to improve
treatment prognosis. The adherence to treatment and the positive self-management
behaviors may be influenced by symptoms and physiologic changes due to the diabetes
disease, which may take years develop or be physiological manifested.200 Thus,
understanding the impact of good management practices on day-to-day activities and
well-being may lead to better adherence and ultimately improved glycemic control.
There have been studies assessing the relationship between glycemic control and
quality of life, but these have been contradictory and/or are not based on nationallyrepresentative US population.83-88, 201, 202 Thus, we attempted to assess the relationship
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between glycemic control and HRQOL. We found that these relationships were not the
same for all HRQOL indicators. Specifically, we observed a statistically significant
relationship between poor glycemic control and number of days with poor mental health
and inactivity. However, poor glycemic control was not associated with number of days
of poor physical health or poor self-reported general health.
Our findings are in agreement with the literature which has shown that suboptimal
and/or poor glycemic control is not related to all aspects of health in the same fashion.8388

These studies have however defined quality of life based on SF-36 scores, the validated

instrument with 36 questions about perceived health status and number of disability days.
This instrument is considered the gold standard for evaluating overall health including
physical and mental health. 78
For example, one study of patients from community health clinics in California
followed for one year showed a slight inverse relationship (-0.21 regression) between
HbA1c levels and SF-36 Mental composite scores (higher score indicating better mental
health). 83 However, in that same study83 no significant relationship was observed with
the SF-36 Physical Composite Score. In another study of diabetic adult patients from a
Veterans Affairs Health Care system, perceived poor health (as indicated by SF-36
scores) was associated higher HbA1c levels but mental health was not associated.85 Other
studies have not found any significant relationship between overall quality of life and
glycemic control.81, 201, 202 For example, in a study of non-insulin diabetic patients of a
Veteran’s clinic in North Carolina, HbA1c levels and HRQOL assessed using SF-36 were
not correlated.202
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Glycemic control and self-reported general health, physical health, and activity limitation
A statistically significant relationship between self-reported general health and
glycemic control was not found in our study, which is not surprising given the
inconsistent findings in previous studies. For example, in a double-blind randomized
controlled trial of adults with type 2 diabetes, the treatment group with more strict
diabetes treatment regimen (aimed at improving glycemic control) reported better selfperceived general health and improved cognitive functioning.102 However, other studies
have not found a statistically significant relationship between self-reported general health
and quality of life.88
We also did not observe a statistically significant relationship between glycemic
control and number of days of poor physical health. This is in contradiction to research
that has suggested poor glycemic control to be associated with poor physical health given
the greater likelihood of diabetes complications that cause chronic pain such as
neuropathy among diabetic adults with poor glycemic control.194 Nevertheless, we cannot
compare our findings to other studies due to the lack of studies specifically investigating
the relationship between glycemic control and number of days of poor physical health.
We did, however, find a statistically significant relationship between days of
limited activity and glycemic control. Specifically, those with poor glycemic control were
more likely to have ≥14 days of inactivity (versus 0 days) but were less likely to have 113 days (versus 0 days). These findings are inconsistent with the literature on disability
and diabetes and glycemic control.94, 100 For example, a study using data from the Midlife
Development in the United States Survey among adults between the ages of 25 and 54
years, noted diabetics to have an average of 3.6 impairment days per month although
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diabetes ranked lower than other conditions such as cancer, ulcer, heart disease, and
generalized anxiety disorder in terms of the number of impairment days per month.94
Studies specifically investigating the relationship between self-reported activity limitation
and glycemic control were not found however.
A potential reason for the lack of statistically significant associations between
days of poor physical health and days of inactivity and glycemic control could be due to
the categorization of these variables, as these are somewhat arbitrary categories used in
previous studies.115, 116 The application of categories for these variables could have also
accounted for the differences in the directions of the estimates for days of poor mental
health. Since the numerical variables of number of days of poor physical health, number
of days of poor mental health, and days of inactivity showed over-dispersion and excess
zeros, ZIP analyses were conducted as opposed to traditional linear regression analyses.
The ZIP analyses showed no statistically significant relationships between number of
days of poor mental or physical health or inactivity with glycemic control. Therefore,
further research may be needed, with perhaps better measures, to establish is there is a
relationship between number of days of poor health and inactivity and glycemic control
among US adults with type 2 diabetes.

Glycemic control and mental health
In the present study suboptimal and borderline glycemic control was associated
with lower odds for having 1-13 days of poor mental health (versus 0 days). These
findings suggest that individuals with suboptimal glycemic control rather than good
glycemic control have better mental health. Thus, there may be a level of distress or
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mental discomfort associated with having to maintain very low HbA1c levels among
adults with type 2 diabetes. Our findings are in agreement with studies that have found
that tight or strict glycemic control (e.g. HbA1c levels of less than or equal to 6.5%) is
associated with poor quality of life measures of mental health and physical health.198, 203,
204

One of the reasons why those individuals with tight glycemic control rate their health

as poorer may be due to greater episodes of hypoglycemia when HbA1c levels are
lower,198, 205, 206which can range from 2 to 4 episodes per year among those type 2
diabetics trying to manage their diabetes. For example, the Diabetes Control and
Complications Trial (DCCT) study showed that strict glycemic control increases the
chances of severe hypoglycemia.206 Hypoglycemia may cause psychological symptoms
such as displeasure, feelings of anger, and fatigue207 as well as more visible physiologic
symptoms such as poor coordination, nausea, drowsiness, shaking and sweating.208, 209
Researchers have also suggested a curvilinear relationship between HbA1c levels and
quality of life likely due to the negative aspects of either the intricate treatment regimen
and/or the greater episodes of hypoglycemia due to tight glycemic control.79
In addition to the symptoms of hypoglycemia, the greater days of reported poor
mental health may be due to the sometimes overwhelming chore of diabetes selfmanagement. The diabetes regimen can be mentally taxing since it may require drastic
dietary changes, and the re-scheduling of activities (due to, for example, having to take
medications or insulin injections at certain times of the day or having to eat regularly).39
Furthermore, these lifestyle changes in everyday activities may make others annoyed
which may then result in conflict between the individual with diabetes and his/her
friends, family and co-workers. This conflict may be a contributor to the mental stress
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that adults with diabetes often report.194 Finally, the fear of hypoglycemic events due to
such strict glycemic control, particularly in social settings, may place an additional level
of emotional distress to the individual with diabetes.194 There are no known studies
however investigating the relationship between fear of hypoglycemia and glycemic
control among adults with type 2 diabetes. As hypothesized however, poor glycemic
control (i.e. HbA1c >9) was found to be associated with having greater days of poor
mental health. There are several potential explanations for our findings. One is that the
negative symptoms associated with hyperglycemia (i.e. increased thirst, urination, and
weight loss, as well as fatigue, drowsiness, depression) 210are higher when the person has
their blood glucose levels out of control, thereby leading to reduced feelings of wellbeing and consequently report of poor mental heath.80, 211
On the other hand, it may be that these individuals with diabetes have poor
glycemic control because they are depressed and are in poor mental health to begin with.
This scenario is very likely given the high prevalence of depression among adults with
diabetes, with data suggesting that as many as 9-27% of the diabetes population may
experience depression.212, 213 Thus, it is possible that depression preceded poor glycemic
control in our study sample. These individuals with depression may be having poor
glycemic control due to being more likely to be non-adherent to treatment regimens.214
Individuals with poor mental health may be in denial of their condition and therefore not
follow diabetes management steps thereby leading to further poor glycemic control.215 In
addition, for a percentage of hard to treat individuals with type 2 diabetes, particularly
those newly diagnosed, the lack of reaching good glycemic control levels despite taking
measures may lead to feelings of disappointment despair, emotional distress, and
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consequently poor self-reported mental health. 39, 194, 216 Thus there may be a “negative
reinforcing cycle” in which lack of attainment of good glycemic control despite good
efforts leads to emotional distress, and the emotional distress leads to lack of
encouragement and hope and consequently lack of adherence to treatment, which further
leads to even worse glycemic control.39 Finally, there may be biological mechanisms for
the relationship between depression and glycemic control. For, example it has been
suggested that decreases in serotonin and cortisol due to depression may increase fasting
glucose levels.217 More research is need in this area however.
Although we did not find a statistically significant interaction between sex and
number of days with poor mental health, to be consistent with the literature suggesting a
relationship218, 219, 220 221 we conducted sex-specific analyses for the relationship between
poor glycemic control and poor mental health. In sex-specific analyses, we found that
among females with type 2 diabetes, poor glycemic control was associated with lower
odds for having 1-13 days (versus 0 days) of poor mental health while among males, poor
glycemic control was associated with greater odds of 1-13 days (versus 0 days) of poor
mental health. Our findings are in agreement with studies that have shown that among
women, poor glycemic control is associated with poor overall quality of life (i.e., not
specifically mental or physical health).218, 219 Furthermore, in a Netherlands study, there
was an observed positive association between depression and poor glycemic control
among women but not among men.220 This association may be greater among women
because of the lower estrogen levels as women become older.221 In fact, a study found
that estrogen replacement therapy was associated with improvement in glycemic
control.221 In addition, depression has been associated with changes in estrogen levels.222
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However, one study found depression to be associated with higher HbA1c levels in men
but not in women.223 Thus, the contradictory study findings suggests that further research
is needed to truly understand the sex differences in the relationship between depression
and poor mental health and glycemic control.
Finally, to further investigate why there was a difference in the direction of the
estimate for the relationship between poor mental heath and glycemic control,
multinomial logistic regression analyses for poor mental heath were repeated using
collapsing zero to 5 days of poor mental health into one category. The results, however,
did not reveal any difference whether having zero days as one category by itself or
grouping it with 1-5 days.

Workforce participation and glycemic control
In addition to morbidity outcomes and HRQOL including self report of wellbeing, workforce participation is another measure of the effect of ill health and the
overall burden of disease. Two commonly used measures of workforce participation are
employment status and missed work or absenteeism. Research has shown that adults with
diabetes are less likely to be employed and more likely to miss work,57, 97-99, 201, 224-226
particularly if they have complications from diabetes.94, 100, 101, 227-229 This may be due to
diabetes being a health condition unlike many others that requires self-management in
order to improve disease prognosis, reduce the risk of complications, and increase overall
quality of life.230 Individuals with diabetes usually need to follow strict dietary regimens
as well as medication regimens that require medication (such as insulin injections) to be
followed in a scheduled manner. These regimens may thus need to be implemented
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during work hours, which may appear burdensome to both the employee and the
employer. Such frustration and inability or unwillingness to properly accommodate the
employee may lead to unemployment. In turn, the lack of proper diabetes management
and consequently poor glycemic control and related symptoms may result in greater
absenteeism from work.
Since poor glycemic control is a factor that greatly increases the chance of
diabetes complications, it is more likely that glycemic control is associated with
unemployment and missed work. In the present study the relationship between
employment status, missed work days, and glycemic control was assessed.

Glycemic control and missed work
In the present study, a statistically significant relationship between glycemic
control and missed work days in the previous month was not found. The null finding in
the present study could be due to two reasons.
First, there may not be a relationship between glycemic control and missed work,
since there are contradictory findings in the literature. Similar to the present study, some
studies have not found a statistically significant relationship. For example, in a crosssectional study of adults with diabetes referred to a diabetes program (the Control
Diabetes Services Program) from several centers in the US, there was marginally
statistically association between an HbA1c level of > 8% and self-reported days lost from
work or school during the previous year, after controlling for confounders.104 However,
in that study,104 an HbA1c of 8-10% was not statistically associated with days lost from
work or school during the previous year. Furthermore, HbA1c levels of 7-8%, HbA1c 8-
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10%, or HbA1c of >10% was associated with having greater than five days of missed
work in the previous month or with difficultly accomplishing work tasks among adults
with diabetes enrolled in health maintenance organization in the US.227 However, other
studies have found a statistically significant relationship. In a cross-sectional of patients
with diabetes from Michigan, having an HbA1c of 8-8.9% was associated with greater
probability of missing at least one hour of work using probit models. However, a
statistically significant relationship was not found for HbA1c levels of 7.0-7.99% or
greater than 9.0%.103 Furthermore, in that study,103 missed work was based on hours
missed from work in only the last 4 weeks, which may not be accurate estimation of the
habitual missed work due to glycemic control issues.
Second, literature on absenteeism related to health, or sickness absence, has
suggested that absenteeism is not a factor that is solely determined by the presence of a
medical condition, but rather based on different factors such as an individual’s perception
of his/her health and symptoms related to disease, attitudes related to work and missing
work, job demands and accommodations at work, job strain, and other factors.231 Thus, it
is possible for example that some of these individuals with diabetes are resistant to
missing work regardless of how ill they feel from being in poor glycemic control.232

Glycemic control and unemployment
In the present study we did not observe a statistically significant relationship
between glycemic control and employment status. Our findings are in disagreement with
the sparse studies assessing the relationship between glycemic control and employment
status. In a study of health maintenance organization enrollees with diabetes, HbA1c
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levels of > 10% were associated with greater disability and unemployment.227
Furthermore, in a double-blind randomized controlled trial of adults with type 2 diabetes
the treatment group with more restrictive diabetes treatment regimen were less likely to
report losing their jobs during the follow-up period.102
There are several potential reasons for the lack of a statistically significant
relationship between employment and glycemic control. First, there is the potential of
misclassification of employment given that employment is based on working in the prior
week. Thus the person would be considered unemployed when in fact they were
employed. Second, it is possible that unemployment (or employment) is a result of other
factors not related to health. For example adults 65 years of age or older may be more
likely to unemployed because of retirement and not necessarily due to their level of
glycemic control. However, when analyses were repeated removing those 65 years and
older, there were no statistically significant relationships between glycemic control and
employment status in those less than 65 years of age or 65 years of age or older. Third
and lastly, there may be the potential for healthy worker effect bias. If healthy worker
effect bias is present, then the true association between employment and glycemic control
would be masked given that those employed are generally in better health than those not
employed.
Although no statistically significant interactions were found, since the literature
suggests that there may be differences in employment due to sex129, sex-specific analyses
were conducted. When the full model was stratified by sex, the results remained nonstatistically significant but the direction of the association was different for males and
females.
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Mortality and glycemic control
It is well established that individuals with diabetes are at an increased risk of
death compared to individuals without. The mortality rate ratio of the mortality rates
comparing individuals with diabetes versus those without has been shown to range from
1.5 among individuals age 65-74 years of age to 3.6 among individuals 25-44 years of
age.233 Not surprisingly, diabetes is the sixth leading cause of death based on the most
current national death statistics with a death rate of 23.3 per 100,000 US population
according to CDC 2006 data.6, 234 One of the proposed reasons for the higher mortality
risk is poor glycemic control among individuals with diabetes since poor glycemic
control is associated with increased diabetes complications.10
Several studies have assessed the relationship between glycemic control and allcause and cause-specific mortality risk, although these have led to conflicting findings,
particularly when analyses were sex-specific analyses, and/or based on non nationally
representative sample of adults with diabetes, specifically type 2 diabetes.105-107The only
nationally representative study assessing glycemic control among adults with type 2
diabetes that was recently published found that there was a curvilinear relationship
between HbA1c levels and all-cause and CVD mortality risk.235 However, that study 235
did not assess the relationship between mortality risk glycemic control among diabetic
groups such as those that may be in presumably worse health (e.g. older, insulin taking
type 2 diabetics, or those with hypertension) and therefore be at greater risk of
complications from very strict glycemic control. In addition, that study 235 did not address
the potential impact of confounding by depression in the relationship between glycemic
control and mortality risk. Assessing the role of depression in mortality risk is important
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given it has been associated with increased mortality risk among adults with diabetes.236
In addition, depression has been associated with poor glycemic control, 214, 223plus we
found poor glycemic control to be associated with number of days of poor mental health.
In this study we assessed the effect of suboptimal, borderline, and poor glycemic
control on all-cause and CVD mortality risk. We found that neither suboptimal,
borderline, or poor glycemic control was significantly associated with increased all-cause
or CVD mortality risk, after adjusting for several potential confounders. Nevertheless,
the results did show an effect in the hypothesized direction, with higher non-statistically
significant mortality hazards due to suboptimal or poor glycemic control.
Since the literature suggests that there are differences in mortality by sex130 and
because there was an interaction between BMI category and sex, sex-specific adjusted
hazards models were also undertaken. Even in sex-specific analyses, non-statistically
significant relationships were found between the mortality risk and the dichotomous
variables for glycemic control.
In order to be consistent with the studies on mortality risk and glycemic control,
we also used the HbA1c measure as a continuous variable,106-108 but no statistically
significant relationship was found, except for when stratifying the results by sex, with
statistically significant results found for males only. This finding suggest that perhaps the
benefits in life expectancy due to improved glycemic control may be more pronounced in
males rather than females, however more research in this area is needed.
We did not find that depression was associated with any of the glycemic control
groups nor was it associated with increased mortality risk. Therefore, it was not believed
to be a potential confounder in the relationship between glycemic control and all-cause

116

mortality risk and thus was not added in the final hazard models. Indeed, adding
depression in the hazard models did not result in any change in the association between
all-cause mortality and glycemic control.
Although we hypothesized that suboptimal, borderline, and poor glycemic control
would be associated with greater odds of mortality, the findings are not surprising given
the contradictory findings in previous studies. Among studies that have looked at allcause mortality only, a statistically significant relationship with inadequate glycemic
control has been observed. For example, poor glycemic control has been associated with
all-cause mortality among advanced chronic kidney disease (CKD) and dialysis
patients.105 In a study of patients undergoing maintenance hemodialysis, greater HbA1c
values predicted a greater risk of all-cause and cardiovascular mortality among adults
with diabetes after three years of follow-up, after adjusting for confounders such as
demographics, malnutrition and anemia.107 In a prospective study of individuals
primarily without diabetes in the United Kingdom to assess the relationship between
HbA1c values and all-cause mortality and CVD mortality after a 6 year follow-up,108 it
was shown for every 1% increase in HbA1c level, the all-cause and CVD mortality risk
increased in a dose response fashion. However this study108 did not control for family
history of diabetes or CVD and other potential confounders.
One study, however, did not find a statistically significant relationship between
glycemic control and both all-cause mortality or CVD mortality risk.106 In a study using
data from the Modification of Diet and Renal Disease (MDRD) study, a randomized
controlled study of non-diabetics with CKD, a 1% increase in HbA1c was associated with
a greater risk of all cause mortality, but the association with CVD mortality was not
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significant, after approximately a 7-11 year follow-up period.106 However, in this study,
the incidence of diabetes was not established, a factor which could have distorted the
results. Moreover, most of the studies investigating the relationship between diabetes
management measures (e.g., fasting blood glucose, HbA1c value) and CVD events
including mortality risk has been primarily in men.108-110, 237
In addition to studies on the effect of suboptimal and poor glycemic control on
mortality risk, there has been recent attention to the effects of more strict thresholds for
glycemic control on mortality.238-240 Strict glycemic control is generally considered an
HbA1c value of less than or equal to 6.5% and is often reached by intensive diabetes
management, for example with treatment with sulfonylurea or insulin and with the goal
of reducing their fasting plasma glucose concentration to less than 108 mg/dl. Such
intensive treatment has been associated with reductions in the incidence of nephropathy,
neuropathy, and retinopathy complications by as much as 27%241 and has been shown to
lead to increases in life expectancy, with a slight increase in complications due to longer
survival time.241 However, negative health outcomes due to strict glycemic control, such
as increased mortality risk, have also been reported. For example, in the Action to
Control Cardiovascular Risk in Diabetes (ACCORD) study, individuals in the strict
glycemic control arm, who achieved on average an HbA1c of 6.4%, had greater deaths
(n=257) compared to the group not in the strict glycemic control (with average HbA1c of
7.0-7.95) (n=203 deaths) event after four years of follow-up.242 This translates into a
1.4% death rate per year for the strict glycemic control arm versus 1.1% death rate per
year for the control group.242 This unexpected result in the ACCORD study resulted in
termination of the trial and suggested that very strict glycemic control among certain
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individuals with type 2 diabetes is harmful to health.242 However, the findings of this trial
should be interpreted with caution since the participants were perhaps more
representative of the diabetics with worse health given that most had elevated HbA1c
(average of 8.2 at baseline), had greater length of diabetes duration, were smokers, had
high cholesterol and high blood pressure and were obese; these factors could have
increased the mortality risk.242 Nevertheless, continued debate exists as to whether strict
glycemic control is beneficial in terms of decreasing mortality risk to all individuals, or
whether for some more chronically-ill individuals, intensive treatment can cause more
harm than good.
Given the recent controversy and remaining questions as to which threshold of
glycemic control is most beneficial for improving overall health and reducing mortality
risk,238-240 we performed additional analyses using stricter thresholds for glycemic
control. We found that indeed having an HbA1c value of less than 6.5% was protective
against all-cause mortality among adults with type 2 diabetes. These results are in
agreement with studies among hemodialysis patients.107
The literature also suggests that strict glycemic control may be particularly
harmful to certain diabetic groups such as the older (and therefore likely more frail),
those taking insulin only, and/or those with comorbid conditions such as hypertension, as
implied by results of the ACCORD study.242 However, analyses conducted stratifying by
diabetic groups did not show statistically significant differences associations between
mortality risk and glycemic control, although the hazard ratios were sometimes in the
opposite directions, suggesting possible moderation. Given the differences in direction of
the relationship between all-cause mortality risk and strict glycemic control, the results
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suggest that the effect of strict glycemic control on mortality risk may depend on the age,
gravity of diabetes condition (i.e. whether dependent on insulin or not), and the presence
of other comorbid conditions. Greater research is needed in this area however since these
results were not statistically significant.
Thus, our findings suggest that strict glycemic control may indeed be beneficial in
increasing survival among adults with type 2 diabetes after a 6 to 12 year follow-up,
assuming glycemic control remained relatively constant through the follow-up period.
These findings would be therefore in disagreement with recent findings from the
ACCORD study.242 Differences in diabetic populations in the ACCORD study and the
present study could account for the different findings related to mortality risk from strict
glycemic control.

Strengths and limitations
This study has both strengths and limitations. A limitation of this study was its
cross-sectional design, which does not allow for the establishment of causal relationships.
However, the information gained from this research can generate hypotheses that could
be tested in future analytical studies using for example cohort and prospective designs.
In addition, the individual’s diabetes status and duration of diabetes were based
on self-reported information. However, self report of diabetes has been found to be fairly
accurate when compared to medical criteria, with overall agreement of 96.3% (sensitivity
of 85.2% and specificity of 98.3%).243 In addition, whether the individual had type 1 or
type 2 diabetes is not truly known as individuals were only asked about diagnosis of
diabetes in general not whether their diabetes was type 1 or type 2. The definition for

120

type 2 diabetes that was used in the present study was modeled after definitions used in
several studies in which diagnosis of diabetes after the age of 30 was considered type 2
diabetes.30, 244, 245 However, since type 2 diabetes has been shown to be increasingly
diagnosed in much younger age groups,246 there is the potential for misclassification with
the definition that was used that assumes that individuals diagnosed before the age of 30
have type 1 diabetes.
Also, glycemic control was based on only one HbA1c reading leaving the
possibility of measurement error of glycemic control. However, the possibility of
measurement error is minimal given that the NCHS HbA1c laboratory protocol includes
strict quality control procedures to limit measurement error.114 Specifically, a subset of
laboratory specimens of HbA1c are randomly selected and replicated to test the validity
of the measurements. The coefficient of variation of these specimens of range from 0.902.54%,114 thereby showing high accuracy of the measurements retested. In addition,
research using NHANES III data has shown low variability and high sensitivity of
HbA1c measurements repeated after a two week period in an subset of individuals from
NHANES, with a within-person coefficient of variation of 3.6%.247 Thus, not only do the
HbA1c measurements in NHANES data appear to be relatively free of measurement error
due to for example faulty equipment or laboratory procedures. In addition, an individual’s
level of glycemic control as determined from HbA1c tests do not appear to vary much
even if taken within a few weeks apart. Nonetheless, given the cross-sectional design of
the study and that a diabetic’s degree of glycemic control may vary from a time point to
another (e.g. year to year) and that the consequences of unhealthy lifestyles or
environments (e.g. arduous working conditions) may take months or years to be
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manifested physiologically, the exact nature of the relationship between glycemic control,
work characteristics and mental health may not be ascertained from this study.
Furthermore, although the likelihood of these to alter results are minimal, there
may be some factors affecting the HbA1c reading that could lead to erroneous results
such as hemoglobin disorders, erythrocyte mass and plasma volume, renal disorders, liver
or cardiac function problems, anemia, and menstruation.248, 249 There is also the
possibility of recall-bias, for example for hours of missed work in the past 12 months and
self-report of age of diagnosis, although studies have shown that age of diagnosis of some
diseases is reliable.250
Furthermore, our findings may be skewed due to the healthy worker effect bias,
which says that individuals tend to be in better health than non-employed individuals, or
those working more hours are in better health than those putting fewer hours at work. If
such bias is present in this study, then our results would be attenuated and the association
between suboptimal/poor glycemic control and long work hours is even stronger than
what the study showed. In other words, one would expect those working 1-20 hours to be
in worse glycemic control than those working greater than 20 hours, yet we found the
opposite relationship. In addition, we did not find a statistically significant association
between employment status and glycemic control. Thus, a healthy worker effect bias is
somewhat unlikely in the present study. Of note, only the analyses for hypothesis 1 and
2b using the work variables were based on the employed sample. The analyses for
assessing the relationship between glycemic control and SHS, weight desirability,
HRQOL, and mortality risk were done using both employed and unemployed individuals,
with most analyses controlling for employment status.
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Another limitation in the present study is that other possible determinants of
glycemic control were not measured, such as patient adherence to medication dietary
regimen,251, 252 frequency of self blood glucose monitoring,253 health literacy, 254, 255 diet
256, 257

and frequency of meals consumed per day and caloric beverages.45 Psychological

factors that may also be related to glycemic control were not assessed because these were
not available in NHANES. These factors include stress,258 depression,214 beliefs
regarding how serious the disease is.259 It would have also been beneficial to know the
length of diabetes management or treatment. The length of time the individuals have had
either good or poor glycemic control is also not known. Yet, the length of time of
glycemic control is important given that the risk of diabetic complications, morbidity and
mortality may be dependent on this.105 For example, in the DCCT study, renal
improvements were evident after three years of good glycemic control.206 In addition, the
degree of hypoglycemic events in the individuals is not known, although hypoglycemia
and fear of hypoglycemia is a barrier to good glycemic control,208, 260, 261 particularly
among those treated with insulin.262 We may have also an unreliable measure of missed
work in the present study. This absenteeism measure is based on self report of missed
work in the past month, which may be subject to some recall bias. In addition, ideally
missed work would be based on the missed work in the last three months, given that
glycemic control is based in average glucose levels in the last three months. We also
assume that missed work is directly due to poor glycemic control when in fact it could be
related to other factors not related to health. For example, sickness absence has been
reported to be due to a combination of personality factors such as “coping mechanism”
231

and “behavior of social inequity,” 263 and burnout. 264 In addition, the use of ZIP
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analyses could have possibly not captured the association between missed work days and
glycemic control. However, categorization of the variable missed work days (as opposed
to leaving it as a count variable) did not result in any statistically significant relationship
between it and glycemic control groups either. All of these factors could have led to the
null finding when assessing the relationship between missed work and glycemic control.
We also do not have data on depression for NHANES 1999-2004, yet it may
partially explain the relationship between employment and glycemic control since
depression has been linked with poor glycemic control214 and with unemployment and
disability.227 In addition, reduced performance while at work due to ill health, in other
words presenteeism, was not measured although it can be an additional indicator of the
negative effects of poor glycemic control.
Furthermore, the NHANES utilized a generic instrument to measure quality of life
that was used instead of a disease specific one, which can result in reduced sensitivity.81
Although CDC’s measure for HRQOL is a generic measure, therefore having the benefits
of being able to be compared to findings from people living with other conditions,77, 79 it
might not be the most appropriate measure for diabetics. HRQOL scales that are more
“illness-oriented” for diabetics include the Diabetes Quality of life Measure, the Diabetes
Treatment Satisfaction Questionnaire, and the Problem Areas in Diabetes
Questionnaire.77, 79 These measures are better in that they can assess the impact of
activities or experiences specific to diabetics, such as issues related to using
pharmacological medication and diet.79
Another limitation is that mortality risk is only based on a 6-12 year follow up
since NHANES III data was collected from 1988 to 1994 but the mortality linkage data
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are up to 2000. However the psychological and physiologic effects of poor glycemic
control may take longer to be manifested. There may also be some degree of
misclassification of cause of death.265 For example, a study comparing death certificates
for coding of coronary heart disease as the underlying cause of death with cause of death
judged by a panel of physicians showed that these death certificates have a sensitivity of
83.8%, with a 24.3% overrepresentation of coronary heart disease deaths.265
Furthermore, level of glycemic control was only assessed at baseline in NHANES III and
therefore level of glycemic control at time of death is not known, leading to potential
misclassification. Finally, the small sample size of farm workers likely resulted in loss of
precision of the estimates; this was evident in the widening of the confidence intervals as
covariates were added in the regression models.
Despite these limitations, the present study has many strengths. The strengths of
the present study included the use of data from a nationally representative sample of
adults with type 2 diabetes, the availability of several potential confounders, the
availability of a 6 to 12 year mortality follow-up of a nationally representative sample of
adult with diabetes, the first known study to address the association between health
related quality of life, workforce participation and glycemic control while adjusting for
potential confounders, and the first study to assess the relationship between glycemic
control and weight desirability, secondhand smoke, and work hours and type of
occupation among US adults with diabetes.
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CHAPTER VI.
CONCLUSION
The aims of the present study were to assess the relationship between four
potentially new risk factors (number of hours worked per week, type of occupation,
secondhand smoke exposure, and desire to lose weight) and suboptimal, borderline, and
poor glycemic control using nationally representative secondary data (NHANES III and
1999-2004). We also investigated the consequences of suboptimal, borderline, and poor
glycemic control in terms of HRQOL, employment status, absenteeism, and mortality.
Our findings suggest that the number of hours of work and possibly the type of
occupation an adult with diabetes has does affect their level of glycemic control.
However, whether the adult with diabetes is exposed to secondhand smoke or whether he
or she wishes to lose weight may not have a significant bearing on their degree of
glycemic control and further studies are needed to define these relationships accurately.
In addition, we found that poor mental health to be among those with poor glycemic
control yet better for those with suboptimal glycemic control. Furthermore, individuals
with poor glycemic control may be more likely to have greater days of inactivity.
Interestingly, although greater number of days of poor mental health and inactivity were
reported among those with poor glycemic control, there was no statistically significant
relationship between employment status and missed work days and glycemic control.
Thus, our data suggest that individuals with poor glycemic control are attending work yet
probably are not performing at their optimal level; in other words, there may be greater
preseenteism among adults with poor glycemic control. Finally, our findings imply that
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their may be a linear relationship between HbA1c levels and mortality risk among males.
In addition, strict glycemic control appears to be protective of mortality after a 6 to 12
year follow-up among adults with diabetes, even after controlling for potential
confounders including comorbidity, which contradicts recent reports.242 These main
findings from this study summarized in figure 2 (shown below).

Figure 2. A diagrammatic view of main study findings
Research Question 1:

Research Questions 2 and 3:

Being a farm worker

More days of poor
physical health
More days of
inactivity and
poor mental

Being a service
or blue collar
worker (NS)

Working more
hours

Suboptimal/
Borderline/Poor
Glycemic Control

More missed work
days (NS)
Unemployment
(NS)

Secondhand Smoke
Exposure (NS)

All-cause mortality
prevented if strict
glycemic control

Desire to lose
weight (NS)

Note: NS=non-significant; statistically significant findings appear in bold.

127

Figure 3. A diagrammatic view of key recommendations for good glycemic control
Employer:
o Provide workplace
accommodations
such as greater
breaks and flexible
schedules.
o Provide workplace
social support.
o Gain
understanding of
true work
performance
issues of diabetics.

Patient:
o Communicate to
both employer and
healthcare
provider about
barriers related to
work environment.
o Gain awareness of
rights as employee
and consequences
of poor glycemic
control in terms of
QOL.

Good
glycemic
control

Healthcare provider:
o Learn about the risk of poor
metal health due to poor
glycemic control; provide
referral to mental health
services if needed
o Discuss with patient reasons
for lack of adherence if that is
the reason for poor glycemic
control.
o Educate the patient on how to
manage diabetes at the
workplace, discussing several
medication options.
o Discuss with patient about the
potential protective effects of
strict glycemic control on
mortality risk.

Public health professionals and researchers:
o Develop, implement, and evaluate workplace policies
and prevention programs.
o Continue research to understand determinants of poor
glycemic control as well as it consequences
o Disseminate research findings related to the known and
novel risk factors of poor glycemic control.
o Educate employees on their roles in glycemic control.
o Provide employees information on potential workplace
accommodations.
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There are several implications and recommendations for employers, adults with
diabetes and their primary healthcare providers, and public health advocates,
professionals and researchers from our study findings. The key recommendations are
presented in figure 3.

Employers
Given that work related factors appear to affect glycemic control, it is important
to raise awareness among employers regarding issues that their employees with diabetes
may have in terms of managing their diabetes. Employers should understand the benefits
of having certain minor yet important workplace accommodations for their employees
with diabetes. Such workplace accommodations, and as recommended by the American
Diabetes Association,266 may include healthier food choices at work, private places to
check blood sugars or self-administer insulin, greater or more frequent breaks, more
flexible work-schedules including the option to take time off to be able to visit their
diabetes educator or health care provider, and even provision of diabetes educational
materials and/or educational items or prevention programs on good overall health
practices such as exercise and diet.267
Provision of workplace accommodations may be contingent on the workers with
diabetes telling their employer of their illness. However, because of fear of work
discrimination, the individual with diabetes may choose not to disclose their illness to the
employer, even though such disclosure could result in employer support and workplace
accommodations.268, 269 In fact, compared to individuals with other chronic conditions,
individuals with diabetes may be particularly less likely to disclose their medical status
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for various reasons such as loss of job, rejection by co-workers and employer, and
discrimination.268 The employer may discriminate against an employee with diabetes due
to the false perception that the employee cannot carry on a normal workload, may have
reduced performance due to ill health, may have episodes of hypoglycemia or
hyperglycemia that may lead to hazardous workplace situations, or the belief that these
employees with diabetes may require costly special workplace accommodations.
However, these reasons for discrimination are perhaps without merit. For example,
studies have shown that individuals with diabetes perform well or even better in the job
compared to individuals without diabetes.224, 270 In addition, hypoglycemic events during
work are unlikely262, 271and if they do occur, they typically do not result in any significant
disruptions at work,272 and are particularly less common among adults with type 2
diabetes.208, 273 Thus, the notion that diabetes is an impediment in the workplace has to be
rethought. However, as suggested from our findings, it may be that poor glycemic
control, not necessarily diagnosis of diabetes, may results in poor work performance and
productivity, given the reported greater days of inactivity. This further highlight’s the
importance of workplace policies and programs aimed at supporting effective diabetes
management.
Furthermore, the importance of social support in the workplace needs to be
underscored, since social support, especially among Hispanics, has resulted in
improvements in diabetes management behavior.177, 179 In addition, social support
provided by promotoras (i.e. community health workers) for farm workers has also been
associated with reduced HbA1c levels as well as greater participation in diabetes support
groups.171
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According to the American Diabetes Association, good diabetes control costs
approximately $24 a month, a much lower expense than the $115 a month it would cost
the employer in medical expenditures and loss in productivity to have diabetic workers in
poor health, including those experiencing diabetic complications.274 Thus, it may be costeffective for employers to understand the important role they in the diabetes management
of their employees diagnosed with diabetes. From an economic point of view that
stipulates that individual earnings are a result of the individual’s level of productivity,275
inadequate diabetes management may result in lower income, which could further hinder
the ability of the diabetic patient to purchase pharmacological agents or meals essential
for proper diabetes management.

Individuals with diabetes and their healthcare providers
Given that long work hours or inflexible schedules are sometimes inevitable,
certain accommodations should be considered for individuals with type 2 diabetes to
make sure their blood glucose levels are normalized as much as possible. These
accommodations may involve taking medications that have various duration of action or
extended release properties based on work schedule. This may require keeping logs of the
different work schedules and when each meal would be eaten, especially for workers with
changing schedules.276, 277 For insulin-taking individuals with inflexible work schedules,
awareness of the implications of such work schedule is important so that when speaking
with their health care provider, the employee may be able to ask the physician about this
concern and what actions should be taken to mitigate such consequences; this may
include switching to different diabetes medication options and dosing regimens.278
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Moreover, because some patients may be fearful of hypoglycemic episodes,
which may lead to lack of adherence to treatment regimens,208, 272 patient education and
strategies to prevent hypoglycemia is imperative. For example, the integration of coping
strategies in order to provide the diabetic patient with a “sense of control” may be of
great benefit in diabetes management programs.208 Furthermore, it may be beneficial to
have diabetes self-management programs, particularly among those that are fearful of
hypoglycemia as a consequence of strict diabetes regimens, as these programs have been
shown to reduce the risk of hypoglycemia.279
In addition, health care provider or diabetes educators should take into account
barriers to healthy food choices for an individual with diabetes, particularly barriers due
to work factors such as break times, work hours, and food availability and/or place to
store/prepare foods.280 Given that eating in a scheduled pattern or timely manner may not
be feasible in certain occupations no matter how planned it is, it may be imperative to
provide more tailored diabetes education. For example, one approach may be to educate
how to adjust insulin based on the carbohydrate intake rather than carbohydrate intake
based on insulin administration. A study among the Australian population showed that
tailored eating program can result in benefits such as reduced HbA1c levels, minimal
hypoglycemic episodes, and improved quality of life.281
Diabetes management has been associated with a degree of burden and
consequently perceived worse quality of life282 and techniques such as cognitive
behavioral therapy, coping skills training, counseling, and patient empowerment
programs have been found to be successful among individuals with diabetes.283-285 Thus,
the use of these techniques in diabetes management programs is recommended. These
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strategies may help off-set the feelings of emotional distress among adults with diabetes
and consequent risk of poor adherence and poor glycemic control.286 However, since it
has been suggested that primary health care providers may not know how to properly
counsel a diabetic patient with poor mental health,286 referrals to professionals in the
psychology or mental health field is recommended.

Public health advocates and professionals
Given the association between glycemic control and work-related factors and the
fact that much of a person’s time is spent at work, the workplace should be an avenue in
which to educate both employers and employees with diabetes about diabetes
management. Workplace health programs have in fact been shown to be effective at
improving health among employees.287 Furthermore, increasing the prevalence of health
promotion programs in the US is one of the goals of Healthy People 2010.288 However, it
is important that these worksite health promotion programs be available to all workers,
which appears to not be the current situation. For example, one study found that nonprofessional, Black, and less educated workers were less likely to report having received
any sort of health promotion in the worksite.289 In addition, when these worksite health
programs are available, certain workers, such as those workers receiving a higher salary
and white collar workers appear more likely to participate than other workers.290, 291 The
lack of participation in these worksite programs may be in part due to the work schedule
of these individuals.292 Public health professionals should also work to address
discrimination encountered by adults with diabetes that can hinder the proper
management of diabetes.
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To offset such discrimination, awareness of the rights of workers with diabetes
and education of both the employers and employees should be required. This should
entail proper education on the reality of living with diabetes as well as the legal
terminology when speaking about individuals with chronic conditions including what the
term “disability” means.293 When individuals with diabetes argue that they need special
accommodations, assuming these are considered “reasonable”, the employers should
provide them in accordance with the Americans with Disabilities Act (ADA). 267
However, since this act is based on individuals with more clear cut disabilities such as
blindness, diabetes is often times not considered a hindering disability or covered by this
act, and there is lack of clarity of the rights of adults with diabetes.267, 293 Thus, changes
to the ADA, such as clear statements regarding what constitutes a reasonable and
justifiable accommodation for an adult with diabetes should be implemented.267
Furthermore, policies such as insurance reimbursement of nutrition education services or
free nutrition education among adults without insurance may prove to be beneficial since
research has shown that adults with diabetes may not know the importance of nutrition
and have been shown to not be compliant with visiting their dietitian; yet proper nutrition
is key to diabetes management and improved patient prognosis.159

Future research
Further research is needed however to clearly understand the mechanisms
involved in the relationships between work hours, the type of occupation, and glycemic
control. Such studies would benefit from including surveys or questionnaires that ask
about several work related characteristics, such as shift-work, night shift, number of
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breaks, degree of flexibility to take time off from work, and usual tasks at work. In
addition, studies on the relationship between presenteeism and glycemic control are
needed. However this is contingent on the availability and feasibility of reliable
measures of presenteeism.
Moreover, research is needed to understand the mechanisms involved in the
relationship between poor mental health and glycemic control. Finally, prospective and
longitudinal studies assessing the risk of mortality due to various degrees of glycemic
control among a nationally representative sample of adults are needed. These studies
would benefit from recording data on the number of hospitalizations, diabetes
complications, changes in diabetes treatment, and episodes of hypo and hyperglycemia,
as well as repeated measures of HbA1c tests.
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